Mare endometrium : physiological and pathological involvement of hormones and neutrophil extracellular traps by Crisóstomo, Maria Rosa Rebordão Cordeiro Simões
UNIVERSIDADE DE LISBOA 








MARE ENDOMETRIUM- PHYSIOLOGICAL AND PATHOLOGICAL INVOLVEMENT OF 






















Tese especialmente elaborada para obtenção do grau de Doutor em Ciências Veterinárias na 









































UNIVERSIDADE DE LISBOA 





MARE ENDOMETRIUM- PHYSIOLOGICAL AND PATHOLOGICAL INVOLVEMENT OF 









Doutora Graça Maria Leitão Ferreira Dias 
 
 
Tese especialmente elaborada para obtenção do grau de Doutor em Ciências Veterinárias na 





Presidente: Professor Doutor Rui Manuel Vasconcelos e Horta Caldeira 
Vogais:  
- Professor Doutor Emilio Arsenio Martinez Garcia 
- Professor Doutor António Luís Mittermayer Madureira Rodrigues Rocha 
- Professora Doutora Graça Maria Leitão Ferreira Dias 
- Professora Doutora Graça Maria Alexandre Pires Lopes de Melo  
- Professor Doutora Luísa Maria Freire Leal Mateus  



































































































There are no words to express my thanks to the “Best Supervisor of the world”. To Professor 
Graça Maria Leitão Ferreira-Dias: “Bem Haja”, an expression that manifests gratitude and 
recognition, characteristic of Beira Baixa, a Portuguese region. Throughout the years of 
development of this work it was possible not only to establish scientific connections but also 
create friendly relations with several persons. This national and international cooperation was 
only possible thanks to the scientific, professional, and human qualities of Professor Graça. 
Thank you for giving me the opportunity to be part of such a great team. Thank you for your 
friendship, support and opportunities. This work is a reminder of all the challenging moments 
that we have been through.  
This thesis is the result of the joint work of several people without whom it would not be 
possible to achieve. I would like to address my profound thanks: 
To Professor Dariusz Skarzynski, for having welcomed me with open arms in his laboratory, 
in the Institute of Animal Reproduction and Food Research, of PAS. Thank you for letting us 
use the facilities as if it was ours and making available all the material and staff. Thank you 
for the personal way you received me in Olsztyn and for your friendship. 
To Karolina Lukasik, Anna Szóstek, Katarzyna Piotrowska-Tomala and pani Kasia 
Jankowska special thanks for your technical and human support.  
To Professor Antonio Mollo, for all the personal and technical conditions that allowed the 
accomplishment of the experimental work carried out in Faculty of Veterinary Medicine of 
Padova. 
To Doctor Angela Tramontano, for all the help in Padova and her friendship. 
To Doctor Alexandre Leitão, for being a constant source of encouragement and enthusiasm in 
NETs work and for always being available for technical and scientific discussions whenever 
doubts arose.  
To Professor Graça Alexandre-Pires, for the long hours spent in front of the scanning electron 
microscope (SEM), without which the wonderful SEM images would not exist.  
To Professor Luísa Mateus, for the technical and scientific support, friendship and for the 
“push” towards the end. 
To Professor Luís Tavares and Professor Luís Costa, coordinators of the Center for 
Interdisciplinary Research in Animal Health (CIISA) for the financial support given to present 
some work at scientific meetings. 
To Mrs. Carla Carneiro, for all the microbiological laboratory support. 
To Doctor António Miguel Galvão, for all the laboratory knowledges, fellowship, joy and 
laughter at work. It is a great pleasure to work with you and to be your friend.  
 
 iv 
To Doctor Elisabete Silva, for all the teachings and laboratory help in molecular biology area 
and friendship. 
To Dr. Paula Serrão, for all the assistance in laboratory work and friendship. 
To Dr. Ana Amaral, for all laboratory analysis support.  
To Mrs. Maria do Rosário Luís for her assistance on histology preparations. 
To Cátia Pereira, for our friendship, talks and laughter in our office. Thank you for your help 
in image treatment. 
To Dr. Pedro Pinto-Bravo, for all the moments of field and laboratory work and of scientific 
discussions. Thank you for bringing me into the area of equine reproduction and for the 
various teachings. Nevertheless, I am still waiting for you to pay me the various dinners you 
owe me! 
To Coimbra College of Agriculture (ESAC)/Polytechnic of Coimbra, for all the support given 
to me and allowing me the time to perform the experimental work and to present work at 
scientific meetings. 
To all my colleagues in the Department of Animal Science, for all the support and 
comradeship received and for taking on the workload whenever requested. 
A special thanks to Professor Roberto Costa for suggesting Professor Graça Ferreira-Dias as 
my PhD supervisor. Your support as a friend and for substituting me whenever needed has 
been valuable during this time. 
To Mrs. Conceição Cravo, for her help and assistance in laboratory work, friendship, and 
encouragement. Thank you for being an incredible person with whom we can always count 
on. 
To my family, for their unconditional support and love, and for everything that we have 
missed because work always came in the way. 
I cannot finish without remembering Professor Cristina Vilela, who sadly passed away. 
Always with great enthusiasm, encouraged me, when in our work, we were unable to obtain 













This work was supported by: 
 (i) - Fundação para a Ciência e Tecnologia (FCT), Portugal:  
 
  - PTDC/CVT/121805/2010; Coordinator: Prof. Graça Ferreira-Dias 
  - PTDC/CVT-REP/4202/2014; Coordinator: Prof. Graça Ferreira-Dias 
- Joint Projects under the Agreement on Scientific Cooperation between 
Ministry of Sciences and Higher Education of Poland and the Portugal 
Foundation for Science and Technology (FCT), for:  2011-2012; 2013-2014; 
2015-2016; 2017-2018; coordination of Prof. Graça Ferreira-Dias (FMV/UL, 
Portugal) and Prof. Dariusz Skarzynski, Department of Reproductive 
Immunology, Institute of Animal Reproductive and Food Research of PAS, 
Olsztyn, Poland. 
 
(ii) - European project present by Polish Academy of Sciences, Olsztyn, Poland, under 
the European Commission CORDIS, Seventh Framework Program (FP7): 
 
- REFRESH-FP7-264103, (2010-2013); Coordinator: Prof. Mariusz Piskula. 
 
(iii) - National Polish Research Center, Poland:  
 
- NRC 2011/02/A/NZ5/00338; Coordinator: Prof. Dariusz Skarzynski 
 





























































THESIS TITLE: Mare endometrium- physiologic and pathologic involvement of hormones 
and neutrophil extracellular traps 
 
ABSTRACT  
Two reproductive topics in mares were addressed in this thesis. The aims of the studies were 
to evaluate:  (i) the effect of chronic oxytocin administration to mid-luteal phase mares on 
luteal maintenance and its cellular and molecular mechanisms at endometrial level; (ii) the 
capacity of equine neutrophils to produce neutrophil extracellular traps (NETs) in vitro when 
stimulated with bacteria obtained from mares with endometritis, and to determine if NETs 
release also occurred in vivo in mares with endometritis; (iii) the in vitro effects of some 
NETs components on mare endometrial fibrogenic capacity and to determine if they could 
depend on endometrial inflammatory lesions or estrous cycle phases; and (iv) the involvement 
of PGF2α and PGE2 pathways in collagen deposition on mare endometrium, challenged with 
NETs proteases. In the first study, luteal maintenance occurred in 67% of oxytocin treated 
mares, which may be related to oxytocin and progesterone (PGR) receptors spatial expression 
in endometrium. Reduction of endometrial estrogen receptor 2 (ESR2) may be responsible for 
the maintenance of PGR in luminal and glandular epithelium and may attenuate ESR1 
endometrial transcriptional activity. Equine neutrophils were able to release NETs in the 
presence of bacteria that cause mare endometritis, and might be a complementary mechanism 
to fight endometritis. By in vitro studies with NETs proteases, increased collagen type I 
(COL1) production characteristic of fibrosis was observed, although endometrial response to 
each NETs protease depended on estrous cycle and/or endometrial category. Also, NETs 
proteases were linked to fibrogenesis, by increased synthesis of PGF2a and/or PGF2a 
receptor transcripts and impaired PGE2 or PGE2 receptor 2 transcripts associated to increased 
COL1. These effects were influenced by endometrium type and estrous cycle phases. Injury 
induced-changes on PG mediators by NETs components may instigate PGF2α or PGE2 vias, 
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Título da dissertação: Endométrio da égua: envolvimento fisiológico e patológico de 
hormonas e de redes extracelulares de neutrófilos. 
 
Resumo:  
Nesta tese foram abordados dois temas reprodutivos em éguas. Os objectivos destes estudos 
consistiram na avaliação: (i) da administração crónica de ocitocina na manutenção do corpo 
lúteo em éguas na fase lútea média, e os mecanismos celulares e moleculares no endométrio; 
(ii) da capacidade dos neutrófilos equinos para produzirem redes extracelulares de neutrófilos 
(NETs) in vitro e in vivo quando estimulados com bactérias de éguas com endometrite; (iii) 
dos efeitos in vitro de componentes das NETs na fibrogénese do endométrio equino e sua 
associação com lesões inflamatórias no endométrio ou com o ciclo éstrico; e (iv) do 
envolvimento das vias da PGF2α e PGE2 na deposição de colagénio no endométrio da égua, 
incubado com proteases das NETs. No primeiro estudo, o prolongamento da função lútea em 
67% das éguas tratadas com ocitocina, parece estar relacionado com alteração da expressão 
espacial dos receptores de ocitocina e progesterona (PGR) no endométrio. A diminuição do 
receptor 2 dos estrogénios (ESR2) pode ser responsável pela manutenção do PGR no epitélio 
luminal e glandular do endométrio e atenuar a transcrição do ESR1. Os neutrófilos equinos 
libertaram NETs na presença de bactérias causadoras de endometrite podendo ser um 
mecanismo complementar no combate à endometrite. As proteases das NETs in vitro 
aumentaram a produção de colagénio do tipo I (COL1), característico de fibrose, no 
endométrio, embora a resposta a cada protease dependesse do ciclo éstrico e/ou da categoria 
do endométrio. O aumento do COL1 associado ao incremento de PGF2α e/ou da transcrição 
do seu receptor e à diminuição da PGE2 e/ou do seu receptor 2, parecem implicar as 
prostaglandinas e as proteases das NETs na fibrogénese no endométrio equino. Alterações nos 
mediadores das prostaglandinas, induzidas pelos componentes das NETs, podem instigar as 





































































Título da dissertação: Endométrio da égua: envolvimento fisiológico e patológico de 
hormonas e de redes extracelulares de neutrófilos. 
 
Resumo alargado:  
 
Nos cavalos envolvidos em actividades desportivas o comportamento do estro está associado 
a um efeito negativo no desempenho e no treino, devido a uma mudança na atitude da égua, 
que se pode expressar por comportamentos distintos. Dentro dos vários métodos possíveis de 
supressão do estro, a administração exógena de ocitocina, nos dias 7 a 14 do ciclo éstrico, 
demonstrou ser um método eficaz de supressão de estro a longo prazo em éguas de desporto.  
A endometrose, que consiste no processo degenerativo crónico do endométrio, tem sido uma 
grande preocupação no campo reprodutivo da égua levando à morte embrionária precoce. 
Parece existir uma relação entre o grau de fibrose do endométrio e a taxa de fecundidade. 
Embora seja um dos principais temas de investigação na área reprodutiva da égua, a etiologia 
e os mecanismos que levam à fibrose do endométrio continuam por elucidar. Na égua, a 
endometrite persistente devido à presença de bactérias ou sémen no útero induz um estado 
inflamatório caracterizado por um influxo de neutrófilos para o lúmen uterino. Esta situação 
quando continuada, pode originar o desenvolvimento de uma inflamação crónica, com a 
activação de células fibróticas e alterações degenerativas crónicas no endométrio, 
relacionadas com a formação de fibrose. No entanto, a associação entre o desenvolvimento da 
endometrose e a inflamação crónica do endométrio continua a ser um tópico controverso. 
Estes dois temas atrás mencionados, relativos à reprodução em éguas, foram o foco principal 
deste trabalho. No primeiro estudo avaliou-se o efeito da administração crónica de ocitocina 
exógena na manutenção da função lútea em éguas. Foi igualmente estudada a expressão no 
endométrio equino das sintases da prostaglandina endoperoxidase 2 (PTGS2), F2a, E2 e I2 
(PTGFS e PTGES) e dos receptores de ocitocina (OXTR), progesterona (PGR) e estradiol 
(ESR1 e ESR2). No ensaio in vivo, foi administrada ocitocina a éguas entre os dias 7 e 14 do 
ciclo éstrico. Como se pretendeu comparar as condições do endométrio da fase lútea média 
antes da luteólise com as condições após a supressão da luteólise induzida pela administração 
de OXT, os estudos de expressão no endométrio foram realizados em biopsias obtidas no dia 
10 pós-ovulação nas éguas controlo e no dia 24 em éguas com função lútea persistente. A 
administração de OXT às éguas na fase lútea média foi eficaz no bloqueio da luteólise e 
prolongou a fase lútea em 67% (4/6) das éguas tratadas com OXT. A função lútea prolongada 
associada ao tratamento crónico com OXT parece estar relacionada com um aumento e com 
uma diferente expressão espacial dos OXTR e PGR no endométrio. Nas éguas tratadas com 
OXT, foi detectado um aumento da expressão dos OXTR nas células do estroma do 
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endométrio. Uma vez que durante os eventos fisiológicos que ocorrem na fase lútea tardia do 
ciclo éstrico é necessário um aumento da expressão dos OXTR no epitélio superficial do 
endométrio para desencadear a luteólise, a administração crónica de OXT parece desviar a 
expressão dos OXTR do epitélio do lúmen uterino para o estroma, levando deste modo à 
manutenção da função lútea. Além disso, a diminuição da expressão dos ESR2 observada nas 
éguas tratadas com OXT pode ser responsável pela manutenção dos PGR no epitélio 
superficial e glandular do endométrio.  
O segundo estudo, teve como objectivo avaliar a capacidade dos neutrófilos equinos para 
produzir NETs não só in vitro após estimulação com estirpes Streptococcus equi spp 
zooepidemicus, Escherichia coli ou Staphylococcus capitis obtidas de endometrite das éguas, 
mas também in vivo nas secreções do endométrio de éguas com endometrite bacteriana. Neste 
estudo, conseguimos mostrar que os PMN equinos estimulados são capazes de libertar NETs 
na presença de bactérias Gram-positivas e Gram-negativas específicas que causam infecção 
uterina na égua. Além disso, este estudo mostrou que as bactérias que causavam endometrite 
na égua estavam presas nas NETs mostrando existir um contacto directo entre as NETs e as 
bactérias. Além disso, a expressão de histonas, mieloperoxidase e elastase nas NETs in vivo, 
sugere que as NETs possam ter um efeito antimicrobiano, actuando como um possível 
mecanismo complementar pelo qual as éguas são capazes de resistir à endometrite. 
Na terceira parte deste trabalho, postulámos que a persistência dos componentes das NETs 
pode desencadear um efeito nocivo no endométrio, levando à deposição de colagénio e ao 
desenvolvimento de fibrose na égua. Através de estudos in vitro em que explantes dos 
endométrios foram incubados com diferentes doses de proteases das NETs (elastase, 
mieloperoxidase e catepsina), abordámos a persistência de NETs como potenciais mediadores 
de fibrose no endométrio em éguas susceptíveis à endometrite. A influência da fase do ciclo 
éstrico, bem como a ausência ou a presença de alterações patológicas no endométrio foram 
também avaliadas. Neste estudo, observou-se no endométrio um aumento da produção de 
COL1, característico de fibrose, quando na presença de todas as proteínas das NETs 
estudadas, embora a resposta do endométrio a cada protease específica dependesse da fase do 
ciclo éstrico e/ou da categoria do endométrio. No entanto, a elastase aumentou a produção de 
COL1 em todas as categorias de endométrios, independentemente da fase do ciclo éstrico. 
Além disso, todas as proteases das NETs estudadas induziram um aumento da produção de 
COL1 nos endométrios obtidos na fase folicular, independentemente da presença de 
alterações patológicas. Assim, a fase folicular parece ser a fase do ciclo éstrico em que a égua 
apresenta maior risco de desenvolver essa patologia. 
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Nas duas últimas partes deste trabalho, foi abordado um dos múltiplos possíveis mecanismos 
envolvidos na patogénese extremamente complexa da fibrose do endométrio da égua. 
Também fazendo uso de estudos in vitro com as proteases das NETs, as vias de 
prostaglandinas foram consideradas como potenciais mediadores do desenvolvimento de 
fibrose do endométrio devido à persistência das NETs. No nosso estudo, o aumento da síntese 
de PGF2α após 24h de incubação de endométrio equino com elastase ou catepsina só foi 
detectado em endométrios obtidos na fase folicular e sem alterações anatomopatológicas ou 
com ligeiras lesões patológicas e associado a um aumento da produção do COL1. No entanto, 
o aumento da produção de COL1 e da transcrição do gene do receptor da PGF2α (FP) foram 
observados em todas as categorias de endométrios obtidos na fase folicular, após o tratamento 
com catepsina. Também foi notado um aumento dos níveis de transcrição dos FP em 
endométrios com lesões moderadas a intensas, obtidos na fase lútea média. Ambas as 
circunstâncias podem estimular o desenvolvimento de fibrose no endométrio da égua, uma 
vez que na espécie humana, os aumentos da síntese de PGF2α actuando no seu próprio 
receptor (FP) estão relacionados com a formação de fibrose em vários sistemas orgânicos. 
A PGE2, ao sinalizar através dos seus receptores 2 (EP2) e 4 (EP4), é considerada um 
mediador anti-fibrótico. Ao diminuírem os níveis de PGE2 ou do EP2 nos tecidos, a PGE2 
deixa de poder exercer as suas funções anti-fibróticas. Os nossos resultados sugerem que no 
endométrio da égua, o EP2 possa ser responsável pelos possíveis efeitos anti-fibróticos da 
PGE2. No presente estudo, foi observada uma diminuição da síntese de PGE2 no endométrio 
de éguas com lesões moderadas a intensas, independentemente da fase do ciclo éstrico. Uma 
vez que o aumento da produção de COL1 e a diminuição dos transcritos de EP2 só foram 
observados em endométrios obtidos na fase folicular após incubação com elastase, sugere que 
a diminuição do EP2 possa estar envolvida no mecanismo de fibrogénese neste tipo de 
endométrio. Assim, em condições fisiológicas, os endométrios na fase folicular parecem ser 
mais propensos a desenvolver fibrose na presença de um estímulo pró-fibrótico, devido a uma 
menor capacidade para sintetizar o mediador anti-fibrótico EP2. Além disso, em endométrios 
saudáveis ou com ligeiras alterações patológicas obtidos na fase lútea média, a via da PGE2 
pode desempenhar um papel chave no desencadeamento de fibrose, devido a uma supressão 
da acção anti-fibrótica da PGE2. O aumento da produção de COL1 induzido pela elastase e 
catepsina nestes tipos de endométrios estava associado com uma diminuição da síntese de 
PGE2 ao longo do período experimental, sem alterações nos outros mediadores da via de 
PGE2 estudados e ligado a baixos níveis de expressão do gene FP. Portanto, os nossos 
resultados sugerem que alterações nos mediadores das prostaglandinas, induzidas pelos 
componentes das NETs, podem fomentar as vias da PGF2a ou da PGE2, como mecanismos 
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adicionais de fibrose do endométrio da égua. No entanto, embora os nossos dados in vitro 
sugiram o envolvimento das NETs no desenvolvimento da endometrite crónica na égua, 
podendo actuar como possíveis mediadores de fibrose do endométrio, são necessários mais 
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In equine sports avoiding estrus behavior is a major concern, since it is associated with a 
negative effect in the performance or training of horses, due to a change in mare attitude, 
which can be expressed by distinct behaviors (Vanderwall, 2013). In the reproductive 
management of mares to control estrus behavior, it is important to take into consideration the 
effects of those practices on mare reproductive efficiency not only during their athletic careers 
but also on their future reproductive function. Different methods have been used to suppress 
estrus in the mare. Between them, exogenous administration of oxytocin (OXT) has been 
proved to be an effective and reproductively-safe long-term method of suppressing estrus in 
performance mares (Vanderwall et al., 2016). This hormone has dual effects depending on the 
endometrial endocrine environmental and when used exogenously can act in a dissimilar way 
and alter reproductive physiological events (Rebordão et al., 2016). Although OXT is 
essential to trigger luteolysis during the physiological events that occur in the late luteal phase 
of mare estrous cycle, it also acts as anti-luteolytic agent, inducing luteal maintenance when it 
is exogenously administrated from day 7 to 14 of the estrous cycle (Vanderwall et al., 2016; 
Rebordão et al., 2017a).  
Mare endometrosis has been a major concern in mare reproductive field leading to early 
embryonic death and a direct link between the degree of fibrosis and the foaling rate has been 
proposed (Kenney & Doig, 1986). This source of subfertility/infertility is responsible for 
major economic losses in horse industry, since performance mares are used in sport activities 
until an old age when endometrial fibrosis is frequently present.  In the mare, persistent 
endometritis due to different insults like microorganisms or semen involves the influx of large 
numbers of polymorphonuclear neutrophils (PMN) and other proteins into the uterine lumen, 
which may lead to chronic inflammation with activated fibrotic stromal cells and chronic 
degenerative changes of mare endometrium and related with fibrosis formation (LeBlanc & 
Causey, 2009; Hoffmann et al., 2009; Cadario, 2014). PMN are able to release neutrophil 
extracellular traps (NETs) when stimulated by different stimuli, like bacteria and semen 
(Brinkmann et al., 2004; Alghamdi & Foster, 2005). Although nucleic and cytoplasmic 
proteins and DNA associated proteins of NETs possess strong antimicrobial properties their 
persistence may cause disease themselves (Brinkmann & Zychlinsky, 2012).  
These two issues regarding reproduction in mares were the main focus of this work. In the 
first part of this study, we investigate cellular and molecular mechanisms behind the 
exogenous use of oxytocin to alter the normal physiological luteolysis and prolong luteal 
function. In the second part, we prove that equine PMN are able to release NETs in the 
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presence of bacteria that cause mare endometritis, not only in vitro, but also in vivo, 
demonstrating a possible complementary mechanism by which mares can resist endometritis. 
In the third part, by in vitro studies with NETs proteases, we address persistence of NETs as 
potential mediators of mare endometrial fibrosis in mares susceptible to endometritis. The 
influence of estrous cycle phase and healthy or pathological conditions of endometrial tissues 
are also studied. In the last part of this work, also making use of in vitro studies with NETs 
proteases, we attempt to unravel prostaglandins pathways as putative mediators that trigger 
the development of endometrial fibrosis due to the presence of NETs persistence.  By 
understanding the mechanisms involved in luteostasis and in endometrial fibrosis 
development in the mare, this work will contribute not only for advancing scientific 
knowledge but also to improve reproductive efficiency in horses and to reduce economic 
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2. Objectives  
 
The major objectives of this work were: 
 
1)- To investigate the effect of chronic oxytocin administration to mares in mid-luteal phase 
to prolong luteal function and if that effect may be achieved by modulation of PG pathways, 
steroid hormones and OXT receptors in the endometrium.  
The developed work was published: Rebordão, M.R., Galvão, A., Pinto-Bravo, P., Pinheiro, 
J., Gamboa, S., Silva, E., Mateus, L. &  Ferreira-Dias, G. (2017a). Expression of 
prostaglandin synthases, ovarian steroids and oxytocin receptors in equine endometrium 
during luteal maintenance induced by chronic administration of oxytocin. Theriogenology, 87, 
193–204. 
 
2)- To evaluate the in vitro capacity of equine PMN to secrete NETs by chemical activation, 
or when stimulated with bacteria strains obtained from mares with endometritis, and to 
determine if NETs release also occurred in vivo in the endometrium of mares with bacterial 
endometritis.  
The developed work was published: Rebordão, M.R., Carneiro, C., Alexandre-Pires, G., 
Brito, P., Pereira, C., Nunes, T., Leitão, A., Vilela, C. & Ferreira-Dias, G. (2014). Neutrophil 
extracellular traps formation by bacteria causing endometritis in the mare. J Reprod Immunol, 
106, 41-49. 
 
3) To assess the in vitro effect of some NETs proteases on mare endometrial fibrogenic 
capacity and determine if that effect could depend on endometrial inflammatory lesions or 
estrous cycle phase.  
The developed work was submitted for publication: Rebordão, M.R., Amaral, A., Lukasik, K., 
Szóstek-Mioduchowska, A., Pinto-Bravo, P., Galvão, A., Skarzynski, D.J. & Ferreira-Dias, G. 
(2018). Constituents of neutrophil extracellular traps induce in vitro collagen formation in 
mare endometrium.  Theriogenology (THE 14442; in press).  
 
4) To investigate the role of PGF2α pathway on the potential ability of NETs components to 
induce endometrial fibrosis and if that effect could be influenced by endometrial 
inflammatory/fibrotic lesions or estrous cycle phase.  
The developed work will be submitted for publication: Rebordão, M.R., Amaral, A., Lukasik, 
K., Szóstek-Mioduchowska, A., Pinto-Bravo, P., Galvão, A., Skarzynski, D.J. & Ferreira-Dias, 
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G. (2017). Neutrophil extracellular traps proteases stimulate fibrogenic PGF2α pathway in 
mare endometrium. Submitted to Journal of Immunology Research (manuscript 4806546). 
 
5) To evaluate the involvement of PGE2 pathway in collagen deposition on mare 
endometrium, challenged with NETs proteases and if that effect could change with 
endometrial inflammatory/fibrotic lesions or with estrous cycle phase.  
The developed work will be submitted for publication: Rebordão, M.R., Amaral, A., Lukasik, 
K., Szóstek-Mioduchowska, A., Pinto-Bravo, P., Galvão, A., Skarzynski, D.J. & Ferreira-Dias, 
G. (2017). Impairment of anti-fibrotic PGE2 pathway might influence neutrophil extracellular 
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1. Endocrine physiological events in mare endometrium 
 
The equine estrous cycle is defined as the repetitive sequence of events that prepare the mare 
for conception, lasting on average 21 days. The mare estrous cycle can be divided in four 
stages according to the changes in steroid hormones concentration and endometrial structural 
and functional events: follicular phase (estrous/ovulatory phase; day 16-17 to 21, the latter 
usually being called day 0), early luteal phase (day 1 to 4), mid luteal phase (around day 8) 
and late luteal phase (day 12 to 15) (Aurich, 2011).  
Estrus is the period during which the mare is sexually receptive to the stallion, the ovulatory 
(dominant) follicle(s) develop and ovulation occurs. During follicular phase, estrogens (E2) 
produced in the ovarian follicles are the main steroids that dictate the different physiological 
events that occur in the female body, specifically in the uterus. Under the influence of E2 
during estrus, the uterine wall thickens, muscular tone increases and vascularity becomes 
greater. The cervix is relaxed and open (Aurich, 2011). Histologic observation of the mare 
endometrium in this stage depicts that endometrial glands proliferate and become active and 
the lamina propria is highly edematous. This E2-induced edema leads to reduced gland 
density and a loosely woven appearance of the stroma (Kenney, 1978). Neutrophils (PMN) 
can be seen to marginate venules and capillaries, but they do not migrate through the stroma. 
Therefore, the presence of neutrophils (PMN) in the stroma is indicative of inflammation 
(Kenney, 1978). At a molecular level, E2 stimulates or upregulates its own receptors (ESR), 
as well as the progesterone (P4) receptors (PGR) in mare’s endometria (Hartt et al., 2005). 
Estrogen receptors (ESR) consists of two predominant isoforms of nuclear receptors, ESR1 
and ESR2. ESR1 appears to be the dominant mediator of uterine reproductive functions. 
Some studies in other species than the mare indicate that ESR2 may function to attenuate the 
transcriptional activity of ESR1 in the uterus (Large & DeMayo, 2012). In the mare, during 
estrus, high endometrial levels of ESR1, ESR2 and PGR mRNA and proteins are detected in 
luminal (LE) and glandular epithelia (GE), and stromal cells (Watson et al., 1992; Hartt et al., 
2005; Honnens et al., 2011; Gebhardt et al., 2012; Silva et al., 2014). Moreover, relative 
mRNA expression of ESR1 and ESR2 seems to be positively correlated in mare endometrium 
(Honnens et al., 2011). In mare endometrium OXT receptors (OXTR) are low at estrus (Sharp 
et al., 1997; Ruijter-Villani et al., 2014).  
Diestrus is the period during which the mare is not receptive to the stallion and the genital 
tract prepares for the reception and nurturing of the conceptus. During diestrus, the ruptured 
ovulatory follicle develops into a corpus luteum (CL) that secretes P4 and, in the non-
pregnant mare, it regresses 14-15 days after ovulation. During the luteal phase, P4 becomes 
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the main steroid hormone influencing uterine environment. During this stage, the influence of 
P4 leads to a decrease in uterine wall thickness, myometrial tone and endometrial gland 
activity. The cervix becomes firmer and is tightly closed (Aurich, 2011). Histologically, 
during diestrus, gland density increases due to decreased stromal edema and the increased 
tortuosity of glands (Kenney, 1978). Organelles increase in number and size in stromal and 
glandular epithelial cells, indicating active protein synthesis during this stage of the cycle 
(Ferreira-Dias et al. 1999). At a molecular level, when circulating P4 levels are high, 
endometrial expression of ESR and PGR are inhibited. Concentration of E2 and P4 receptor 
proteins decreases by mid to late diestrus in mare endometrium (Watson et al., 1992). 
Likewise, abundance of ESR1 and PGR mRNA decreases from days 0 to 11 of estrous cycle 
and increases by late diestrus (McDowell et al., 1999; Honnes et al., 2011; Gebhardt et al., 
2012; Silva et al., 2014). In pregnancy, gene transcription for both types of receptors 
decreases with increasing days of gestation and sustained P4 concentration (Watson et al., 
1992; McDowell et al., 1999). In the presence of P4, a negative-feedback loop down-
regulates the expression of PGR. On day 11 and 14 of mare estrous cycle, ESR and PGR 
expression decreased in stroma and in deeper glandular epithelia and they were not detected 
in luminal epithelium (Hartt et al., 2005). On days 14 to 16 of mare estrous cycle luteolysis 
occurs (Ginther et al., 2011). Then, oxytocin exerts a variety of physiological processes 
including luteal function regulation. Oxytocin is stored in vesicles in the neurohypophysis and 
released into the peripheral blood circulation in high frequency bursts in late diestrus 
(Vanderwall et al., 1998). This hormone is also synthesized and secreted by mare endometrial 
cells into the uterine lumen where it acts in an autocrine/paracrine fashion to control uterine 
contractility, and luteolysis (Watson et al., 2000). In late diestrus, OXT gene expression 
increases in the equine endometrium (Behrendt-Adam et al., 1999). In the ewe, during late 
diestrus (day 12–13 of estrous cycle), E2 interacts with P4 primed uterus and increased 
expression of ESR1, stimulates transcription of OXTR gene and increases the concentration 
of this receptors in the endometrium (Fleming et al., 2006). Although follicles and estradiol 
are apparently not required for luteolysis in mares (Ginther et al., 2005), in all other 
mammals, E2 is considered a key regulator of OXTR gene expression (Kimura et al., 2003). 
Besides, in the mare estradiol-17β begins to increase in the circulation approximately 2 days 
before the beginning of luteolysis and the start of growth rates deviation between the future 
dominant versus subordinate follicles of the ovulatory follicular wave (Ginther et al., 2005). 
Oxytocin receptor activation stimulates the mitogen activated protein kinase (MAPK), which 
regulates prostaglandin-endoperoxide synthase (PTGS) enzymes gene expression (Soloff et 
al., 2000). These enzymes convert arachidonic acid to prostaglandin H2 which can be 
 
     11 
State of the art 
converted to PGF2a by aldo-keto reductase family 1 member C3 (AKR1C3) in the uterus. At 
Day 15 in equine cycling endometrium raises in both mRNA and protein levels of PTGS2 in 
luminal epithelium were detected (Boerboom et al., 2004; Atli et al., 2010). In late luteal 
phase (days 14-15), cyclic mare endometrial OXTR concentration increases and mediates 
prostaglandin release (Ruijter-Villani et al., 2014). Oxytocin binding to OXTR stimulates the 
concentration and amplitude of PGF2a peaks from the endometrium, which are necessary for 
luteolysis (Sharp et al., 1997; Starbuck et al., 1998). In response to luteolytic pulses of PGF2a 
over a 23-h period, the CL undergoes functional and structural regression and P4 
progressively decreases to < 1ng/mL (Ginther et al., 2011).  Between days 17 to 20 of cyclic 
mares, ESR and PGR transcripts and proteins increased and were present in luminal 
epithelium, glandular epithelium and in stroma cells of the endometrium (Hartt et al., 2005). 
Nevertheless, during early pregnancy, ESR and PGR were not detected in the luminal 
epithelium, and were lower in the stroma and deeper glandular epithelium (Hartt et al., 2005). 
So, the development of the endometrial luteolytic mechanism and uterine release of luteolytic 
pulses of PGF2a occur in the presence of high circulating levels of P4. As suggested for the 
ewe (Fleming et al., 2006), in the mare, the lack of response to luteolytic mechanisms during 
luteostasis periods (days 7-14 of estrous cycle and in early pregnancy) may be due to the 
absence of ESR and PGR in luminal epithelium.  
The deep knowledge of cellular and molecular mechanisms, including the cross-talk between 
different cells, hormones and receptors that control the estrous cycle, allows its manipulation 
and is the basis of several reproductive techniques namely of several methods of estrus 
suppression. An example is given by the dual and antagonist role that oxytocin may have in 
the mare reproduction. Endogenous or exogenous oxytocin has a pro-luteolytic effect between 
days 10 and 15 after ovulation, while its acts as an anti-luteolytic factor during mid-luteal 
phase (Rebordão et al., 2016; Vanderwall et al., 2016). 
 
 
2. Estrus behavior suppression 
 
Veterinary practitioners are often requested by horse mare owners to suppress estrus behavior 
during sports activities and other events, since undesirable and/or inconstant behavior in 
mares in estrus can interfere with and decrease their performance. Although several methods 
can be used to suppress estrus behavior, they should not affect athletic performance of the 
mare, and they should have no effect on the mare´s reproductive efficiency during and 
subsequently to their athletic careers (Nath, 2014). Artificial extension of the luteal phase by 
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luteolysis inhibition and subsequent suppression of heat signs in the mare can be achieved by 
non-pharmacological or pharmacological methods.  
Manual reduction of the conceptus and insertion of intrauterine devices are non-
pharmacological methods used to suppress estrus behavior in mares. Embryo manual crushing 
on day 16–22 post-ovulation, is a method that allows the maintenance of the CL, despite 
embryo loss, and suppresses estrus behavior for at least 60 days (Lefranc & Allen, 2004). 
Considerable investment in first establishing a pregnancy and ethical issues are constraints 
that limit its use (Vanderwall, 2013; Nath, 2014).  
Insertion of intrauterine devices (IUD) like glass balls or water-filled plastic balls is the most 
common method used for preventing estrus signs in the mare that does not require 
administration of exogenous hormones, and allows continued secretion of endogenous P4 to 
keep mares out of heat (Nie et al., 2003; Rivera del Alamo et al., 2008). Prolonged CL 
function was achieved in 39% of the mares that retained the glass balls inside the uterus and 
the duration of estrus suppression was approximately 90 days (Nie et al., 2003).  Likewise, 
after intrauterine placement of a water-filled plastic ball, 75% of the mares had an extended 
luteal function with an average duration of 57 days (Rivera del Alamo et al., 2008). The 
efficacy of IUD seems to be dependent on the mares´ age. Intrauterine device-treated mares 
with extended luteal function were younger than those without CL prolongation (Katila, 
2015). A moderate degree of angiopathy was detected in some of the mares that did not 
respond to IUD with CL prolongation, suggesting that adequate perfusion and drainage of the 
endometrium may be important for the IUDs to function effectively (Katila, 2015). It has been 
suggested that IUD can mimic an embryo by simulating maternal recognition of pregnancy 
(that occurs when a mobile embryo is present in the uterus prior to day 14 post-ovulation), 
suppressing PGF2α and inducing CL maintenance (Rivera del Alamo et al., 2008). There was 
no evidence that IUD induced an inflammatory response in the uterus (Rivera del Alamo et 
al., 2008).  In addition, in the mares that develop prolonged CL function, the IUD prevented 
up-regulation of endometrial gene expression of PTGS2, which is the key regulatory enzyme 
in PGF2a  synthesis/secretion (Rivera del Alamo et al., 2010). While the placement of these 
IUD does not seem to have an adverse effect on fertility (Nie et al., 2003; Rivera del Alamo et 
al., 2008), severe complications can result if they are retained for a prolonged time, like 
fibrosis of cervical canal due to cervical adhesions of fragmented glass ball and pyometra 
(Klabnik-Bradford et al., 2013, Turner et al., 2015).  
Intrauterine infusion of plant oils has also been proposed as a possible reversible method for 
prolonging the luteal phase in mares, but further studies are needed to confirm its efficacy. In 
a previous study, intrauterine infusion of plant oils on day 10 post-ovulation prolonged luteal 
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phase in 92% of the treated mares (Wilsher & Allen, 2011). It was suggested that the fatty 
acid milieus in plant oils might modulate or attenuate the synthesis and/or secretion of PGF2a 
at the expected time of luteolysis, resulting in prolonged function of the CL (Wilsher & Allen, 
2011). Nevertheless, a recent report failed to replicate those results: intrauterine fractionated 
coconut oil administration on day 10 of diestrus lowered P4 levels and shortened rather than 
prolonged the luteal phase of the mares (Diel de Amorim et al., 2016). 
Pharmacological prevention of luteolysis in the mare by maintaining the secretion of P4 from 
the CL may be achieved by the use of exogenous administration of human chorionic 
gonadotropin (hCG), P4, synthetic progestagens or oxytocin. Seventy five percent of the 
mares treated with hCG ovulated within 72 hours after treatment with hCG, which resulted in 
prolonged luteal phase that lasted for 58 to 82 days after treatment (Hedberg et al., 2006). 
However, the use of hCG to induce a late diestrus ovulation does not appear to be a reliable 
method of blocking estrus behavior in mares (Vanderwall, 2013). Exogenous hCG has to be 
administrated to mares in diestrus when a follicle greater than 30 mm is detected in the 
ovaries.  In addition to the need to continually monitor mares to evaluate their suitability for 
treatment, some mares may not develop a diestrus follicle large enough to be eligible for 
treatment (Vanderwall, 2013). 
For the past decades, P4 or progestogen have been used to control estrus behavior. Daily 
administration of altrenogest, a synthetic progestin, has been the most widely used method 
and it is considered to be the ‘gold standard’ for suppressing estrus behavior in mares (Nath, 
2014; Vanderwall et al., 2016). Besides being expensive, the need for oral administration of 
altrenogest every 24h, encompasses safety risks for personnel during handling, and there is a 
risk of development of putative uterine infection in the mare due to maintenance of a closed 
cervix. All of these are limitations for long-term progestin therapy (Vanderwall, 2013; Nath, 
2014; Vanderwall et al., 2016). Additionally, concerns regarding the use of exogenous steroid 
hormones in performance horses and stricter doping regulations, has led to the study of 
alternative methods. 
Administration of exogenous OXT on days 7 to 14 after ovulation is an effective method of 
disrupting luteolysis and prolonging CL function that can be used as a means of suppressing 
estrous behavior in mares (Stout et al., 1999; Vanderwall et al., 2007;  Gee et al., 2012; Keith 
et al., 2013; Vanderwall, 2012). Intramuscular (im) administration of 60 units of oxytocin 
every 12 h prolonged luteal function in 70% to 100 % of the treated mares (Vanderwall et al., 
2007; 2012; Keith et al., 2013). It has been proposed that once-daily im administration of 
60 IU of OXT during this phase of the cycle is as effective as the twice-daily protocol first 
described, inducing prolonged CL in 60% to 70% of treated mares (Vanderwall et al., 2016). 
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To preclude the need to determine the exact day of ovulation before initiating treatment, 
administration of OXT im can be initiated randomly at any point in the estrous cycle with no 
loss in efficacy (i.e., over 70% response) extending the duration of OXT treatment to 29 days 
(Vanderwall et al., 2016).  Although OXT treatment effectively prolonged CL function, a 
weak estrus behavior was occasionally observed in some mares during the period of 
prolonged CL function Vanderwall, 2013). It has been proposed that OXT treatment 
suppresses PGF2 a  secretion by preventing upregulation of endometrial gene expression of 
PTGS2 (Keith et al., 2013). An advantage of using OXT treatment to prolong CL function is 
that it can be readily reversed by the administration of a PGF2a luteolytic dose to initiate 
cyclical reproductive activity. The main disadvantage of the OXT protocol is the daily 
administration of an intra-muscular injection, leading to potential difficulties with its use in 
mares with a needle aversion (Vanderwall et al., 2016). No side effects were reported 
regarding body temperature, heart rate or respiratory rate treatment (Vanderwall, 2013). There 
was no evidence of abdominal cramping and/or transient signs of colic before or after the 
treatment (Vanderwall, 2013). However, mild sweating, urticaria around the injection site, 






Neutrophils (PMN) are the most abundant inflammatory cells produced in the bone marrow 
from myeloid precursors (Kazzaz et al., 2016; Nakazawa et al., 2017). They are involved in 
host defense at the inflamed tissues (reviewed by Kazzaz et al., 2016; reviewed by Nakazawa 
et al., 2017). In healthy humans, PMN are the major leukocytes (40–80%) in peripheral blood 
and the biggest PMN pool in the organs is in the lungs, where they act as sentinels against 
infection (Lacy, 2016). The ability of PMN to rapidly localize the sites of tissue inflammation 
and subsequently capture and destroy the invading pathogens is a hallmark of the highly 
conserved innate immune response (Zinkl & Kabbur 1997; Brinkmann, 2011; Oliveira et al., 
2016). While PMN circulate in the blood stream, they respond to inflammatory stimuli by 
migrating to the sites of inflammation in various tissues (Kazzaz et al., 2016). These 
extremely well-coordinated events rely on the interaction of adhesion molecules on the PMN 
surface with their respective ligands existing on the vascular endothelium (Kazzaz et al., 
2016). In order to cross the endothelial barrier, PMN develop cytoplasmic membrane 
extensions that help these cells to overcome the high shear stress of blood flow (Sundd et al., 
2012). Then, PMN β2 integrins (LFA-1 and Mac-1) firmly adhere to endothelial cell 
 
     15 
State of the art 
intracellular adhesion molecule 1 (ICAM-1) and ICAM-2 and cross the endothelium barrier 
(Sundd et al., 2012; reviewed by Kazzaz et al., 2016). 
In the context of inflammatory cues, PMN express over 30 different types of receptors that 
can detect pro-inflammatory factors that mediate PMN migration to the inflammation site and 
their function (Oliveira et al., 2016).  Among those pro-inflammatory receptors are included 
the G protein-coupled receptors (GPCRs), Fc receptors, adhesion receptors, cytokine 
receptors, as well as pattern recognition receptors (PRRs) (Futosi et al., 2013). In PMN, the 
signaling vias downstream of G protein-coupled receptors that can sense pro-inflammatory 
cues, are involved in PMN gene transcription modulation, phagocytosis, apoptosis, 
degranulation and reactive oxygen species (ROS) production (Sun & Ye, 2012). The 
recruitment of PMN to the site of tissue damage is a complex and well-regulated process that 
occurs in three major phases, as reviewed by Oliveira and co-authors (2016). Understanding 
this biological process becomes even more challenging, when based on some evidence that 
PMN migration differs in response to signals produced either by the host or by the pathogen 
(Deng et al., 2012; Yan et al., 2014). In the early phase, as soon as tissue injury happens, 
short-lived signs sent from the damaged cell trigger the release of damage-associated 
molecular patterns (DAMPs) that activate hydrogen peroxide (H2O2) production and stimulate 
the chemotaxis of PMN present in the neighboring cells previously recruited through the SRC 
family kinase LYN (Oliveira et al., 2016). After initiating the migration of resident PMN, 
DAMPs further stimulate the production of CXC motif chemokine ligand 8 (CXCL8) family 
chemokines, as well as other pro-inflammatory cytokines, interleukins (IL-1β) and lipid 
mediator leukotrienes (LTB4) from the surrounding tissues to attract other early PMN 
(Oliveira et al., 2016). These previously recruited PMN present in the tissue, are continuously 
activated by LTB4 or by IL-1β that increases CXCL8 family chemokines. In addition, 
necrotic PMN, as occurs in damaged tissue in the initial phase of PMN recruitment, also 
cause further DAMPs release after cell damage that will modulate transcriptional activation of 
tissue cells and CXCL8 release (Oliveira et al., 2016).  Both CXCL8 and LTB4 will further 
attract PMN from blood circulation and amplify this recruitment process. When an infection 
is present, additional levels of signaling are needed to extend and intensify PMN recruitment. 
In contrast to the initial stage of aseptic tissue injury, hydrogen peroxide release is not a 
required signal for PMN to detect and localize the infection by Pseudomonas aeruginosa, 
Gram-negative bacteria (Deng et al., 2012). When an infection is present, the release of 
pathogen-associated molecular patterns (PAMPs) and the involvement of other immune cell-
like tissue residents and recruited inflammatory macrophages (LY6C), T cells and dendritic 
cells are mandatory (Oliveira et al., 2016). As a result, pro-inflammatory cytokines such as 
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IL-1β and TNFα stimulate CXCL8 family chemokines and leukotrienes release, prolonging 
and amplifying PMN recruitment (Oliveira et al., 2016). As a major pro-inflammatory 
cytokine, TNF-α triggers a cascade of events, including the production of other cytokines and 
chemokines by mast cells and resident tissue macrophages, which attract PMN to the 
inflammatory site. This cytokine also induces a stop signal that results in PMN firm adhesion 
to blood vessels´ endothelium (Locksley et al., 2001; Wiemer et al., 2010; Souza et al., 2011). 
This enables PMN to cross this cell barrier and reach the site of infection, being PMN 
polarization and chemotaxis inhibited (Wiemer et al., 2010), while some of their other 
functions like oxidative burst (Nathan, 1987), phagocytosis and degranulation are activated 
(van der Poll et al., 1992). Since the inflammatory process should be sustained until the 
infection no longer exists, this time frame does influence the duration of tissue damage 
(Oliveira et al., 2016). Matrix metalloproteinases (MMPs) expressed in activated PMN, may 
also enhance PMN chemotaxis by cleaving CXCL8 family chemokines or by acting on 
collagen itself to release collagen-derived chemotactic peptides (Tester et al., 2007; Afonso et 
al., 2013). 
A purposeful response to acute injury is resolving inflammation in situ through PMN 
clearance to avoid tissue damage (Oliveira et al., 2016). Nevertheless, PMN appear to have a 
dual effect: while their aim is to fight inflammation or infection, they themselves trigger an 
inflammatory response by undergoing receptor mediated respiratory burst and degranulation 
(Lacy, 2006). Even though PMN removal can be achieved through apoptosis, necrosis or 
macrophage phagocytosis, some PMN do not undergo apoptosis at inflamed tissues. Instead, 
they leave inflamed and damaged tissues in a process called “neutrophil reverse migration”. 
This consists on a retrograde chemotaxis back toward the main circulation, as it was first 
visualized in vivo in zebrafish larvae (Mathias et al., 2006). It is worth noting that many 
aspects of “neutrophil reverse migration” are still very challenging and yet to be understood, 
such as the fate of those PMN and its role in disease. 
 
 
4. Neutrophil Extracellular Traps 
 
Once in the inflamed tissue, PMN purpose is to kill the invading pathogen. They do so 
through several mechanisms, such as the extracellular release of lytic enzymes and 
phagocytosis (Neeli et al., 2009; Souza et al., 2011).  As a new paradigm of innate immunity, 
PMN were found to have the ability to extrude their deoxyribonucleic acid (DNA) in response 
to infectious stimuli to form web-like structures called neutrophil extracellular traps (NETs) 
(Brinkmann et al., 2004). This finding has proved that other mechanisms of the innate 
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immune system, rather than PMN classical functions of extracellular release of lytic enzymes 
and phagocytosis, should be involved in NETs formation (Neeli et al., 2009; Brinkmann et 
al., 2004; Brinkmann, 2011; Nakazawa et al., 2017). Although NETs are widely used to 
combat infection, their antimicrobial mechanism remains an enigma (Halverson et al., 2015).  
Besides the antimicrobial activity attributed to the nucleic and cytoplasmic proteins bound to 
the DNA backbone, it appears that DNA itself contributes for the antibacterial nature of NETs 
(Halverson et al., 2015). However, it might also act as a signal perceived by microbes to elicit 
host-resistance strategies (Halverson et al., 2015). 
The word NETosis was initially proposed as the release of NETs by PMN with their death. 
Nevertheless, PMN stimulated by pathogens are also able to induce a rapid and vital form of 
NETosis, in which the PMN keep their phagocytic, chemotaxis, and bacteria killing functions 
after producing NETs (Jorch & Kubes, 2017). The stimulus seems to play an important part in 
determining which kind of NETosis is induced (Jorch & Kubes, 2017). In induced “suicidal 
NETosis”, which occurs after hours of stimulation, like with phorbol-myristate acetate 
(PMA), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is activated, ROS are 
produced and protein-arginine deiminase 4 (PAD4; an enzyme that converts arginine to 
citrulline on histones) is activated, which results in chromatin decondensation. Further 
unfolding of chromatin is promoted by translocation of PMN elastase (ELA) and 
myeloperoxidase (MPO) into the nucleus with disruption of the nuclear membrane. 
Chromatin is then released into the cytosol, where it becomes decorated with granular and 
cytosolic proteins. After disruption of the plasma membrane NETs are released, forming a 
netlike structure outside the cell, and the PMN die (Jorch & Kubes, 2017). “Vital NETosis” 
occurs very quickly after stimulation of PMN with bacteria or bacterial products. This 
activation can be done (i) through both complement receptors and TLR2 ligands (with 
Staphylococcus aureus), (ii) directly via TLR4 (with Escherichia coli) or (iii) indirectly via 
TLR4-activated platelets. PAD4 is activated, perhaps without any need for oxidants, and 
induces chromatin decondensation. Elastase is translocated into the nucleus to promote further 
unfolding of chromatin and nuclear-membrane disruption. The chromatin, in direct contact 
with PMN proteins, is expelled via vesicles, and the PMN stay alive for further functions. 
How mitochondrial ROS production is involved in one or the other form of NETosis has not 
yet been completely elucidated (reviewed by Jorch & Kubes, 2017). Nevertheless, the term 
“Vital NETosis” is still under debate because it is not clear, if PMN actually remain alive 
thereafter (Zawrotniak et al., 2017). 
As a result of NETosis, NETs proteins components, like histones and enzymes as elastase 
(ELA), proteinase 3, cathepsin G (CAT) and myeloperoxidase (MPO), may be involved in 
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microorganism killing (Weinrauch et al., 2002; Wartha et al., 2007; Brinkmann, 2011; Windt 
et al., 2012; Marin-Esteban et al., 2012). In addition, besides having potent antimicrobial 
functions, the proteins forming NETs might also have immune-modulating capacities 
(Lögters et al., 2009). Among the pathogens that induce NETs release, bacteria (Fuchs et al., 
2007, Pilsczek et al., 2010; Rebordão et al., 2014; Rebordão et al., 2017b), Floyd et al., 
2016), protozoa (Guimarães-Costa et al., 2009, Wardini et al., 2010; Abdallah et al., 2012), or 
yeast, have been reported (Urban et al., 2006, 2009). Interestingly, in some bacteria, like the 
Pseudomonas aeruginosa, the flagellar motility is required for the induction of NETs, rather 
than the binding of the flagellum to host cells sensing receptors (Floyd et al., 2016). Thus, at 
localized inflammation/infection sites, NETs are abundant. They have been found in 
spontaneous appendicitis in humans, endometritis in the mare, pyometra in the queen and 
bitch, peritoneal fluid of endometriosis human patients, mastitis in sheep, or skin infection in 
mice (Brinkmann et al., 2004; Berkes et al., 2014; Rebordão et al., 2014; 2017b; Pisanu et al., 
2015; Halverson et al., 2015). Besides PMN response to infectious agents, also many 
physiologic inducers of NETs formation, like sterile stimulation with chemicals or cytokines 
have been reported (reviewed by Brinkmann & Zychlinsky, 2012; Kazzaz et al., 2016).  
Apparently, NETs may act as a physical barrier to prevent further spread of microorganisms 
that get trapped at the infection site, limiting bacterial dissemination keeping an abscess from 
becoming bacteremic or confining tissue infection to local sites (Beiter et al., 2006; O'Brien et 
al., 2017). Although PMN are not capable of directly catching circulating pathogens, by 
producing NETs, they can increase the catching capacity of the liver (Kolaczkowska et al., 
2015). It has been suggested that a major role for NETs is to trap rather than kill microbes 
since the majority of bacteria bound to NETs were alive when liberated by DNase treatment 
(Menegazzi et al., 2012). Whenever NETs release is not physiologically controlled, it can be a 
major trigger of tissue injury or can exacerbate the disease as in some cancers, metabolic 
disorders, autoimmune diseases, and thrombotic diseases (Corsiero et al., 2016; Nakazawa et 
al., 2017). The formation of NETs may be also mediated by immunoglobulin A immune 
complexes, as occurs in humans with joint damage due to rheumatoid arthritis, thereby 
increasing the severity of the disease (Aleyd et al., 2016). While deamination of histones 
present in NETs is a physiological mechanism, this process may be intensified under 
inflammatory conditions (Corsiero et al., 2016).  In some individuals carrying a genetic 
predisposition to develop auto-immune diseases, such as rheumatoid arthritis, NETs 
themselves modulate the production of self-antigens, and contribute to the expansion and 
differentiation of antibody producing B-cells (Corsiero et al., 2016). Thus, antibody-antigen 
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complexes are among those NETs inducers that maintain an inflammatory milieu propitious 
for further NETs stimulation (Garcia-Romo et al., 2011; Corsiero et al., 2016).  
While NETs can disarm both Gram-positive and Gram-negative pathogens (Brinkman et al., 
2004), PMN appear to discriminate between different Gram-negative bacteria 
lipopolysaccharide (LPS), depending on species-specific bacteria and also on serotype-
specific bacteria (Pieterse et al., 2016). Human saliva mucin is also capable of inducing 
NETs. This mucin-induced NETs have a higher capacity to attach and destroy bacteria and 
they are more DNase-resistant than NETs induced by bacteria Staphylococcus aureus and 
Streptococcus pyogenes or by PMA (Mohanty et al., 2015). Saliva-induced NETosis is 
dependent on the mitogen-activated protein kinase/extracellular signal-regulated kinase 
pathway but not on NADPH oxidase or elastase (Mohanty et al., 2015). Depending on the 
affected organ, NETs persistence and amount (acute versus chronic process), NETs can either 
fight disease or cause disease themselves (Brinkmann & Zychlinsky, 2012). However, despite 
all the research carried out on NETs, their dual and somewhat antagonist functions- 
antimicrobial and pro-inflammatory actions - remain an enigma.  
 
 
5. Neutrophil Extracellular Traps (NETs) and NETs components in fibrosis formation 
 
The connection between inflammation and fibrosis is well recognized and non-resolving 
inflammation after chronic injury is seen as a major driving force in the development of 
fibrotic disease (Liu 2011; Zeisberg & Kalluri, 2013; Wynn & Vannella, 2016). Although 
uncontrolled NETs release has been linked to the development of several disease conditions 
(reviewed by Jorch & Kubes, 2017; Nakazawa et al., 2017) the role of NETs in fibrosis has 
recently been established.   
In an in vitro study, NETs released by PMN treated with different fibrosis-related agents, 
triggered the activation and differentiation of lung fibroblasts into myofibroblast phenotype. 
This was significantly decreased after degradation of NETs with different agents 
(Chrysanthopoulo et al., 2014). Also, IL-17 expression in NETs promoted the fibrotic activity 
of myofibroblasts but not their differentiation, suggesting that priming by NETs components 
like DNA, histones and MPO is essential for IL-17-driven fibrosis. The role of PMNs in 
fibrogenesis in those in vitro findings was further supported by the identification of NETs 
near α-smooth muscle actin (α-SMA)-positive fibrocytes in biopsies from human patients 
with fibrotic interstitial lung disease or from skin scar tissue (Chrysanthopoulou et al., 2014). 
It was proposed that PMN infiltration in tissues affected by chronic inflammation, caused by 
either pathogens or environmental agents, may perpetuate tissue injury through NETs release. 
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NETs components, including histones, antimicrobial peptides, and cytokines, in conjunction 
with a possible defect in NETs clearance by either DNase or macrophages may impact 
fibroblast activation, contributing to disease progression towards fibrosis (Chrysanthopoulou 
et al., 2014). In a murine model of atherosclerosis, cholesterol crystals trigger PMN to release 
NETs, which prime local macrophages to transcribe immature IL-1β. Cholesterol crystals 
serve a second role as a danger signal that activates inflammasomes, which process immature 
IL-1β secretion. NETs prime macrophages for cytokine release and activate T-helper type 17 
(Th-17) cells that amplify immune cell recruitment in atherosclerotic plaques (Warnatsch et 
al., 2015). 
Persistence of other NETs components in chronic inflamed tissues, like NETs proteases may 
also be involved in fibrogenesis. NETs are a major contributor to chronic inflammation and 
lung tissue damage in chronic obstructive pulmonary disease human patients (Grabcanovic-
Musija et al., 2015). Uncontrolled protease release by PMN contributes to the destruction of 
lung tissue in cystic fibrosis (Dubois et al., 2012). The dominant proteolytic activity in NETs 
was attributed to ELA, but when ELA was immune-depleted, the remaining activity was 
attributed to CAT (O’Donoghue et al., 2013). The NETs released in the liver vasculature 
remain anchored to the vascular wall. In this case, liver injury was attributed to PMN-ELA 
and a large portion (at least 80%) of that damage was due to NETs production (Kolaczkowska 
et al., 2015). The effectiveness of DNase treatment seems to be limited in terms of removal of 
the most dangerous NETs components, since the removal of DNA with DNase failed to 
remove all histones or proteases from the vascular wall (Kolaczkowska et al., 2015). 
Neutrophil-derived ELA has been shown to play a pivotal role in the pathogenesis of 
pulmonary fibrosis (Takemasa et al., 2012). In the early-stage of a pulmonary fibrosis model, 
the ELA level was increased in the lungs and a PMN-ELA inhibitor (Sivelestat) inhibited the 
fibrotic changes, the numbers of total cells (including macrophages, PMN and lymphocytes) 
and the levels of the active form of transforming growth factor-β1 (TGF-b1) and phospho-
Smad2 (Takemasa et al., 2012). 
Cathepsin G (CAT) was also shown to be associated with the formation of atheromas in 
human carotid arteries (Legedz et al., 2004). In stenotic valves, CAT was present in mast cells 
and showed increased expression which correlated positively with the expression levels of 
TGF-b1 and type I and III collagens (Legedz et al., 2004). Cathepsin G is capable of 
generating angiotensin II, a powerful pro-fibrotic and pro-inflammatory mediator in the 
pathogenesis of aortic stenosis, characterized by extensive remodeling of the valves, including 
infiltration of inflammatory cells, extracellular matrix degradation, and fibrosis (reviewed by 
Helske et al., 2006) 
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Neutrophil ELA and CAT are proteolytic activators of MMP-9 (Vandooren et al., 2013). 
Additionally, MMPs (particularly MMP-2 and MMP-9) enhance the release of TGF-b1. TGF-
b1 stimulates tissue inhibitor of metalloproteinase (TIMP), resulting in inhibition of 
extracellular matrix (ECM) degradation, which further induces ECM accumulation, vascular 
remodeling and vascular fibrosis (Harvey et al., 2016). 
 
6. Cellular and molecular mechanisms of tissue fibrosis 
 
Fibrogenesis is the deposition of pathological extracellular matrix (ECM) by cells. It is widely 
believed to be a wound-healing response to tissue injury that does not resolve (Zeisberg & 
Kalluri, 2013; Duffield, 2014; Wynn & Vannella, 2016). Excessive deposition of ECM leads 
to the destruction of organ architecture and impairment of organ function. Chronic loss of 
organ function in most organs, including bone marrow, heart, intestine, kidney, liver, lung and 
skin is associated with fibrosis (Zeisberg & Kalluri, 2013).  
Fibrosis is a very complex pathology since different etiologies and pathogenesis are involved 
in organ fibrosis. It is triggered by activation of different type of cells into myofibroblasts and 
different molecular and immunological mechanisms that initiate, maintain and terminate the 
differentiation of quiescent fibroblasts into actively proliferating ECM-producing 
myofibroblasts (Wynn & Ramalingam, 2012; Duffield, 2014; Wynn & Vannella, 2016). 
The main source of collagen in fibrosis are “activated fibroblasts” (reflecting their increased 
biosynthetic and proliferative activities). Phenotypically, activated fibroblasts are 
characterized by a pronounced rough endoplasmic reticulum, stress fibers, and a large 
nucleolus. Since the observation that the majority of collagen-producing fibroblasts are 
labeled with antibodies to the filament a-smooth muscle actin (a-SMA) (Kalluri & Zeisberg, 
2006), the terms “activated fibroblasts” and “myofibroblasts” are used as synonymous. They 
both refer to the fibroblasts that mediate fibrosis (Zeisberg & Kalluri, 2013). However, α-
SMA expression is an imperfect marker for such an important cell type (Liu, 2011; Duffield, 
2014), since is not exclusive to myofibroblasts, as it is also present in vascular smooth muscle 
cells (Liu, 2011). Nevertheless, the majority of cells that produce collagen type I are shown to 
also express α-SMA and abundance of α-SMA is closely correlated with the severity of 
fibrosis in several organs (Liu, 2011, Duffield, 2014). Other markers have been proposed to 
characterize myofibroblasts, including fibroblast specific protein–1 (FSP-1), heat shock 
protein–47, and vimentin, although none of these markers is specific (Liu, 2011; Duffield, 
2014). 
While there is a consensus that (activated) fibroblasts are the principal source of collagen and 
prominent mediators of fibrogenesis, it is not yet clear where these activated fibroblasts 
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originate from (Zeisberg & Kalluri, 2013). Contribution to fibroblast accumulation and 
fibrogenesis may differ substantially among organs, and disease models (Zeisberg & Kalluri, 
2013). Although resident fibroblasts are important cells by their own activation and 
proliferation, other cells also contribute to fibroblast accumulation. Among them are bone 
marrow-derived fibrocytes, vascular smooth muscle cells, pericytes and transdifferentiation of 
epithelial cells into epithelial-mesenchymal transition (EMT) and of endothelial cells into 
endothelial-mesenchymal transition (Liu, 2011; Ueha et al., 2012; Zeisberg & Kalluri, 2013). 
The relative contribution, and even the very existence, of each particular myofibroblast-
generating pathway to fibrosis is a matter of intense discussion (Liu, 2011). This is due to the 
difficulty in identifying and tracking fibroblasts owing to the lack of specific markers for this 
cell type (Liu, 2011). In addition, fibroblasts exhibit enormous phenotypic heterogeneity, 
probably reflecting their diverse origins, activation status, localization and stage of 
fibrogenesis (Liu, 2011). 
The classic view on the relationship between inflammation and fibrosis is that they are 
mediated in a paracrine fashion, whereby inflammatory cells secrete pro-fibrotic cytokines 
that act on resident fibroblasts and tubular cells to promote fibrogenesis (Liu, 2011).  The 
cross-talk of the injured epithelium with fibroblasts and inflammatory cells is of foremost 
relevance for triggering the fibrotic process (Zeisberg & Kalluri, 2013).  In addition to the 
release of pro-fibrotic metabolites (i.e., reactive oxygen species - ROS), injured parenchymal 
cells govern fibrogenesis through secretion of chemokines and growth factors (Zeisberg & 
Kalluri, 2013). Nevertheless, intrinsic connection at the molecular level exists between 
inflammatory signals and fibrosis within the same cells (Liu, 2011). For instance, activation 
of nuclear factor kappa B (NFκB) that is dependent on tumor necrosis factor stabilizes Snail1 
by blocking its ubiquitin-mediated degradation. As Snail1 is a key transcription factor that 
promotes EMT, fibroblast migration and renal fibrosis, this finding provides a molecular link 
between inflammatory signaling and fibrosis (Liu, 2011).  
When tissues are injured during infection or following toxic or mechanical injury, an 
inflammatory response is induced to damage-associated molecular patterns (DAMPs) and 
pathogen-associated molecular patterns (PAMPs) released by dead and dying cells and 
invading organisms, respectively (Zhang et al., 2010; Wynn & Vannella, 2016). These 
molecules induce a complex inflammatory response that is characterized by the recruitment, 
proliferation, and activation of a variety of hematopoietic and non-hematopoietic cells. 
Neutrophils, macrophages, innate lymphoid cells, natural killer (NK) cells, B cells, T cells, 
fibroblasts, epithelial cells, endothelial cells, and stem cells together make up the cellular 
response that conducts tissue repair (Wynn, 2008; Wynn & Vannella, 2016). When the wound 
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healing response is well organized and controlled, the inflammatory response quickly resolves 
and normal tissue architecture is restored. However, if the wound healing response is chronic 
or becomes dysregulated it can lead to the development of pathological fibrosis (Wynn & 
Vannella, 2016). Although inflammation is an integral part of the host defense mechanisms in 
response to injury, non-resolving inflammation after chronic injury is a major driving force in 
the development of fibrotic disease because it creates a vicious cycle of inflammation, tissue 
damage and fibrosis (Liu, 2011). Figure 1 depicts the complexity of fibrogenesis. 
 
 
Figure 1- Schematic representation of some mediators and pathways involved in tissue 
fibrosis. AMMP- active matrix metalloproteinase; CTGF-connective tissue growth factor; 
CXCL- CXC motif chemokine; ECM- extracellular matrix; FGF- fibroblast growth factor; IL- 
interleukin; MMP- matrix metalloproteinase; NOX- NADPH oxidase; PDGF- platelet-derived 
growth factor; ROS- reactive oxygen species; TGF- transforming growth factor; TIMP- tissue 
inhibitor of metalloproteinase; TNF- tumor necrosis factor; SMA- smooth muscle actin.  
 
6.1. Innate and adaptive immunity triggers fibrosis formation 
Fibroblasts are triggered by components of the innate and adaptive immunity and upon 
activation they modulate immune cell behavior by conditioning cellular and cytokine 
microenvironment leading to chronic inflammation.  Tissue damage, infections with bacteria, 
viruses, fungi, parasites, foreign body implants, autoimmune diseases, or tumors could 
progress to an adverse chronic inflammation, which subsequently leads to fibrotic disease 
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The first-line defense of the innate immune system largely depends on a sophisticated array of 
pattern recognition receptors (PRR), which recognize conserved pathogen-associated 
molecular patterns (PAMPs) (Van Linthout et al., 2014). Fibroblasts express a variety of 
pattern recognition receptors, including Toll-like receptors (TLRs), and activation of those 
receptors can directly activate fibroblasts and promote their differentiation into 
myofibroblasts (Van Linthout et al., 2014).  
Platelets also express a range of TLRs, contributing to their immune cell function in the state 
of infection and inflammation (Van Linthout et al., 2014). Activated platelets by releasing 
several growth factors, like TGF-β1, platelet-derived growth factor (PDGF) and epidermal 
growth factor (EGF) are also an important source of paracrine stimuli in fibroblast activation 
which stimulate the deposition of ECM (Van Linthout et al., 2014; Elpek, 2014). 
Neutrophils (PMN) act as a first-line defense and initiate an acute inflammatory response to 
engulf dead cells and tissue debris in order to facilitate tissue repair. However, excessive and 
persistent PMN infiltration or their delayed elimination exacerbate tissue injury by releasing 
inflammatory mediators and proteinases (Van Linthout et al., 2014). Neutrophils release large 
amounts of ROS during the respiratory burst via the multicomponent enzyme nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase. Reactive oxygen species-released by 
PMN are a proven pro-fibrotic mediator in systemic sclerosis, pulmonary fibrosis, and hepatic 
fibrosis (Van Linthout et al., 2014; Elpek, 2014). In fact, inhibition of NADPH oxidase 
attenuates cardiac fibrosis post-myocardial infarction (reviewed by Van Linthout et al., 2014; 
Elpek, 2014). In addition, PMN secrete granules containing enzymes such as MMPs, elastase, 
and cathepsin capable of cleaving collagenous and non-collagenous connective tissue 
components, involved in tissue remodeling during the fibrotic process. In addition, neutrophil-
derived elastase (NE) has been shown to play a pivotal role in the pathogenesis of pulmonary 
fibrosis (Takemasa et al., 2012). Inhibition of NE suppressed both neutrophilic inflammation 
and TGF- b activation, which resulted in the suppression of pulmonary fibrosis (Takemasa et 
al., 2012). Also, PMN by activating further cellular components of the innate immune system 
such as macrophages play an indirect pro-fibrotic effect (Van Linthout et al., 2014). 
Although many cell types are involved in tissue repair, because of their highly flexible 
programming, macrophages have been shown to exhibit critical regulatory activity at all 
stages of repair and fibrosis (Wynn & Vannella, 2016). Macrophages stimulated by TLR 
ligands and interferon (IFN)-g undergo classical M1 activation, while those stimulated by IL-
4 and IL-13 become M2 macrophages (Van Linthout et al., 2014). M1 macrophages express 
IL-1, IL-12, IL-23, and induce T-helper type 1 (Th1) cell infiltration and activation (Ueha et 
al., 2012). M2 macrophages express immunosuppressive molecules such as IL-10, which 
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suppress the induction of Th1 cells that produce the anti-fibrotic cytokine IFNγ (Ueha et al., 
2012). M2 macrophages are involved in wound healing, tissue remodeling, fibrosis, and 
inflammatory responses (Van Linthout et al., 2014). Although pro-inflammatory and anti-
inflammatory macrophages are two phenotypes involved in studies of wound repair and 
fibrosis it is not clear if they represent distinct subsets or whether it is the pro-fibrotic 
microenvironment that drives macrophage toward a M2 phenotype (Ueha et al., 2012; 
Wynn & Vannella, 2016). Disturbances in macrophage function can lead to abnormal repair, 
with uncontrolled inflammatory mediator and growth factor production. Also, deficient 
generation of anti-inflammatory macrophages, or failed communication between 
macrophages and epithelial cells, endothelial cells, fibroblasts, and stem or tissue progenitor 
cells, may contribute to a state of persistent injury and lead to the development of pathological 
fibrosis (Wynn & Vannella, 2016). 
Macrophages produce important pro-fibrotic mediators like TGF-β1 considered the most 
significant pro-fibrotic agent involved in the progression of chronic fibrotic diseases of 
several organs (Van Linthout et al., 2014; Wynn & Vannella, 2016). Inhibition of 
alternatively activated macrophages (M2) has been shown to abrogate TGF-β-driven lung 
fibrosis (Van Linthout et al., 2014). Activated macrophages also produce cytokines such as 
IL-1, IL-4, IL-10, IL-13, and TNF-a, which have been shown to activate fibroblasts (Van 
Linthout et al., 2014). Macrophages are the main source of several types of MMPs as well as 
tissue inhibitors of MMPs (TIMPs). The MMPs mediate not only the degradation of ECM, 
but they also amplify the inflammatory response and influence the progression of tissue 
remodeling (Van Linthout et al., 2014; Wynn & Vannella, 2016). Some MMPs are drivers of 
fibrosis. For example, MMP-12 is a macrophage-secreted elastase that is highly induced by 
IL-13 in the lung and liver during the development of IL-13-dependent fibrosis (Wynn & 
Vannella, 2016). Activated macrophages are also able to recruit myofibroblasts and 
exacerbate inflammatory cell infiltration to sites of tissue injury, leading to profound 
production of a variety of chemokines, cytokines, and growth factors (Van Linthout et al., 
2014). It has been showed that hepatic macrophages enhance myofibroblast survival by 
stimulating NF-κB activity in fibroblasts, which is critical for the development of liver 
fibrosis (Wynn & Vannella, 2016).  
The contribution of T lymphocytes to organ fibrosis seems to be context dependent. The 
factors present in the environment trigger specific T-cell populations will subsequently 
determine the fibrotic outcome (Ueha et al., 2012; Van Linthout et al., 2014). CD4+ T cells 
are divided into unique subsets on the basis of the cytokines they secrete and their distinct 
functional abilities (Wynn & Ramalingam, 2012). Th1 effector T cells, defined by their 
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production of IFN-γ, have anti-fibrotic activity by antagonizing the pro-fibrotic activity of 
TGF-β1, IL-4- and IL-13 and directly inhibiting fibroblast proliferation (Wynn & 
Ramalingam, 2012; Van Linthout et al., 2014). Prolonged inflammation seems to induce a 
shift from a Th1 to Th2 phenotype inducing the infiltration of pro-fibrotic eosinophils via 
cognate chemokine (e.g., eotaxin) production (Ueha et al., 2012). T-helper type 2 (Th2) cells, 
characterized by the secretion of cytokines IL-4, IL-5, and IL-13, have been implicated in 
several experimental and natural models of fibrosis (Wynn & Ramalingam, 2012; Van 
Linthout et al., 2014). IL-13 can induce fibrosis by stimulating the production and activation 
of TGF-β and also by directly activating fibroblasts, epithelial cells and smooth-muscle cells 
(Wynn & Ramalingam, 2012).  
CD4+ Th17 cells that express the pro-inflammatory cytokine IL-17A, has also been pointed 
out in the development and progression of fibrotic disease in lung, heart and liver (Van 
Linthout et al., 2014). IL-17A seems to promote fibrosis indirectly by inducing tissue damage 
and inflammation, like persistent neutrophilia that induces apoptosis of vascular endothelial 
cell. In addition, IL-17A may directly stimulate TGF-β and MMP-1 (Wynn & Ramalingam, 
2012). Nevertheless, Th17 cells seem to play a dual role in the fibrosis process, since it has 
been shown that IL-17A down-regulated the expression of connective tissue growth factor 
(CTGF) and type I collagen in fibroblasts of healthy patients (Van Linthout et al., 2014). 
Probably, the presence of regulatory mediators, such as chemokines, transcription factors, and 
receptors in the particular inflammatory environment, can guide the Th17 response in a pro-
fibrotic or anti-fibrotic direction (Van Linthout et al., 2014). 
 
6.2. Molecular activation of myofibroblasts 
Fibroblast activation is induced by various stimuli that arise when tissue injury occurs. The 
expression and synthesis of ECM proteins by the matrix-producing cells is primarily 
controlled at gene transcription level in response to various extracellular fibrogenic signals. 
TGF-β1, CTGF and PDGF released from injured epithelial cells and infiltrating cells are pro-
fibrotic mediators (Kalluri & Zeisberg, 2006; Liu, 2011; Wynn & Vannella, 2016). In 
addition, altered MMPs-TIMPs balance and prostaglandins (PG) pathways have also been 
implicated in fibrogenesis. 
 
6.2.1. Transforming growth factor-β  
The classical pro-fibrotic growth factor, which plays a role in fibrogenesis in all organs, is 
TGF-β. The prominent role of TGF-b in fibrogenesis was first observed when subcutaneous 
 
     27 
State of the art 
injection of purified TGF-b induced fibrotic lesions at the injection site. Its action was further 
corroborated by the observation that neutralization of TGF-b  with antiserum ameliorated 
experimental fibrosis in the kidney, heart and liver (Zeisberg & Kalluri, 2013). TGF-b  is 
overexpressed in all fibrotic tissues, and it induces collagen production in cultured fibroblasts 
irrespective of their origin (Zeisberg & Kalluri, 2013). However, fibrosis can develop 
independent from TGF-b, as through an IL-13-mediated pathway (Zeisberg & Kalluri, 2013).  
TGF-β plays a central role in fibroblast activation and fibroblast-to-myofibroblast 
differentiation, and induces the expression of genes for ECM components including collagen 
type I (Ueha, et al., 2012; Zeisberg & Kalluri, 2013; Seki & Brenner, 2015). However, despite 
its great potential as a therapeutic target for fibrosis, inhibition of TGF-β signaling has 
unacceptable side effects due to the critical role of this cytokine in the maintenance of 
homeostasis (Ueha, et al., 2012). While a key role of TGF-β signaling in organ fibrosis is 
supported by ample evidence, specific mechanisms involved in deregulation of this pathway 
towards fibrotic outcomes vary depending on the affected organ (Nakerakanti & 
Trojanowska, 2012). 
TGF-β exerts biological effects by interacting with two types of transmembrane receptors, 
type I (TGFBR1, also termed Activin Like Kinase 5, ALK5) and type II (TGFBR2) receptors 
with intrinsic protein serine/threonine kinase activity (Shi & Massague, 2003). The ratio of 
type I to type II receptor may determine the biological effect of TGF-β on proliferation and 
target gene expression (Nakerakanti & Trojanowska, 2012).  While the TGFBR2 has a high 
affinity for the ligand, TGFBR1 does not bind to TGF-β. The type II receptor is involved in 
initial ligand binding. Once the ligand is bound, the type II receptor binds to a type I receptor 
forming a complex; type I receptor is then phosphorylated by the kinase domain of type II 
receptor, resulting in a transduction of down-stream signals (Shi & Massague, 2003). 
Signaling pathways induced by TGF-b1, as well as TGF-β family members, are generally 
divided into Smad-dependent and Smad-independent ones, like of mitogen-activated protein 
kinase (MEK/ERK1/2) and phosphatidyl inositol 3 kinase (PI3K) pathways. 
Once phosphorylated receptor type I of TGF-β1 is then able to exert its serine-threonine 
kinase activity phosphorylating Smad2 and Smad3. Receptor type I of bone morphogenetic 
protein (BMP-7 or ALK3) phosphorylates instead Smad1, Smad5, and Smad8. Upon 
phosphorylation, they form heterodimers with Smad4, a common mediator of all Smad 
pathways. The resulting Smad heterocomplexes translocate into the nucleus where they bind 
directly to DNA and activate specific target genes (Strippoli et al., 2016). TGF-β-mediated 
Smad2/3 activation induces the transcription of type I and III collagen, promoting fibrosis 
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(Seki & Brenner; 2015). A third group of Smads composed of Smad6 and Smad7, also called 
inhibitory Smads, limit BMP-7 and TGF-𝛽1-triggered Smad signaling, respectively (Strippoli 
et al., 2016).    
TGF receptors may also activate signaling pathways independently of Smads. Mitogen 
activated protein kinases (MAPKs), and PI3Kinase/ Akt (serine-threonine protein kinase, also 
termed protein kinase B) pathways are relevant in different cellular function elicited by TGF- 
𝛽1 in different EMT experimental systems (Strippoli et al., 2016).   Both Smad and non-Smad 
pathways converge on activation of Snail, the master factor of EMT (Strippoli et al., 2016). 
While many fibrotic disorders are characterized by the elevated levels of TGF-β, additional 
mechanisms could also account for the increased TGF-β signaling in fibrosis (Nakerakanti & 
Trojanowska, 2012). As TGF-β is secreted in inactive form, factors that contribute to its 
activation locally in the affected tissues might play a critical role in perpetuation of the 
fibrotic process during chronic stages of the disease (Nakerakanti & Trojanowska, 2012). 
TGF-β is secreted and deposited into ECM as a latent complex (Annes et al., 2003) that is 
cleaved by MMP-9 and MMP-2 (Nakerakanti & Trojanowska, 2012). In addition, TGF-β1 
can directly induce MMP-9 expression via TGF-β receptor (Nakerakanti & Trojanowska, 
2012). 
Reproductive fibrotic disorders are also characterized by elevated levels of TGF-β.  
Polycystic ovary syndrome is a reproductive and endocrine disease, characterized by 
hyperandrogenism, which has been associated with ovarian fibrosis. Dehydroepiandrosterone 
(a metabolic intermediate in the biosynthesis of androgen)-induced rats exhibited higher 
levels of fibrosis in both ovarian and uterine tissues mediated by TGF-β1; although it was not 
determined whether the pathway involved was Smad dependent or Smad independent (Zhang 
et al., 2013). Aberrant activation of fibrosis may be involved in the pathology of intrauterine 
adhesions (IUAs), a syndrome of partial or complete obliteration of the uterine cavity in 
human patients. Expression of TGF-β, CTGF and type I and III collagens was increased in 
endometrial tissues with IUAs (Hu et al., 2015).  
 
6.2.2. Connective tissue growth factor 
Connective tissue growth factor (CTGF) is a potent pro-fibrotic factor that does not behave 
like a traditional growth factor or cytokine since it does not appear to have a unique receptor 
to which it binds with high affinity to induce signal transduction (Lipson et al., 2012). CTGF 
acts by modulating the interaction of cells with the ECM to modify the cellular phenotype 
(Lipson et al., 2012).  CTGF expression is induced by many cytokines and its presence 
induces formation, activation and deposition of myofibroblasts and remodeling of ECM 
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proteins. The CTGF gene is primarily regulated by TGF-β at transcription level via the Smad 
pathway, and can act in concert with TGF-β to activate a number of key cell activities 
(Abraham, 2008). CTGF also induces the expression of a variety of cytokines such as TGF-
β and vascular endothelial growth factor (VEGF) which further enhance the expression of 
CTGF. In the absence of CTGF, fibroblasts are unresponsive to stimuli like TGF-β (Lipson et 
al., 2012).  CTGF has been found over-expressed in several human fibrotic disorders, like 
liver cirrhosis, keloids and hyperopic scars, diabetic nephropathy, atherosclerosis, cardiac 
disease, pulmonary hypertension and fibrosis (Abraham, 2008). CTGF also seems to play an 
important role in arterial aging and vascular fibrosis (Harvey et al., 2016). 
 
6.2.3. Platelet derived growth factor 
PDGF signaling is required for many aspects of embryogenesis and regulates the 
proliferation, migration, survival, and differentiation of mesenchymal progenitor cells that 
give rise to diverse types of stromal cells in the adult organism (Iwayama et al., 2013).  
PDGF is secreted by platelets, monocytes, vascular endothelial cells, and other cell types as a 
disulfide-linked dimer of two PDGF peptides, giving rise to multiple isoforms including 
PDGF-AA, BB, AB, CC, and DD (Trojanowska, 2008; Iwayama et al., 2013; Dobie et al., 
2015). Mesenchyme-derived cells, for example fibroblasts, smooth muscle cells, and 
pericytes, are all responsive to PDGF (Iwayama et al., 2013). PDGF signal through two cell 
surface tyrosine kinase receptors (PDGFRa and PDGFRb) (Trojanowska, 2008; Iwayama et 
al., 2013; Dobie et al., 2015). Binding of the ligand to the receptor induces receptor 
dimerization and downstream signaling through phosphorylation of tyrosine residues on the 
intracellular domain of the receptor (Trojanowska, 2008; Iwayama et al., 2013; Dobie et al., 
2015). PDGF binding induces PDGFR activity, which in turn activates multiple downstream 
signaling pathways (Iwayama et al., 2013).  
Excessive activity of PDGF has been associated with several human disorders, including 
atherosclerosis, pulmonary hypertension, organ fibrosis and tumorigenesis (Trojanowska, 
2008). In severe lung fibrosis induced by irradiation therapy, up-regulation of PDGF (A–D) 
isoforms expression leading to phosphorylation of PDGF receptor was observed, which was 
strongly inhibited by PDGFR inhibitors (Abdollahi et al., 2005). In the pathogenesis of 
systemic sclerosis (SS), pro-fibrotic pathways can be activated by TGF-β and PDGF. In SS 
fibroblasts, a positive cross-talk between PDGF and TGF-β1 seems to exist. PDGFR 
expression is up-regulated in response to TGF-β thereby creating an autocrine PDGF-A/ 
PDGFR loop (Trojanowska, 2008). Also, in dermal fibroblasts, PDGF has been shown to 
stimulate TGF-β receptors, suggesting an additional reciprocal mode of regulation 
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(Trojanowska, 2008). PDGF receptors are expressed on adult stem or progenitor cells located 
in perivascular niches in most mouse organs (Iwayama et al., 2013). Vascular damage is 
likely an early event in SS, preceding dermal fibrosis and characterized, in the first phases of 
SS, by perivascular infiltrate of mononuclear immune cells in the vessel wall, obliterative 
microvascular lesions, and rarefaction of capillaries. Thus, it was proposed that besides 
directly promoting fibrosis, PDGFR signaling could also be involved in the vasculopathy 
causing capillary occlusion and regression independently of fibroblast activation (Luchetti et 
al., 2016). PDGF pathway has also been shown to have profound effects on hepatic 
fibrogenesis, playing a key role in hepatic stellate cell (HSC) and liver myofibroblast biology 
(Dobie et al., 2015). In HSC, both PI3K/AKT and ERK/ MAP signaling are central to PDGF-
induced proliferation and migration (Dobie et al., 2015).  
 
6.2.4. Matrix metalloproteases (MMP-2 and MMP-9)	 and tissue inhibitors of 
metalloproteinase (TIMPs) 
The ECM is a multi-molecular complex structure comprising fibers of collagen, elastin, 
glycoproteins like fibronectin and laminin, and mucopolysaccharides (Harvey et al., 2016). 
Fibrosis is the result of a disruption of the balance of the ECM, with increased synthesis and 
deposition of ECM components and decreased degradation of those ECM products. Matrix 
metalloproteases (MMPs) and TIMPs have been considered as being part of the highly-
regulated systems that control ECM turnover.  
MMPs are a family of more than 20 metallopeptidases that includes gelatinases, collagenases, 
stromelysins, matrilysins and membrane-type MMPs (Vandooren et al., 2013).  Membrane 
type MMPs (MT-MMPs) may be regarded as cell receptors for their substrates or inhibitors 
(Vandooren et al., 2013).  MMPs are secreted as zymogens (pro-MMPs) into the extracellular 
space from a large number of cell types. MMP activity is controlled at three levels: gene 
transcription, proenzyme activation, and activity inhibition. MMPs transcriptional regulation 
of gene expression is achieved through different growth factors, cytokines, hormones, and 
cell-extracellular matrix, and cell-cell interactions. Signaling pathways involved in regulating 
MMP transcription can enhance or repress MMP expression in a cell type dependent manner 
(Harvey et al., 2016). MMPs are regulated by MAPKs (Vandooren et al., 2013). Post-
transcriptional regulatory processes include mRNA stability, protein translational efficiency, 
and regulation by microRNAs (Pardo et al., 2016). After translation, zymogen activation of 
different MMPs may take place intracellularly, at the cell surface, or in the extracellular 
space. MMPs are activated in the pericellular space by other MMPs, including membrane-
type MMPs and MMP-3, or by serine proteases (Harvey et al., 2016). When MMPs are 
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anchored to the cell membrane they can target their catalytic activity to specific substrates 
within the pericellular space (Vandooren et al., 2013). Then, the activity of MMPs is inhibited 
by different mechanisms and molecules, such as TIMPs, α2-macroglobulin, and the 
membrane associated RECK (reversion-inducing Cys-rich protein with Kazal motifs) (Pardo 
et al., 2016). TIMPs are specific endogenous inhibitors that bind to the active site of the 
MMPs blocking access to ECM substrates. Four TIMPs (TIMP-1, -2, -3 and -4) have been 
identified and are responsible for the inhibition of more than 20 MMPs (Harvey et al., 
2016).  TIMP-1 is a specific inhibitor for MMP-9 (Vandooren et al., 2013), while TIMP-2 
and MMP-14 (also known as MT1-MMP) regulate MMP-2 activity (Giannandrea & Parks, 
2014). Although the primary action of TIMPs is to inhibit MMPs, numerous studies have 
reported cell growth-promoting, anti-apoptotic, steroidogenic and antiangiogenic activities, 
which are in part independent of MMP inhibition. The main cellular sources of TIMP-1 are 
macrophages and fibroblasts (Robert et al., 2016). 
Regarding the fibrogenic process, the activities of MMPs that can degrade ECM, might be 
observed to be under-expressed in fibrosis or, if present, could function to resolve the excess 
matrix. However, some MMPs are indeed anti-fibrotic, whereas others can have pro-fibrotic 
functions (Giannandrea & Parks, 2014). Although there are many common mechanisms for 
generating fibrosis among different organs, it is important to note that the roles for specific 
MMPs are not necessarily the same among different organ systems (Giannandrea & Parks, 
2014). 
MMP-2 and MMP-9 are enzymes involved in ECM remodeling by degradation of mainly 
denatured collagens (gelatins) and other matrix-associated substrates such as elastin 
(Vandooren et al., 2013). Although several studies have investigated the effect of those 
MMPs on fibrosis development in several organs, obtained results are contradictory with both 
inhibitory and stimulatory effects being observed. In a study that summarized the effect of 
MMPs on the development or inhibition of fibrogenic process in different organs, while 
MMP-9 seems to have a pro-fibrotic effect, MMP-2 anti-fibrotic actions were seen in kidney 
and liver (Giannandrea & Parks, 2014). It has been reported that MMP-2 participates in the 
resolution of liver fibrosis by suppressing collagen type I expression instead of its degradation 
(Duarte et al., 2015). Although MMP-9 expression has been detected in the early stages of 
hepatic fibrogenesis and it may release/activate TGF-β, MMP-9 may promote hepatic stellate 
cell apoptosis in the presence of low levels of TIMP-1 (Duarte et al., 2015). Nevertheless, in 
induced pulmonary fibrosis models, a temporal difference in the expression and localization 
of MMPs and TIMPs was seen. In the early stages of this disease, MMP-9 activity appears to 
be predominant, contributing to the disruption of the alveolar epithelial basement membrane 
 
     32 
State of the art 
and enhancement of fibroblast invasion to alveolar spaces (Cataldo et al., 2002; Wang et al., 
2011). In the late stages of the disease, MMP-2 prevails. TIMP-1 gene expression is also up-
regulated during fibrosis, which might prevent MMP-induced ECM degradation and 
participate in its accumulation (Cataldo et al., 2002; Wang et al., 2011). The expression of 
MMP-2 and MMP-9 during the progression of fibrosis suggests that MMP-9 may be linked to 
inflammation-induced tissue remodeling, while MMP-2 may be associated with impaired 
tissue remodeling, leading to pathological collagen deposition and interstitial fibrosis (Wang 
et al., 2011). Also, in idiopathic pulmonary fibrosis (IPF) the synthesis of MMP-2, MMP-8, 
and MMP-9 may facilitate the trans-endothelial and tissue migration of fibrocytes and also 
contribute for the remodeling of ECM during the development of IPF (Pardo et al., 2016). 
Likewise, in vascular fibrosis, MMP2/MMP9 activation through TGF-b1/Smad signaling, 
induced myofibroblasts activation, collagen production and fibronectin secretion, processes 
that lead to collagen accumulation in the vascular wall; TGF-b1 further stimulated TIMP, 
resulting in inhibition of ECM degradation, which further induces ECM accumulation and 
vascular remodeling and fibrosis (Harvey et al., 2016).   
TGF-b and TNF-a induce MMP-9 expression. TGF-b can up-regulate the expression of 
MMP-9 genes by activating a heteromeric serine/threonine kinase receptor complex, which 
subsequently activates Smads signaling (Vandooren et al., 2013). Proteolytic activators of 
MMP-9 include MMP-3, plasmin and neutrophil ELA, among others. In addition, ELA is able 
to inactivate TIMP-1 when already in complex with MMP-9. This allows pro-MMP-9 to be 
activated more readily by MMP-3 (Vandooren et al., 2013). MMP-1 and MMP-3 can 
indirectly induce the expression of MMP-9 in macrophages by triggering the release of TNF-
a that induces the expression of PTGS2 and PGE2 secretion. PGE2 subsequently binds to 
PGE2 receptor 4 (EP4) in the cell membrane and stimulates MMP-9 production through 
MAPK/ERK1/2 signaling (Vandooren et al., 2013). Regulated expression of MMP-9 by most 
cell types coincides with the expression of TIMP-1 (Vandooren et al., 2013). It has been 
speculated that TIMP-1 may be involved in the modulation of inflammatory responses and 
may also function to stabilize matrix components deposited in the injured lung (Robert et al., 
2016). 
 
6.2.5. Prostaglandins pathways in tissue fibrosis 
The role of prostaglandins (PG) in promoting human diseases has been widely studied 
particularly in inflammatory disorders. Recently, additional pathways, other than fibrotic 
cytokines, eicosanoids such as PGE2 and PGF2a, have been considered in fibrogenesis. 
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Prostaglandins are lipid autacoids derived from arachidonic acid (AA) that sustain 
homeostatic functions and mediate several pathogenic mechanisms, including the 
inflammatory response (Ricciotti & FitzGerald, 2011). Phospholipases A2 (PLA2) enzymes 
catalyze the release of AA from membrane glycerophospholipids which is sequentially 
metabolized to prostaglandin G2 (PGG2) and then to PGH2 by prostaglandin-endoperoxide 
synthase 1 (PTGS1) and/or PTGS2. PTGS1 is constitutively expressed in most tissues and 
responsible for housekeeping functions, while PTGS2 is regulated by several factors such as 
cytokines and supports sustained production of PG (Fortier et al., 2008). PGH2 is then 
converted to various bioactive PGs (thromboxane A2, PGD2, PGE2, PGF2α and PGI2) (Ueno 
et al., 2005).  The PG produced by a given cell largely depends on the expression profile of 
the individual prostaglandin synthase enzymes (Hata & Breyer, 2004). PGF2α is produced 
through the reduction of PGH2 by aldoketoreductase 1C synthases (AKR1C3) (Fortier et al., 
2008). Three types of PGE synthases (PTGES) controlling PGE2 production in cells have 
been identified. Two are membrane-associated (mPTGES-1 and mPTGES-2) and the third is 
cytosolic (cPTGES). mPTGES-2 is constitutively expressed in many tissues, whereas 
mPTGES-1 expression is responsible for sustained production of PGE2 (Fortier et al., 2008) 
and is induced in response to inflammation (Stichtenoth et al., 2001). PG are ubiquitously 
produced and act locally in an autocrine or juxtacrine manner, through specific receptors, due 
to their extremely short half-life in blood (Hata & Breyer, 2004; Oga et al., 2009). They elicit 
a diverse set of effects that modulate many physiological systems, like reproductive ones, but 
also has been implicated in a broad array of diseases (Hata & Breyer, 2004). Activation of a 
given prostaglandin receptor by its associated ligand may elicit various responses in different 
cell types and tissues. 
PGF2α acting on its receptor (FP) was recently discovered to enable pulmonary fibrosis (Oga 
et al., 2009). Increased collagen I (COL1) and III (COL3) through a FP receptor/protein 
kinase C (PKC)/Rho kinase cascade was depicted not only in cardiac fibroblasts (Ding et al., 
2012), but also in an in vivo animal model where myocardial fibrosis was induced (Ding et 
al., 2014). In a bleomycin-induced pulmonary fibrosis model, plasma PGF2α metabolites 
were associated to disease severity and prognosis (Aihara et al., 2013). In the lungs, PGF2α – 
FP appears to act on fibrosis but not on inflammation (Oga et al., 2013). Nevertheless, 
whether TGFβ-1 and PGF2α stimulate fibrogenesis through independent pathways has been 
questioned, and differs depending on study models. Some authors have referred that PGF2α 
stimulates TGF-β production (Hou et al., 2008) and plays a central role in the establishment 
of fibrosis (Oga et al., 2009). In fibroblasts from mice with dermal sclerosis, alpha2-
antiplasmin (2AP), a serine protease inhibitor (serpin) elevated in fibrotic diseases, induced 
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PGF2α synthesis that in turn promoted TGFβ-1 production and fibrosis (Kanno et al., 2013). 
However, in contradictory studies, PGF2α, which was abundant in broncho-alveolar lavage 
fluid of mice with induced pulmonary fibrosis, stimulated proliferation of lung fibroblasts and 
collagen production via PGF2α receptor (FP) and independently of TGF-β (Oga et al., 2009). 
Using a mice model lacking each prostaglandin receptor, Oga and co-authors (2009) showed 
that loss of FP selectively attenuated pulmonary fibrosis, without interfering with 
phosphorylation of Smad2. Deficiency of FP and inhibition of TGF-β signaling additionally 
decrease fibrosis (Oga et al., 2009). PGF2α mobilizes signaling to induce collagen production 
through Rho kinase pathway (Oga et al., 2013). Besides, in primary rat cardiac fibroblasts, 
treatment with PGF2a increased COL1 and COL3 expression by activating the FP 
receptor/PKC/Rho kinase cascade independent of TGF-β1, and downregulating the PI3K/Akt 
pathway (Ding et al., 2012). Also, synovial fibrosis establishment was positively associated 
with PGF2a levels, while inhibition of TGFβ-1 signaling had no effect on the pro-fibrotic 
changes (Bastiaansen-Jenniskens et al., 2013). Thus, in some systems, PGF2α-FP signaling 
facilitates fibrosis independently of TGF-β1 (Oga et al., 2009; Olman, 2009; Ding et al., 
2012; Bastiaansen-Jenniskens et al., 2013).  
Several biological effects in many organs have been ascribed to PGE2, such as pro- and anti-
inflammatory actions, which depend on the activation of its four subtypes prostanoid 
receptors (EP1, EP2, EP3 or EP4) (Kalinski, 2012). Signaling through EP2 and EP4 mediates 
the dominant aspects of the PGE2 anti-inflammatory and suppressive activities (Kalinski, 
2012). In addition, PGE2 is known to be an anti-fibrotic mediator acting as an autocrine factor 
and controlling cellular over-activation (Sokolova et al., 2005). As an anti-fibrotic mediator, 
PGE2 protects different tissues by inducing fibroblast apoptosis (Huang et al., 2009), 
decreasing fibroblast proliferation, migration and differentiation into myofibroblasts and 
reducing collagen production and deposition by inhibition of its mRNA synthesis (Sokolova 
et al., 2005; Stratton & Shiwen 2010; Ueha et al., 2012). One putative mechanism by which 
PGE2 may exert its antifibrotic effects is by inhibiting TGF-b–induced myofibroblast 
differentiation (Bozyk & Moore, 2011). PGE2 ability to alter cytoskeletal architecture and 
disrupt the formation of focal adhesions, by activating PTEN (phosphatase and tensin 
homolog deleted on chromosome 10), may also limit myofibroblast differentiation (Bozyk & 
Moore, 2011). Previous studies using the bleomycin model of pulmonary fibrosis have shown 
the protective effects of PGE2 known to act through cAMP/ protein kinase A (PKA) signaling 
(Dackor et al., 2011). In a model of bleomycin-pulmonary fibrosis, anti-fibrotic effect of 
noscapine (an alkaloid used as an antitussive medication in humans) was related with a rapid 
and profound activation of cAMP/PKA signaling mediated by EP2 in pulmonary fibroblasts 
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(Kach et al., 2014). Furthermore, PGE2 had no therapeutic effect on these parameters when 
administered 14 days after bleomycin challenge (Kach et al., 2014).  
In fibroblasts from patients with severe fibrosing systemic sclerosis, levels of mPTGES and 
PGE2 were greatly elevated compared to healthy controls (Stratton & Shiwen, 2010). 
Likewise, mPTGES-1 protein expression was elevated in systemic sclerosis skin fibroblasts 
and in bleomycin-exposed mice (McCann et al., 2011). In addition, mPTGES-1-null mice 
were resistant to bleomycin-induced inflammation, collagen production and myofibroblast 
formation (McCann et al., 2011). Nevertheless, diminished PGE2 levels in patients with 
pulmonary fibrosis and reduced synthesis of PGE2 from fibroblasts obtained from those 
patients were also reported (Moore et al., 2000; Sokolova et al., 2005).  Consistent with the 
notion that inflammation is involved with the onset of fibrosis, it was suggested that early 
PGE2 release following tissue injury promotes inflammatory cell infiltration (Stratton & 
Shiwen, 2010; McCann et al., 2011). This in turn enhances ECM gene induction, via the 
release of TGF-β or PDGF by inflammatory cells, which may cause secondary enhancement 
of fibroblast activation (Stratton & Shiwen, 2010).  
Anti-fibrotic action of PGE2 has also been linked to EP2 or EP4 signaling, although the 
subtype of receptor that is involved on this action seems to be tissue-dependent. In lung 
fibrosis EP2 appear to be responsible for PGE2 anti-fibrotic effects (Huang et al., 2010; Kach, 
et al. 2014; Wei et al., 2014). However, endogenous PGE2-EP4 signaling appears to have 
protective roles against cardiac fibrosis (Ishiwata, et al., 2013; Harada et al., 2017; Wang, et 
al. 2017) and renal fibrosis (Nakagawa, et al. 2012). Nevertheless, in chronic kidney failure 
both EP2 and EP4 receptors seem to be equally important in preserving the progression of 
fibrosis (Xi et al., 2016). Besides being tissue-dependent, the functions of these receptors also 
seem to be context dependent, since increased-EP4 fibrotic effects have been reported. In fact, 
chronic administration of EP4-selective agonist exacerbated albuminuria and fibrosis of the 
kidney in an animal model of type 1 diabetes, through IL-6 (Mohamed et al., 2013). Diabetes-
induced expression of inflammatory cytokines (TNF-a or TGF-b), COL1, CTGF and IL-6 
was enhanced in EP4 agonist-treated mice. Nevertheless, the EP4 agonist used did not alter 
macrophage infiltration. So PGE2–EP4 pathways may play an active role in the progression 
of renal tubulointerstitial fibrosis via EP4 (Mohamed et al., 2013).  It has been proposed that 
high level of IL-1 acts to induce PGE2 production in human lung fibroblasts through PTGS2 
induction and that fibroblast proliferation inhibitory activity of PGE2 is biphasic. EP2 
signaling mediates the proliferative suppressive effects of high concentrations of PGE2, while 
EP3 signaling reduction mediates the proliferative stimulatory effects of mid-range 
concentrations of PGE2 (White et al., 2008). 
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Several conditions that prime the suppression of different PGE2 mediators in the tissues, by 
preventing them from exerting their anti-fibrotic functions, may trigger fibrogenesis. Besides 
impaired PGE2 synthesis, decreased PTGS2 or mPTGES-1 or deficiency of EP2 have been 
shown to promote fibrogenesis. The ability of fibrotic cells to release PGE2 upon thrombin 
stimulation was significantly impaired compared with normal cells (Sokolova et al., 2005). A 
similar reduced capacity of PGE2 synthesis in fibrotic lung fibroblasts was reported for other 
stimuli, in particular for TGF-b1, phorbol myristate acetate (PMA), lipopolysaccharide (LPS), 
and IL-1, due to the diminished ability of fibrotic cells to upregulate PTGS2 mRNA level 
(Sokolova et al., 2005). Impaired production of PGE2 was responsible for enhanced 
fibrogenesis in bleomycin-induced pulmonary fibrosis in granulocyte-macrophage colony-
stimulating factor (GM-CSF) deficient mice. Although GM-CSF is a cytokine that regulates 
the proliferation and differentiation of cells in the granulocyte-macrophage lineage, enhanced 
fibrogenesis was not related to increased recruitment of inflammatory cells (Moore et al., 
2000). In addition, mice deficient in mPTGES-1 exhibited more severe fibrotic lesions and a 
decrease in PGE2 content in lungs after bleomycin treatment (Wei et al., 2014). In cultured 
human lung fibroblast cells, siRNA-mediated knockdown of mPTGES-1 augmented TGF-β1 
and α-SMA protein expression, which was reversed by treatment with PGE2, selective EP2 
agonist and focal adhesion kinase (FAK) inhibitor (Wei et al., 2014). Activation of mPTGES-
1-PGE2-EP2 signaling pathway also seems to exert an essential effect against kidney fibrosis 
(Jia, 2015).  Besides, patients with idiopathic pulmonary fibrosis (IPF) and fibroblasts 
obtained from those patients showed diminished PGE2 synthesis. Yet, those fibroblasts and 
mice with induced fibrosis did not respond to exogenous PGE2 treatment. Down-regulation of 
EP2 and consequent PGE2 resistance in fibroblasts from both mice and humans with 
pulmonary fibrosis were both mediated by DNA hypermethylation; treatment with DNA 
methylation inhibitors decreased EP2 methylation, increased EP2 mRNA and protein 
expression levels, and restored PGE2 responsiveness in fibrotic fibroblasts (Huang et al., 
2010). Also, increased ECM stiffness has been linked to the suppression of lung fibroblast 
expression of PTGS2 and synthesis of PGE2 (Liu et al., 2010).  
Three recent reports recognized PGE2 as an endogenous physiological inhibitor of NETosis 
through EP2 or EP4-signaling. PGE2 clearly reduced NETs formation and directly suppressed 
PMN phagocytosis (Marey et al., 2014). Human patients that highly expressed PGE2 after 
hematopoietic stem cell transplantation have enhanced susceptibility to bacterial pathogens 
and reduced NETosis. Administration of PGE2 resulted in reduced NETosis in vitro and in a 
mouse model (Shishikura et al., 2015). It was proposed that inhibition of NETs by PGE2 
signaling is a universal feature of PMN, since this effect has been observed with PMN 
 
     37 
State of the art 
obtained from different organic compartments and animal species. Also, PGE2 was able to 
inhibit NETosis induced by a variety of stimuli (Domingo-Gonzalez et al., 2016). So, this 
novel role for PGE2 as an inhibitor of NETosis may also be a mechanism of protection 
against the development of chronic diseases. By preventing the uncontrolled release of NETs, 
it prevents perpetuation of stimuli that can trigger a chronic inflammatory process and 
consequent fibrosis. Therefore, this role of PGE2 appears to be directly related to its EP2 or 
EP4 mediated anti-inflammatory and anti-fibrotic effect. 
 
6.3. Molecular mechanisms involved in the persistence of fibroblast-activated state in 
fibrotic tissues 
In tissue fibrosis, fibroblasts maintain their activated state, often until organ death (Kalluri & 
Zeisberg, 2006). The exact molecular mechanisms behind the persistence of this activated-
state fibroblasts in fibrotic tissues, even when the initial insult has regressed are still 
unknown. The continuous secretion of ECM constituents, growth factors and cytokines by 
activated fibroblasts results in a self-perpetuating autocrine loop, which stimulates other 
fibroblasts and prevents resolution of the initial injury (Kalluri & Zeisberg, 2006). Activated 
fibroblasts release chemokines that promote the recruitment and activation of circulating 
leucocytes that produce MMP-9, allowing degradation of the basal membrane and subsequent 
trans-endothelial migration (Van Linthout et al., 2014). In a recent study, it was suggested 
that although TGF-β1 is a critical cytokine in the process of trans-differentiation of proximal 
tubular cells (PTC) in interstitial myofibroblasts, other factors are likely to act in a 
cooperative way to complete the process (Yen et al., 2016). While TGF-b1 alone caused 
incomplete and reversible transdifferentiation of PTC, combination of TGF-b1 stimulation 
and contact with type I collagen substratum cooperatively caused complete and irreversible 
PTC transdifferentiation; also, a time and dose-dependent induction of MMP-9 in PTC was 
seen (Yen et al., 2016). Disruption of the tubular basement membrane by MMP-9 and contact 
of PTC with interstitial components appear to be essential to the TGF-b1-induction of 
epithelial-mesenchymal transition. It was speculated that transdifferentiated PTC once moved 
into the interstitium, attached in a microenvironment rich in type I collagen, causes an 
irreversible phenotypic alteration (Yen et al., 2016). Also, in lung fibrotic tissue, increased 
tissue mechanical stiffness due to ECM components deposition might play a critical role in 
fibroblast activation that promotes and amplifies progressive fibrosis (Liu et al., 2010). This 
self-sustained fibroblast proliferation and ECM synthesis response to increasing ECM 
stiffness was due to the suppression of PTGS2 expression and PGE2 synthesis (Liu et al., 
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2010). Fibroblasts within a stiffened fibrotic lesion were primed to engage in further 
fibrogenic activities (Liu et al., 2010). Since similar stiffness levels and cellular behaviors are 
observed during fibrogenesis in other soft tissues, it was proposed that the mechanobiological 
feedback loop detected in lung fibrotic tissue may represent a common feature of progressive 
fibrosis (Liu et al., 2010). In the early stage of renal fibrosis, the collagen matrix is 
susceptible to proteolysis, and therefore makes fibrosis potentially reversible, leading to 
wound healing (Liu, 2011). However, biochemical modifications of the ECM proteins by 
cross-linking, induced by enzymes such as tissue transglutaminase and lysyl oxidase, render 
them stiff and resistant to proteolysis, as fibrosis progresses (Liu, 2011). 
It was suggested that disease persistence brings about lasting changes to myofibroblasts- a 
form of reprogramming (Duffield, 2014). Studies of liver disease suggest the equivalent 
cellular lineage, such as hepatic stellate cells, can revert to pericytes following resolution of 
chronic disease in vivo, but are persistently reprogrammed to respond more vigorously to a 
new injury (Kisseleva et al., 2012). Epigenetics may also be an explanation for distinct risks 
for developing fibrosis (Zeisberg & Kalluri, 2013). Studies on reprogramming of 
myofibroblasts have focused on DNA methylation patterns in human cells grown from 
diseased versus normal kidney (Bechtel et al., 2010). Fibroblasts from diseased kidney show 
distinct methylation patterns that result in silencing of the RAS intracellular signaling 
pathway and myofibroblast persistence (Bechtel et al., 2010). Chronic stimulation of 
fibroblasts with pro-fibrotic cytokines triggers epigenetic modifications in fibroblasts 
phenotype, like aberrant promoter methylation of specific genes, leads to silencing of genes 
and to the maintenance of an activated phenotype. This endogenous pro-fibrotic mechanism 
exacerbation has been described in systemic sclerosis and in liver, lungs and heart fibrosis 
(Bechtel et. al., 2010; Huang et. al., 2010; Watson et. al., 2014; Bergmann & Distler, 2017). 
 
 
7. Mare endometrial fibrosis 
Endometrosis, chronic degenerative endometritis, endometrial fibrosis and chronic 
degenerative endometrial disease are common names for the same nosological entity. It is a 
severe and complex age-related fibrotic disease (Hoffmann et al., 2009a). Endometrosis is 
characterized by stromal endometrial fibrosis accompanied by periglandular fibrosis, 
sometimes with pathologic nesting of gland branches within a fibrotic matrix around 
periglandular branching points. Lymphatic lacunae and reduction in the number of uterine 
glands and atrophy can also be observed (Kenney et al., 1978). Endometrial vascular 
alterations, such as angiosis and elastofibrosis of arteries, veins and lymphatic vessels in the 
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uterine wall are also seen (Oikawa et al., 1993; Snider et al., 2011; Hanada et al., 2014). The 
incidence and severity of the angiopathies increase as mares age (Schoon et al., 1999; Hanada 
et al., 2014).  Degenerative processes, such as elastosis, lymphangiectasia, excessive exudate, 
loss of epithelium and epithelial hyperplasia, will interfere with mare’s ability to become 
pregnant (LeBlanc & Causey, 2009). 
 For the last 40 years, endometrial biopsy has been the main procedure for histopathologic 
assessment of equine uterine health (Kenney et al., 1978; Snider et al., 2011). A scoring 
system was developed to evaluate endometrial health based on the quality of glands and 
lymphatics, fibrotic changes, and infiltration of inflammatory cells. This score is associated 
with the prognosis of carrying a foal to term (Kenney & Doig, 1986). Mares were classified 
into 4 categories according to the acute and chronic changes observed in the histopathology of 
the endometrium (Kenney & Doig, 1986). An endometrium graded as category I is considered 
normal and healthy, with active, evenly distributed uterine glands and little to no 
inflammatory cells. In category IIA are included endometria with mild, scattered 
inflammation and mild fibrosis, while category IIB corresponds to moderate scattered 
inflammation and moderate fibrosis. In contrast, dilated glands surrounded by layers of 
fibrotic cells are inactive and considered to impair uterine function. They are assigned to the 
most severe score of category III (Kenney & Doig, 1986). Limitations of Kenney-Doig 
system relate to its disregard of important histological findings, such as angioses and 
endometrial maldifferentiation (Snider et al., 2011).  
More recently, an additional system for endometrial evaluation has been proposed, that 
divides the equine endometrosis in a non-destructive (characterized by mild changes in the 
glandular epithelium) and a destructive form (Hoffmann et al., 2009a). In the destructive 
form, glands show signs of extensive epithelial degeneration with loss of normal glandular 
architecture and invasion of the glandular lumen by the stromal cells (Hoffmann et al., 
2009a). Based on the morphology of the stromal cells, an active or inactive state can be 
distinguished in fibrotic foci (Hoffmann et al., 2009a). Active endometrosis contains 
metabolically active stromal cells with active collagen synthesis and ECM deposition, 
whereas inactive endometrosis involves metabolically inactive stromal cells. Hoffmann et al. 
(2009a), based on morphological/immunohistochemical findings during histological 
evaluation, proposed that the pathogenesis of endometrosis, involves an active fibrosis, 
destructive active fibrosis, inactive fibrosis and destructive inactive fibrosis.  Those entities 
represent different evolution phases of the fibrotic process, which are independent of uterine 
control mechanisms (Hoffmann et al., 2009a). In fibrosis, the main source of collagen are 
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activated fibroblasts. These α-SMA-myofibroblast cells have been characterized in altered 
horse endometrium. 
The hallmark histopathologic feature of equine endometrosis is endometrial periglandular 
fibrosis (EPF), where lymphocytes, plasma cells and macrophages infiltrate the endometrium 
(Granjam & Evan, 2006). Morphologically, EPF consists of concentric layers of transformed 
fibroblasts with myofibroblastic features and deposition of fibrillar collagen around unaltered 
glandular basal laminae (Evans et al., 1998). Using picrosirius red-stain, endometrial 
periglandular collagen volume fraction values varied among the different Kenney endometrial 
categories and increased with aging (Evans et al., 1998). Also in mare endometrial fibrotic 
tissue, periglandular stromal cells, expressing α-SMA were characterized 
immunohistochemically as myofibroblasts, with collagen IV, laminin and fibronectin 
deposition outside the basement membrane (Walter et al., 2001). Category IIB endometria 
exhibit an ongoing active myofibroblastic transformation that is absent in category I 
endometrium and is arrested in category III. This myofibroblastic arrest was related to the 
expansion of the ECM (Granjam & Evan, 2006). According to Hoffmann and co-authors 
(2009a), destructive endometrosis is characterized by a large number of α-SMA 
myofibroblasts, pronounced epithelial expression of vimentin, excessive accumulation of 
ECM, glands alterations (cystic dilations and glands destruction) and alteration of the basal 
lamina. Large discontinuities of the glandular basal lamina are predominantly seen in 
destructive endometrosis (Hoffmann et al., 2009a). Also, in all mares with endometrosis, α-
SMA protein expression was detected in fibroblasts surrounding fibrotic uterine glands and a 
high discontinuity of epithelial basal lamina was noted (Mambelli et al., 2014). 
Although α-SMA myofibroblasts responsible for ECM deposition have been identified within 
fibrotic foci, studies concerning the type of collagen are in part, contradictory. In endometrial 
fibrotic tissue, no alterations in collagens type I and III have been referred (Walter et al., 
2001). Likewise, regarding the collagen type, no differences were found among the affected 
endometrial fibrosis areas in all the endometrial tissues (Lunelli et al., 2013). All samples had 
a predominance of type III collagen, although none of those samples were in category III 
(Lunelli et al., 2013). Nevertheless, in an EPF morphometric analysis using picrosirius red 
stained endometrial tissues, deposition of type III and type I collagen was seen in severe 
endometrosis, with collagen type I predominance (Porto, 2006). Additional studies that 
evaluated the endometrial fibrosis in mares, considering histomorphological, histochemical 
and immunohistochemical characteristics of active fibrosis, destructive active fibrosis, 
inactive fibrosis and destructive inactive fibrosis, showed that the arrangement of collagen 
fibers and their characteristics were related to the evolution of the process (Masseno, 2012; 
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Costa 2015). While in both active and destructive active endometrosis a less dense reticular 
collagen arrangement predominates, in inactive and inactive destructive endometrosis, a 
denser collagen prevails. Samples of active destructive endometrosis presented greater 
expression of α-SMA, while weaker expression of α-SMA in fibrotic nests of inactive 
endometrosis reflects the predominance of fibrocytes in these lesions (Masseno, 2012). A 
parallel study with immunohistochemical and picrosirius red stained endometrial biopsies 
revealed that the dense collagen fibers that correspond to type I collagen were prevalent in 
inactive and inactive destructive endometrosis, while the loose collagen fibers correspond to 
type III collagen and were predominant in active and active destructive endometrosis (Costa, 
2015). In the same study, a greater amount of periglandular myofibroblasts were observed in 
active and in active destructive processes, compared to inactive and inactive destructive 
endometrosis (Costa, 2015). It was suggested that the presence of these cells in active 
processes were strongly related to an increased deposition of collagen type III in fibrotic nests 
(Costa, 2015). 
Concerning glandular estrogen (ESR) and progesterone receptors (PGR) expression within the 
fibrotic tissues, Aupperle and collaborators (2000) referred that expression of those receptors 
in the fibrotic glands were lower when compared with non-fibrotic areas. A cycle-
asynchronous staining for ESR and PGR in the stromal cells in the areas of periglandular 
fibrosis and in the glandular epithelia was noted; the affected areas appear to become 
independent of the endocrine uterine control mechanisms (Hoffmann et al., 2009a; Lehmann 
et al., 2011). A mild increase of epithelial ESR and PGR was seen in active non-destructive 
fibrotic foci, while all other types of endometria showed a decrease in their expression, 
mainly in severe destructive fibrosis (Hoffmann et al., 2009a). Likewise, the majority of 
barren (showing destructive mostly moderate type of endometrosis) and foaling (exhibiting 
mild, nondestructive endometrosis) mares had a markedly reduced fibrotic stromal cell 
expression of ESR and PGR compared with the unaltered stroma. Epithelial ESR and PGR 
expression was mildly increased in active nondestructive fibrotic foci and mildly decreased in 
inactive nondestructive endometrosis, both in barren and foaling mares (Lehmann et al., 
2011). However, contradictory results indicated no differences in ESR and PGR expression in 
the endometrium with fibrosis, although in this study there were no type III endometrial 
samples (Lunelli et al., 2013).  
Glandular basal lamina damage seems to be crucial to tissue fibrosis response. Deposition of 
collagen type IV, laminin and fibronectin outside the basement membrane with large 
discontinuities of the glandular basal lamina were predominantly seen in destructive 
endometrosis (Walter et al., 2001; Hoffmann et al., 2009a). In another study, thickness of 
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basal membrane, but not related to increased expression of type IV collagen was observed in 
the active and active destructive endometrosis, while active destructive and inactive 
destructive endometrosis exhibited disruption areas in type IV collagen fibers (Costa, 2015). 
It was suggested that paracrine mechanisms and severe damage of the basal lamina may 
explain the cycle asynchronous pattern of the glandular epithelia within fibrotic foci, since the 
effect of the steroid hormones on the glandular epithelia is physiologically mediated by the 
adjacent stromal cells (Hoffmann et al., 2009a). Direct stromal-epithelial contact, as well as 
interaction between epithelial cell surface integrins and the fibrotic ECM may alter the 
complex paracrine interactions between the epithelia and the underlying stroma (Hoffmann et 
al., 2009a). Thickening of the basal membrane in active and destructive active endometrosis, 
sometimes with its disruption was also noted by Hanada et al. (2014). It was postulated that 
the presence of degenerated or necrotic epithelial cells in periglandular fibrosis was mainly 
due to damage to the basal membrane. This allows a direct contact between stromal and 
epithelial cells, as well as the interactions between fibrotic ECM and glandular epithelial cells 
(Hanada et al., 2014).  
Local hypoxia is discussed in the pathogenesis of endometrosis as a result of perfusion 
disorders of the endometrium in the context of degenerative vessel alterations (Grüninger et 
al., 1998; Hoffmann et al., 2006, Hoffmann et al., 2009a; Masseno, 2012; Hanada et al., 
2014). Angiosclerosis refers to thickening of vessel walls due to degenerative changes leading 
to reduced elasticity of the walls and lower perfusion. In older maiden mares, vessels were 
frequently affected by angiosclerotic changes and the incidence and severity of angiosis 
increased with the number of previous pregnancies and with advancing age (Grüninger et al., 
1998). The results of Hoffmann et al., (2006) showed that two thirds of the mares with 
endometrosis also have angiosclerosis. Contradictory results reported that although large 
percentage of both barren and foaling mares has angiosclerosis, no correlation was found 
between endometrosis and angiosclerosis (Lehmann et al., 2011). Yet, as fibrotic lesions of 
inactive and inactive destructive endometrosis were related to severe vascular fibrotic lesions 
it was suggested that they trigger endometrosis (Masseno, 2012). It was also proposed that 
mare aging could play a role in the pathogenesis of endometrosis, since elastofibrosis of 
arteries, veins and lymphatic vessels in the uterine wall increased with advancing age (Hanada 
et al., 2014). Circulatory disturbances due to intrauterine angiosis or angiopathy, particularly 
the reduction of the arterial blood supply and disturbance of venous drainage, resulting in a 
reduction of lymphatic drainage (lymphatic edema) may be related to the onset and 
progression of endometrial fibrosis (Hanada et al., 2014). Indeed, decreased uterine blood 
flow in older mares with higher Kenney and Doig endometrial categories and impaired 
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uterine vascular perfusion has been found in early pregnant mares with endometrial 
degeneration (Ferreira et al., 2015). 
7.1. Endometrial secretory alterations during the course of endometrosis  
An altered uterine secretion pattern in endometrial fibrotic tissues seems to be due to a 
different paracrine stimulation of the glands by adjacent fibrotic stromal cells, impaired 
hormonal control and/or progressive epithelial destruction (Hoffmann et al., 2009b; Lehmann 
et al., 2011). In Hoffmann et al., (2009b) work, impaired calbindin, uterocalin (transport 
protein which ensures the nutrient supply for the conceptus during the preimplantation period) 
and glycogen by fibrotic tissues was noted. This may lead to an insufficient nutritional supply 
of the early conceptus with its subsequent death. Besides, decreased uteroglobin secretion 
within fibrotic foci was also referred (Hoffmann et al., 2009b). In another study, barren mares 
showing a destructive mostly moderate type of endometrosis, uteroglobin was decreased in 
affected glands, while an increased expression pattern was noted in foaling mares exhibiting a 
nondestructive endometrosis (Lehmann et al., 2011). It was suggested that impaired 
uteroglobin may support the development of fibrosis by enhancing ECM deposition 
(Hoffmann et al., 2009b; Lehmann et al., 2011). In addition, modified uteroglobin secretion 
pattern, by inhibiting phospholipase A2, a key enzyme in prostaglandin (PG) metabolism, 
may be involved in altered PG synthesis in fibrotic tissues (Hoffmann et al., 2009b; Szóstek 
et al., 2012). An independence of glandular fibrotic nests from the ovarian-uterine control 
mechanisms, exhibiting specific differentiation dynamics was proposed as a possible cause of 
the altered mRNA transcription of PG synthases and PG concentration during the course of 
endometrial fibrosis development (Szóstek et al., 2012). Basal secretion of PGE2 and PGF2α 
from incubated category II endometria was higher compared to the secretion of both PG from 
category I tissues, while it was decreased in category III endometrium compared to category I 
(Szóstek et al., 2013). In addition, the highest concentration of PGF2α was found in healthy 
endometria of mares in the follicular phase, with decreased PGF2α production in categories II 
and III endometria in both follicular and mid-luteal phases (Szóstek et al., 2012). In contrast, 
no changes in the secretion profile of PGE2 and PGF2α during the course of fibrosis was also 
reported (Gajos et al., 2015). In that same study, increased PGE2 production was only noted 
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7.2. Physiopathological mechanisms involved in endometrosis 
The physiopathological mechanisms leading to the endometrial periglandular fibrosis (EPF) 
in the mare are still not completed known. Different growth factors and cytokines, especially 
TGF-β1, might be involved in the differentiation of endometrial stromal cells into 
myofibroblasts in mare endometrium. In a study examining equine endometrial mRNA 
expression of TGF-β1 and TNF-α, no differences were found in the expression of this genes 
between endometrial categories (Cadario et al., 2002). Nevertheless, TGF-β1 or TNF-α 
proteins and their receptors were not evaluated. Granjam & Evans (2006) studying the 
involvement of endometrial TGF-b1 and angiotensin-converting enzyme (ACE) during the 
progression of equine periglandular fibrosis found that both TGF-b1 and ACE were present in 
macrophages, endothelium (during angiogenesis), and myofibroblasts at sites of fibrosis. The 
concentration of TGF-b1 increased proportionally with the degree of severity of endometrial 
fibrosis, suggesting its involvement in the phenotypic transformation of fibroblasts into α-
SMA myofibroblasts (Granjam & Evans, 2006). Angiotensin converting enzyme is involved 
in the formation of angiotensin II, a pro-hypertensive vasoactive agent (Harvey et al., 2016). 
It also has an important fibrogenic role by increasing fibrillary collagen synthesis and 
reducing collagenase activity in human hypertensive heart disease (Harvey et al., 2016). It 
acts by stimulating pro-fibrotic signaling cascades including p38 mitogen-activated protein 
kinases (p38 MAPK) and the TGF-b1/SMAD pathway (Harvey et al., 2016). Since 
endometrial ACE-binding activity was consistently higher in equine category IIB endometria, 
it was proposed that locally generated angiotensin II initiates the expression of TGF-b1 
resulting in myofibroblastic transformation (Granjam & Evan, 2006). In contrast, reduced 
expression of both TGF-α or TGF-β isoforms in stromal cells within the different endometrial 
foci was noted (Kiesow et al., 2011). Disturbed hormonal stimulation or stromal synthesis 
disorders due to altered epithelial/stromal interactions were identified as possible causes for 
the decreased TGFs expression (Kiesow et al., 2011). In a study carried out in our laboratory 
the expression of TGF-β1 and its receptors in category IIB or III mare endometrial tissues was 
evaluated by immunohistochemistry (Cardoso, 2015). Expression of TGF-β1 and its receptors 
was noted in all mares. TGF-β1 and TGFBR1 showed a similar expression pattern and were 
mainly found in the glandular epithelium, endothelium and macrophages. Higher expression 
of TGF-β1 and TGFBR1 in the glandular epithelium of dilated glands or in the glands located 
in fibrotic foci was noted. TGFBR2 showed a different expression pattern, as no expression of 
this receptor was found in endothelial or in glandular epithelial cells. Its expression was more 
sporadic and found mainly in stromal cells involving dilated glands or glandular nests, ciliated 
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cells and macrophages (Cardoso, 2015). Besides, endometrial TGFBR1 and TGFBR2 genes 
transcription was lower in equine category I/IIA endometria, while increased 
TGFBR1:TGFBR2 mRNA ratio in IIB/III tissues were detected (Morazzo, 2017; Morazzo et 
al., 2017). So, the expression of TGF-β1 and its receptors in fibrotic endometrial tissues 
suggests a role of this pro-fibrotic cytokine in the progression of mare endometrosis.  
Nodal is a member of the transforming growth factor-beta (TGF-β) superfamily. The Nodal/ 
Lefty (antagonist that blocks Nodal receptor complex) pathway was shown to be involved in 
endometrial regulation of ECM and connective tissue during the menstrual cycle and Nodal 
activity was upregulated in endometrial carcinomas tissues that lacks Lefty (Papageorgiou et 
al., 2009). Presence of Nodal in the corpus luteum of the mare was related to the mechanism 
responsible for functional luteolysis, decreasing PGE2 and increasing PGF2α (Galvão et al., 
2016). The presence of Nodal and its relationship with fibrogenesis was most recently 
evaluated in mare endometrium (Volpi et al., 2014; Morazzo, 2017; Morazzo et al., 2017). 
Nodal and its receptors ALK-4 and ALK-7 proteins were expressed in superficial and 
glandular epithelium, with lower staining of ALK-7, regardless of estrous phase and 
endometrium category (Volpi et al., 2014).  In addition, mRNA transcription of Nodal and its 
receptors was lower in categories I and IIA, compared to categories with strong fibrosis (IIB 
or III) (Volpi et al., 2014).  When Nodal was used in culture, it was able to enhance mRNA 
expression of TGF-β1 receptors, TGFBRI and TGFBRII, in category I/IIA endometria 
(Morazzo, 2017). Nodal was also able to alter prostaglandin pathways. It inhibited PGE2 
production in follicular phase and gene transcription of its EP2 and EP4 receptors in category 
I/IIA endometria (Morazzo, 2017), both conditions linked to impaired anti-fibrotic action of 
PGE2 in other tissues (Bozyk & Moore, 2011). In addition, the production of PGF2α increased 
in mid-luteal phase endometrial tissues with Nodal stimulation (Morazzo, 2017), which is 
related to a pro-fibrotic effect in other organs, like lung (Oga et al., 2009). 
Since in endometrial fibrosis ECM components deposition occurs, the involvement of ECM 
degrading endopeptidases known as MMPs and their inhibitors (TIMPs) has also been 
addressed. During the normal equine estrous cycle, secretion of MMP-2 and MMP-9 into the 
uterine lumen is minimal, although increased inhibitory activity is seen by TIMP-2 during 
diestrus (Oddsdóttir, 2007). Results concerning MMPs in fibrotic endometria are in part 
contradictory. Walter et al. (2005), reported that overall MMP-2 expression increased in 
severely affected endometrial tissues mainly in diestrus. Likewise, a more intense immune 
reaction for MMP-2 in glandular epithelial cells of category III tissues, but a decreased MMP-
9 in vascular walls in fibrotic tissues were observed (Porto et al., 2011). It was proposed that 
this decreased expression of MMP-9 in vascular walls could be related to impaired 
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angiogenesis, which would lead to a greater accumulation of fibrotic tissue (Porto et al., 
2011). In another study MMP-2 was also increased in stromal cells of all endometrial foci, 
and it was hypothesized this could be responsible for the progressive destruction of the 
glandular basal lamina (Kiesow et al., 2011). Also, we have shown that in mid-luteal phase 
endometrial explants, PMN elastase, increased active MMP-9 expression after 24h 
incubation, and pro-MMP-2 after 48h (Rebordão et al., 2015). The results of these studies are 
consistent with those described in lung fibrosis establishment. In the early stages of this 
disease, the activity of MMP-9 appears to be predominant, and likely contributes to the 
disruption of the alveolar epithelial basement membrane allowing fibroblast invasion of 
alveolar spaces (Wang et al., 2011). In the late stages of the disease, MMP-2 appears to 
become predominant. TIMP-1 gene expression was also up-regulated during fibrosis (Wang et 
al., 2011). Overexpression of TIMPs, leading to an imbalance between MMPs and their 
inhibitors results in a microenvironment unfavorable to collagenolytic activity (Wang et al., 
2011). Epithelial basement membrane integrity plays an important role in determining normal 
lung re-epithelialization or fibrotic response (Wang et al., 2011). Indeed, contact with the 
interstitial components seems to be a crucial event for complete and irreversible fibroblast 
transdifferentiation (Yen et al., 2016). It was proposed that during the progression of lung 
fibrosis MMP-9 was linked to inflammation-induced tissue remodeling, while MMP-2 was 
associated with impaired tissue remodeling, leading to pathological collagen deposition and 
interstitial lung fibrosis (Wang et al., 2011). Nevertheless, MMPs-dependent functions during 
fibrosis are not limited to effects on ECM turnover but they are also involved in regulating the 
activity of a range of immunoregulatory molecules (Giannandrea & Parks, 2014). As MMP-9 
is a potential activator of latent TGF-β1 and, hence, might be a pro-fibrotic mediator 
(Giannandrea & Parks, 2014), besides being involved in the disruption of epithelial basement 
membranes, it can be indirectly involved in myofibroblast formation. However, in other 
studies evaluating MMP-TIMP pathways in the course of endometrosis, dissimilar results 
were obtained. No differences in MMP-2, MMP-9, MMP-14 (an enzyme capable to activate 
MMP-2 and MMP-9) and TIMP-2 expression between endometrial categories were referred 
(Aresu et al., 2012). Also, in another study MMP-2, MMP-14 and TIMP-2 gene expression 
was detected at lower levels in pathologic endometrium, whereas transcription of MMP-9 was 
much higher when compared to healthy tissue values (Falomo et al., 2015). 
7.3. Reproductive implications of endometrosis 
Endometrosis is a multi-factorial disease. Age, repeated pregnancies, parturition, chronic 
inflammation, and endocrine problems are all factors which seem to play a determinant role in 
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the onset and severity of endometrosis (Hoffmann et al., 2009a. The occurrence of aberrations 
in endometrial glands, blood and lymphatic vessels; the altered endocrine milieu; and the 
disturbances in uterine secretory functions in endometrosis create a poor uterine environment 
that may contribute to embryonic loss. 
Fibrosis involving the base of the glands (resulting in the formation of fibrotic nests), or 
surrounding the ducts of the glands, reduces the secretion flow and may result in glandular 
dilation and cysts formation (Walter et al., 2001). Reduction in the number and area of intact 
and healthy glands, decreases the chance of keeping a viable conceptus in the uterus (Kenney, 
1978), since the exchange of nutrients and metabolic end-products via the placenta cannot be 
adequately ensured.  
Some embryonic loss in mares suffering from endometrosis can be explained by insufficient 
uterine secretory activity (Hoffmann et al., 2009b). Collagen deposition around endometrial 
glands, with irregular differentiation of epithelial cell in the fibrotic glands, or associated with 
the basal membrane, compromises the integrity and function of those glands and impairs 
glandular secretions (Walter et al., 2001; Hoffmann et al., 2009b). Altered glandular secretion 
of histotroph, may contribute to pregnancy failure through delayed placental development, 
retarded fetal growth rate or abortion (Kenney, 1978; Walter et al., 2001; Hoffmann et al., 
2009b; Lehmann et al., 2011). Also, reduced uterine blood flow and impaired fetal-maternal 
interactions in endometrosis-affected mares could be unfavorable for embryonic/fetal 
development (Klewitz et al., 2015). Lymphangiectasia secondary to vascular degeneration, 
damage to or lack of endometrial cilia (Ferreira-Dias et al., 1994, 1999), impairing the 
physiological lymphatic and mucociliary uterine clearance will interfere with mare’s ability to 
become pregnant (LeBlanc & Causey, 2009; LeBlanc, 2010). 
In severely and chronically inflamed endometria, there can be loss of the epithelium, 
disruption of luminal architecture, loss of uterine mucus blanket and increased opportunities 
for bacterial adhesion. These changes may further contribute to persistence of uterine 
infection (LeBlanc & Causey, 2009; LeBlanc, 2010).   
In a previous work, fibrosis in the allantochorion was the main histological abnormality seen 
in the allantochorion-endometrium adhesion that occurred in 88% of the mares with retained 
fetal membranes (Rapacz et al., 2012). Adhesion of the allantochorion to the endometrium 
was correlated to abortion and preterm delivery, due to abnormalities in the process of 
placental tissues maturation (Rapacz et al., 2012). Although, in this study the presence of 
fibrotic lesions in the endometrium of these mares was not evaluated, putative development of 
allantochorion fibrosis in mares with endometrial fibrosis may also be related to abortion and 
preterm delivery.  
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7.4. Endometrosis treatment   
Stem cells are characterized by their ability to self-renewal and differentiate into a diverse 
range of specialized cell types (Gulati et al., 2014). Mesenchymal stem cells (MSCs) are a 
heterogeneous subset of stromal cells that have the ability of self-renewal and multipotency, 
which could differentiate into cells of the different lineages and that have several anti-
inflammatory actions (Gulati et al., 2014). By producing bioactive mediators and adhesion 
molecules MSCs reduce scar tissue formation and cell apoptosis, increase angiogenesis and 
stimulate the intrinsic cell population to regenerate function (Gulati et al., 2014). Somatic 
stem cells subpopulation - Side Population cells are cells that present characteristics of stem 
cells (Cervelló et al., 2010). Their presence in the mare endometrium has been shown (Pereira 
et al., 2014; Dias, 2014), although no study has determined their presence in the endometrium 
of mares with fibrosis. 
Currently no effective treatment is available for endometrosis. Recent studies have focused on 
the use of MSCs to try to reverse or delay the progression of mare endometrial fibrosis. 
However, the results obtained in this small number of studies carried out so far are 
inconsistent. Mambelli and co-authors (2013) using a technique similar to artificial 
insemination, were able to show homing of fluorescently labeled equine adipose tissue-
derived MSCs in glandular and periglandular spaces of endometrial biopsies collected 7 and 
21 days after delivery of MSCs into the uterus of mares with endometrosis. Nevertheless, in 
one mare, with a very severe degree of endometrosis, MSCs cells could not be identified. A 
severely affected uterine environment preventing the incorporation of these MSCs or the 
damaged microenvironment might not have allowed reproducible propagation of MSCs 
(Mambelli et al., 2013). In another study, the same group showed that equine adipose tissue-
derived multipotent mesenchymal stem cells (eAT-MSCs) were able to positively modulate 
the expression pattern of secretory proteins. In addition, they were also able to induce 
glandular epithelial cells proliferation suggesting local benefits to committed endometrial 
tissue environment after eAT-MSCs transplantation (Mambelli et al., 2014).  Expression of α-
SMA cells were no longer observed in endometrial uterine glands of fibrotic tissues, 7 days 
after the animals received eAT-MSCs treatment, inducing an early remodeling of endometrial 
tissue microenvironment (Mambelli et al., 2014). It was suggested that the preventive use of 
stem cells therapy by slowing down the degenerative process may be used in those mares with 
severe endometrial degeneration that had not responded to treatment (Mambelli et al., 2014). 
However, in another study it was not possible to detect a clear effect of autologous bone 
marrow (BM)-MSCs transplanted into the endometrium of mares with endometrosis in the 
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expression of the profibrotic cytokine TGF-β1 and its receptors TGFBRI and TGFBRII 
(Cardoso, 2015; Cardoso et al., 2016). After infusion of autologous BM-MSCs in the 
endometrium of 7 mares with endometrosis, a decreased intensity of TGF-β1 and TGFBRI at 
D30 and D60 was only detected in 2 mares but the expression of TGFBRII did not change 
after BM-MSCs treatment (Cardoso, 2015; Cardoso et al., 2016). Likewise, no clear potential 
clinical effect of equine adipose-derived stem cells (ADSCs) on equine endometrosis in in 
vitro experiments were noted in Falomo et al., (2015) study. Although ADSCs were able to be 
incorporated into endometrial periglandular space and in single glands, both positive and 
negative effects of equine ADSCs on inflammatory processes regulation in the endometrium 
was noted (Falomo et al., 2015). Fibrotic endometrial tissues exposure to the ADSCs resulted 
in a reduction of IL1-b, TNFα, IL-10 and IL1RN, downregulating chronic inflammation, but 
it also increased the levels of pro-inflammatory IL-6 and IL-8 (Falomo et al., 2015).  
In view of these results, it seems unlikely that local infusion of MSCs will reverse severe 
fibrotic changes. However, there may be beneficial effects in its use, delaying the evolution of 
the fibrotic process in endometrial tissues with less severe degenerative changes. Further 
longer studies are needed with a larger number of animals, using different MSC protocols 
(source and amount of MSC, phase of the estrous cycle in which local MSC treatment is 
applied, number of required infusions, simultaneous MSC treatment by systemic route, among 
others). Besides, further investigation on the effects of MSC on additional 
inflammatory/fibrotic markers in order to draw conclusions regarding the putative efficacy of 
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1.1. Abstract 
Oxytocin (OXT) has been used to prolong the luteal phase in mares, but its mechanism of 
action is unknown. The aim of this study was to evaluate the effect of chronic exogenous 
oxytocin administration to mid-luteal phase mares on luteal maintenance. Also, endometrial 
expression of prostaglandin endoperoxide synthase 2 (PTGS2), prostaglandin F2a, E2 and I2 
synthases (AKR1C3, PTGES, PTGIS), receptors for oxytocin (OXTR), progesterone (PGR), 
estrogen receptors 1 (ESR1) and 2 (ESR2) were assessed in mares experiencing luteal 
maintenance two weeks after chronic exogenous OXT administration. Control mares (n=5; C-
group) received 6 mL of saline im, while OXT (60 units/mare) was administered im (n=6; 
OXT-group), every 12h, on days 7-14 post-ovulation. After endometrial biopsy in groups C 
(day 10) and OXT (day 24), luteolysis occurred within 3 or 6 days, respectively. Luteal 
maintenance took place in 4/6 (67%) of OXT treated mares. Progesterone in C-group was the 
highest on biopsy day (P < 0.05). In OXT mares, PTGS2, ESR1 (p<0.05), PTGES, PTGIS, 
PGR, ESR2 (P < 0.01) gene transcription decreased, while OXTR increased (P < 0.05) in 
comparison to C-group. In OXT treated mares, endometrial ESR2 protein expression 
decreased (P < 0.05), but OXTR increased (P < 0.05), when compared to control animals. In 
both experimental groups, PTGS2 was mainly immunolocalized in surface epithelium, while 
AKR1C3, PTGES, PTGIS and PGR were in surface and glandular epithelia. ESR1 and ESR2 
were found in glandular epithelium, and OXTR in stromal cells. High immunolabeling for 
PTGES, PTGIS, PGR and OXTR and low for ESR2 was detected in endometrium of OXT-
group mares with extended diestrus. Prolonged luteal function associated with chronic OXT 
treatment may be related to different spatial expression of OXTR and PGR in the 
endometrium. The observed reduction of endometrial ESR2 may be responsible for the 
maintenance of PGR in luminal and glandular epithelium. Also, ESR2 may attenuate the 
transcriptional activity of ESR1 in mare endometrium. This study offers new knowledge on 
the endometrial expression of ovarian steroids and OXT receptors in OXT pharmacologically 
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1.2. Introduction 
Oxytocin (OXT) exerts a variety of actions and is involved in a large number of physiologic 
processes, such as regulation of luteal function. Oxytocin is stored in posterior pituitary 
vesicles and released into the peripheral circulation in high frequency bursts in late diestrus 
(Vanderwall et al., 1998). In the mare, this hormone is also synthesized by endometrial cells 
and secreted into the uterine lumen where it has an important role in the autocrine/paracrine 
control of uterine contractility and luteolysis (Watson et al., 2000). Endometrial OXT 
concentrations are positively correlated with serum estradiol-17b (E2) concentration 
(Behrendt-Adam et al., 1999, Bae & Watson, 2003). Nevertheless, hormonal regulation of 
OXT receptors (OXTR) in equine endometrium appears to differ from ruminants (Fleming et 
al., 2006), since in mares OXTR expression is low at estrus (Sharp et al., 1997; Ruijter-
Villani et al., 2015). 
Luteolysis occurs on days 14 to 16 of the equine estrous cycle (Ginther et al., 2011). 
Although E2 is apparently not required for luteolysis in mares (Ginther et al., 2005), in other 
mammals, E2 is considered a key regulator of OXTR gene expression (Kimura et al., 2003). 
In the mare, E2 plasma concentrations begin to increase approximately 2 days before the 
onset of luteolysis (Ginther et al., 2005). In late luteal phase (day 14-15), OXT gene 
expression (Behrendt-Adam et al., 1999) and OXTR concentration in mare endometrium 
increase and mediate prostaglandin (PG) release (Sharp et al., 1997; Starbuck et al., 1998). 
Afterwards, OXTR activation stimulates mitogen activated protein kinase (MAPK), which 
regulates prostaglandin-endoperoxide synthase gene expression (Soloff et al., 2000). At day 
15, an increase in both mRNA and protein levels of PTGS2 in luminal epithelium has been 
detected (Boerboom et al., 2004; Atli et al., 2010). These enzymes convert arachidonic acid 
to PGH2, which can be converted to PGF2α by AKR1C3 in the uterus. OXT binding to its 
receptor is responsible for stimulating both frequency and amplitude of endometrial surges of 
PGF2α necessary for luteolysis (Sharp et al., 1997; Starbuck et al., 1998). In response to 
PGF2α luteolytic pulses over a 23-h period, the CL undergoes functional and structural 
regression (luteolysis), and progesterone (P4) progressively decreases to values below 
1ng/mL (Ginther et al., 2011). 
Although endogenous OXT action is involved in PGF2α endometrial secretion during 
spontaneous luteolysis in mares (Sharp et al., 1997; Starbuck et al., 1998; Vanderwall et al., 
2007), PGF2α response to exogenous OXT treatment depends on the phase of the estrous 
cycle (Neely et al., 1979; Vanderwall et al., 2016). Although PGF2α endometrial secretion is 
highest around the time of luteolysis (days 11-15 post-ovulation) and is associated with an 
increase in endometrial OXTR expression (Sharp et al., 1997; Starbuck et al., 1998), when 
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exogenous OXT is administered in mid luteal phase (day 8 to 14), it blocks luteolysis and 
prolongs the luteal phase (Stout et al., 1999; Vanderwall et al., 2007; Vanderwall et al., 2012; 
Gee et al., 2012; Keith et al., 2013). The exact mechanism involved in this action is unknown.  
Since ovarian steroid hormones are essential mediators of utero-ovarian function acting 
through specific receptors and PG pathways, their relationship with OXT throughout the mare 
estrous cycle has to be considered. As in other mammalian species, in mare endometrium, E2 
produced in the follicular phase up-regulates its own nuclear receptors (ESR), as well as P4 
receptors (PGR) (Hartt et al., 2005). The effects of E2 are exerted in the endometrium via 
ESR1 and ESR2, which are the two-main classical nuclear receptor isoforms (Hapangama et 
al., 2015). Although there are two predominant isoforms of nuclear PGR (PGR-A and PGR-
B), PGR-A is the major functional isoform in the uterus (Conneely & Lydon, 2000). In the 
mare, during estrus, high endometrial levels of ESR1, ESR2 and PGR mRNA and protein 
have been detected in luminal, glandular epithelia and stromal cells (Watson et al., 1992; 
Hartt et al., 2005; Honnens et al., 2011; Gebhardt et al., 2012; Silva et al., 2014). Moreover, 
the relative mRNA expression of ESR1 and ESR2 in mare endometrium seems to be 
positively correlated (Honnens et al., 2011). In the luteal phase, when circulating levels of P4 
are high, endometrial expression of ESR1, ESR2 and PGR are inhibited (Hartt et al., 2005). 
This expression decreases in stroma and deeper glandular epithelium and does not exist in 
luminal epithelium on days 11 and 14 of the mare estrous cycle (Hartt et al., 2005). Between 
days 17 to 20 of the estrous cycle, both ESR and PGR transcripts and protein increase in 
luminal and glandular epithelia and in stromal cells (Hartt et al., 2005). We hypothesized that 
chronic OXT administration to mares in mid-luteal phase would be able to prolong luteal 
function by modulating PG pathways, steroid hormones and OXT receptors in the 
endometrium. Several studies have implicated those endometrial pathways in the beginning of 
OXT induced luteal maintenance (Day 14 post-ovulation) (Stout et al., 1999; Vanderwall et 
al., 2007; Vanderwall et al., 2012; Keith et al., 2013). Thus, the aim of the present study was 
to evaluate the endometrial expression of PTGS2, AKR1C3, PTGES, PTGIS, OXTR, PGR, 
ESR1 and ESR2 following the administration of exogenous OXT in mid to late luteal phase 
(day 7 to 14 after ovulation) to induce luteal maintenance.       
1.3. Materials and methods 
1.3.1. Animals 
This study was carried out on Lusitano mares aged from 3 to 17 years, weighing between 450 
and 500 Kg. All had normal estrous cycles throughout the study period (between early June 
and early August). The animals were housed in boxes, fed grass hay and commercial 
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concentrate mix with free access to trace mineral salt blocks and water. All mares were 
routinely subjected to regular husbandry procedures, such as deworming and vaccinations. 
The protocol was approved by the Ethical Committee of the Faculty of Veterinary Medicine, 
University of Lisbon, Lisbon, Portugal. 
  
1.3.2. Experimental design 
Throughout the entire experimental period, all mares were teased daily by a single stallion to 
detect estrous behavior. Each mare’s genital tract was evaluated every-other-day by 
transrectal palpation and ultrasonography (Falco, 6MHz linear transducer) for detection of 
ovulation (day 0), corpus luteum (CL) size monitoring and signs of estrus return (endometrial 
edema). A crossover design was used, so that the same animal received each of the two 
treatments sequentially. On day 7 of the estrous cycle, mares were randomly assigned to two 
groups: control group (n=5; C-group) and oxytocin group (n=6; OXT-group). On days 7-14 
after ovulation, OXT mares received 60 units (10 units/mL) of oxytocin, im, every 12 hours; 
control mares received 6 mL of saline solution im on the same schedule. Blood samples were 
obtained every-other-day via jugular venipuncture.  
 
1.3.3. Endometrial biopsies  
Nonsurgical endometrial biopsies were collected using sterile uterine alligator jaw forceps 
guided through the cervix into the uterus. Two biopsies per mare were obtained from the 
ventral wall at the base of each uterine horn. We have observed that endometrial biopsy in 
mares in mid-luteal phase stimulates luteolysis in about 3 days (unpublished data), thus 
obtaining endometrial samples for evaluation of causes for OXT-stimulated luteal 
maintenance disturbed the process of luteal maintenance. Collecting endometrium at the time 
of expected endometrial secretion of PGF2 in response to OXT (endogenous or exogenous) 
(Sharp et al., 1997; Starbuck et al., 1998) in control mares to compare with samples obtained 
following confirmation of OXT-stimulated luteal maintenance was therefore necessary. 
Control group endometrial biopsies were performed on day 10 post-ovulation, when a 
functional and structurally mature CL was present (Ferreira-Dias et al., 2006). In OXT treated 
mares, biopsies were obtained following luteal maintenance for 8-10 days beyond the 
expected time of normal luteolysis, on day 24, which was the earliest feasible time to confirm 
a retained CL; spontaneously prolonged luteal function in mares persists for at least 30 and 
often 60 days post-ovulation (Vanderwall et al., 2007; Vanderwall et al., 2012). Thus, 
comparisons were made of endometrial conditions before luteolysis in saline treated mares 
and after initiation of prolonged luteal function in OXT treated mares. 
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Biopsy samples were divided and placed in RNA stabilization reagent (RNAlater®, 76104, 
Qiagen, Hilden, Germany) for mRNA assessment (Real Time PCR); stored at –80º C for 
protein quantification (Western blot); or placed in 4% buffered formaldehyde for histologic 
evaluation and immunohistochemistry. Samples preparation included fixing with 
formaldehyde overnight, dehydration in a series of ethanol dilutions, xylene infiltration, and 
embedding in paraffin. Tissue was cut into 4 µm histological sections and stained with 
hematoxylin eosin for tissue microscopic evaluation.  
 
1.3.4. Analysis of blood samples 
Blood samples were collected using heparinized tubes (monovettes®, Sarstedt, Numbrectht, 
Germany). Plasma obtained after centrifugation was kept frozen at -20ºC until further 
analysis. Circulating concentrations of P4 were assayed in duplicate and measured by a 
validated solid-phase Radioimmunoassay (RIA), without extraction, using a commercial kit 
(Coat-A-Count; Diagnostic Product Corporation, Los Angeles, CA, USA), and a Wallac 
(Wizard 1470) counter. The limit of detection of the assay was 0.02 ng/mL, all samples were 
run in the same assay and the intra-assay coefficient of variation for all samples was 3.4%. 
Circulating P4 concentrations were used to evaluate luteal function. Concentrations higher 
than 1 ng/mL were considered indicative of functional luteal tissue. 
 
1.3.5. Real-Time PCR 
Real Time PCR was used to assess mRNA gene expression of PTGS2, AKR1C3, PTGES, 
PGIS, OXTR, ESR1, ESR2 and PGR, as described (Galvão et al., 2012). Briefly, RNA 
extraction from frozen endometrial biopsy samples was performed using a Total RNA 
Extraction and Purification kit (ref. 74124, Qiagen GmbH, Germany), and DNA digestion 
with RNase-free DNase Set (ref. 50979254, Qiagen, Germany). Reverse transcription by 
superscript III enzyme (N2511, Promega, Madinson, USA), was carried out from 0.8 µg total 
RNA in a 20 µL reaction volume, using oligo (dT) primer (C1101, Promega, Madinson, 
USA) and cDNA was stored at -20ºC. Specific primers for PTGS2, AKR1C3, PTGES, PTGIS, 
OXTR, ESR1, ESR2, PGR and reference genes were designed (Table 1), as before (Galvão et 
al., 2010). Four potential reference genes were tested to determine the most stable internal 
control gene for our endometrial samples: glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), succinate dehydrogenase A complex, subunit A, flavoprotein (SDHA), beta-2-
microglobulin (B2M) and ribosomal protein L32 (RPL32). RPL32 was found to be the most 
stable internal control gene (less than 2-fold changes between different biological conditions) 
(Dheda et al., 2004). After primer concentration optimization, Real-time PCR assays were 
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performed using the 7300 Real Time PCR System. Detection of PCR products was achieved 
with DNA-intercalating dye SYBR Green I, in a 25uL reaction volume. Relative mRNA 
quantification data were analyzed with the Real-time PCR Miner algorithm (Zhao & Fernald, 
2005). Expression of target genes was normalized against that of reference gene and mRNA 
expression compared between control and OXT treated mares. 
 
Table 1- Primer sequences used for prostaglandin synthases, ovarian steroids and oxytocin 
receptors real time PCR analysis of mare endometrial biopsies. 
 
AKR1C3- aldo-keto reductase family 1, member C3; ESR1- estrogen receptor 1; ESR2- estrogen 
receptor 2; OXTR- oxytocin receptor; PGR-  progesterone receptor; PTGES- microsomal prostaglandin 
E2 synthase 1; PTGIS- prostaglandin I2 synthase; PTGS2- prostaglandin-endoperoxide synthase; 
RPL32- ribosomal protein L32;   
 
1.3.6. Immunohistochemistry analysis 
The presence of PTGS2, AKR1C3, PTGES, PTGIS, OXTR, ESR1, ESR2 and PGR was 
assessed by immunohistochemistry (IHC). The detection was performed on 4 µm endometrial 
sections by an immunoperoxidase method using specific antibodies and NovoLink Max 
Polymer Detection System Kit (Leica Biosystems Newcastle Ltd, Newcastle, United 
Kingdom), as previously described (Galvão et al., 2013). Primary antibodies dilution, 
incubation time and temperature are specified on Table 2. The primary antibody was detected 
by incubating samples with anti-mouse/rabbit IgG -Poly-HRP (each at 8µg/mL) containing 
10% (v/v) animal serum in TBS/0.09%ProClinTM 950 for an additional 30 min. Staining was 
achieved by a 5min incubation in 3,3-diaminobenzidine (DAB) peroxidase substrate solution. 
Slides were counterstained with hematoxylin prior to mounting. 
 
Rebordão et al.  
 




















Forward: ACCACCCTCCCACAGAAGGT 177 
Reverse:  AAAGAGGAGGAGGCGGTCAC 
OXTR 
(XM_001491665.2) 
Forward: TGGACGCCATTCTTCTTCGT 141 
 Reverse: GCCCGTGAACAGCATGTAGA 
ESR1  
(GeneID: 791249) 
Forward: ACGATGCCACCAGACCATTT 160 
Reverse:  AGCCAGGCACATTCCAGAAG 
ESR2 
(GeneID: 100033964) 
Forward: CCCTTCACCGAGTCCTCCAT 232 
Reverse:  TCCCTGTCCAGAACGAGGTC 
PGR 
(GeneID: 100033883) 




Forward:  AGCCATCTACTCGGCGTCA 144 
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Table 2- Primary antibodies dilution, incubation time and temperature used in 
immunohistochemistry and western blotting analysis of mare endometrial biopsies. 
 
PTGS2- mouse anti-rat COX2 antibody, Clone 33, (610204, BD Biosciences); PGFS rabbit Anti-
AKR1C3 antibody (ab137546, abcam); PTGES- rabbit Prostaglandin E Synthase-1 (microsomal) 
Polyclonal Antibody (160140, Cayman Chemical); PGIS- rabbit Prostaglandin I Synthase Polyclonal 
Antibody (100023, Cayman Chemical); OXTR- rabbit Oxytocin-R (H60) Antibody (SC 33209, Santa 
Cruz biotechnology); ERα- rabbit anti- Estrogen Related Receptor alpha antibody (ab 16363, abcam); 
ERβ- rabbit anti-Estrogen Receptor beta antibody (ab 3577, abcam); PR- mouse anti-Progesterone 
Receptor, Clone 1A6 (PR08-1150, Invitrogen); ON- overnight; RT-room temperature. 
 
Negative controls were performed with primary antibody replaced by rabbit polyclonal IgG 
(ab 27478, Abcam) and mouse IgG (550878, BD Bioscience) for antibodies developed in 
rabbit and mouse respectively, at the same concentration and incubation time. 
Immunostaining appeared as a characteristic brown staining, and was assessed by light 
microscopy (Olympus BX51, Tokyo, Japan) equipped with a DP11 Olympus camera (Tokyo, 
Japan). Luminal and glandular epithelial and stromal staining area and intensity were assessed 
on 10 random fields by three evaluators blinded to treatment groups. Intensity of 
immunolabeling was quantified by a subjective score (1. no staining; 2. weak staining; 3. 
moderate staining; 4. intense staining). Scores from all evaluators were averaged for each 
endometrium slide. 
 
1.3.7. Western blot analysis 
Western blot was used to quantify PTGS2, ESR1, ESR2 and OXTR protein expression. 
Protein extracts were prepared from frozen endometrial biopsy samples. Briefly, tissues were 
homogenized on ice in RIPA buffer (50 mM Tris-HCl, pH 8; 150 mM NaCl; 1% Triton X-
100; 0.5% sodium deoxycholate; 0.1% sodium dodecyl sulphate) with protease inhibitors 
(Complete Mini Protease Inhibitor Cocktail Tablets, 1 tablet per 10 ml of buffer; Roche) and 
disrupted using an Ultrasonic homogenizer (Bandelin Sonopuls; Berlin, Germany). Protein 
content of the supernatants was quantified using the Bradford (ref. 500-0006, Bio-Rad, 
Hercules, CA, USA) method, and 100 µg of protein was separated by SDS-PAGE (10% 
Rebordão et al. 
 
Table 2. Primary antibodies dilution, i cubation time and temperature used in 
immunohistochemistry and western blotting analysis of mare endometrial biopsies. 
 
 
PTGS2- mouse anti-rat COX2 antibody, Clone 33, (610204, BD Biosciences); PGFS- 
rabbit Anti-AKR1C3 antibody (ab137546, abcam); PGES- rabbit Prostaglandin E 
Synthase-1 (microsomal) Polyclonal Antibody (160140, Cayman Chemical); PGIS- rabbit 
Prostaglandin I Synthase Polyclonal Antibody (100023, Cayman Chemical); OXTR- rabbit 
Oxytocin-R (H60) Antibody (SC 33209, Santa Cruz biotechnology); ERα- rabbit Anti-
Estrogen Related Receptor alpha antibody (ab 16363, abcam); ERβ- rabbit Anti-Estrogen 
Receptor beta antibody (ab 3577, abcam); PR- mouse anti-Progesterone Receptor, Clone 














 Immunohistochemistry Western blot 
Primary 
antibody 
Dilution Incubation Dilution Incubation 
Time/Temperature Time/Temperature 
PTGS2 1:100 ON, 4ºC 1:250 ON, 4ºC 
AKR1C3 1:100 ON, 4ºC   
PTGES 1:100 ON, 4ºC   
PTGIS 1:100 ON, 4ºC   
OXTR 1:500 1h, RT 1:1000 1 h, RT + 0,5h, 37ºC 
ESR1 1:100 ON, 4ºC 1:500  ON, 4ºC 
ESR2 1:500 ON, 4ºC 1:1000 ON, 4ºC 
PGR 0,6µg/ml ON, 4ºC   
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acrylamide gel; ref. 161-0155, Bio-Rad, Hercules, CA, USA). Gels were subsequently 
transferred to nitrocellulose membranes (Ref. 10401396, Whatman; GE Healthcare Europe 
GmbH, Lisbon, Portugal) and incubated with the same specific primary antibodies used for 
immunohistochemistry analysis. Table 2 lists the specific dilution, temperature and time of 
incubation of primary antibody. To normalize loaded protein, diluted (1:10,000) mouse 
monoclonal antibody against β actin (A5441, Sigma) was used. Incubation with secondary 
antibodies was performed, for 2.5h at room temperature, with 1:20,000 diluted horseradish 
peroxidase (HRP)-conjugated anti-rabbit (P044801- Dako, Denmark) for all rabbit produced 
primary antibodies and HRP-conjugated goat anti-mouse (A2554, Sigma) for PTGS2, PGR 
and for β-actin (1:10,000 dilution). Chemiluminescent detection was achieved by incubation 
of the membrane with SuperSignal® West Pico (34077, Thermo Scientific, Waltham, MA, 
USA) and its exposure to a photographic film (Kodak BioMax Light Film; Kodak-Industrie, 
Chalon-sur-Saone, France). Target proteins expression was normalized dividing the units of 
arbitrary densitometry by β-actin density for each band. ImageJ 
(http://rsb.info.nih.gov/ij/index.html) was used to evaluate densitometry signals (Miller, 
2010).  
 
1.3.8. Statistical analyses 
Two-tailed unpaired t-test was used to analyze plasma P4 concentration, day of luteolysis 
after biopsy, gene and western-blot and immunohistochemistry protein expression data. In 
order to detect differences between groups in plasma P4 levels in the first 11 days after 
ovulation, a repeated measures ANOVA followed by Bonferroni comparison test was used. 
Mean differences were calculated with 95% confidence interval and differences were 
considered significant when P < 0.05. Statistical analyses were performed using GraphPAD 
PRISM (Version 5.00, GraphPad Software, San Diego, CA, USA). Results were expressed as 
means ±SEM. 
1.4. Results 
1.4.1. Estrous cycle length and plasma progesterone concentration 
One mare in control group underwent luteolysis during the treatment period and was therefore 
excluded from the study. Two of the mares subjected to exogenous OXT administration 
experienced luteolysis (OXTRE-group) in the last day of treatment (day 14) and were also 
excluded from further gene and protein endometrial studies. Prolonged luteal function 
occurred in 4 of the 6 (67%) mares in OXT-group, as demonstrated by CL persistence in the 
ovaries, absence of endometrial edema (Fig. 2A, B) and plasma P4 concentrations >1ng/ml 
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(Fig. 2C). Plasma P4 concentrations between control and OXT-group did not differ (P = 0.42) 
in the first 11 days after ovulation. Plasma P4 was higher (13.7±1.5 ng/mL) in C-group, than 
in the OXT-group (8.33±1.8 ng/mL; P < 0.05) on biopsy day (P< 0.05). In mares with OXT-
induced prolonged luteal function (n=4), plasma P4 levels remained higher than 1ng/mL 
throughout 30 days post-ovulation. Luteolysis in response to biopsy was significantly delayed 
in the OXT treatment group compared with controls (3.2±0.2 for Controls and 6.0±1.4 days 
for OXT group; P < 0.05).  
 
 
Figure 2- Corpus luteum (A) and uterus (B) 24 days post-ovulation and plasma progesterone 
concentration (C) in oxytocin treated mares with prolonged luteal function. Values represent 
mean ± SEM. Control- mares treated with saline; (n=4); OXT- mares treated with 60 units of 
oxytocin/mare (n=6); OXTPLF- oxytocin treated mares with prolonged luteal function (n=4); 
OXTRE- oxytocin treated mares that underwent luteolysis at the normal time (n=2); P4- 
progesterone. 
 
All mares with OXT-extended luteal function presented a functional CL (confirmed by 
transrectal ultrasound and by plasma P4, plus an absence of ovarian follicles with meaningful 
sizes (< 25 mm), similar to mid-diestrus. Endometrial histology revealed characteristic 
features of diestrus (higher density and tortuosity of glands with a “string of pearls” 
appearance (Kenney, 1978). 
 
 





























































     63 
Experimental Work 
1.4.2. Prostaglandin synthases, ovarian steroids and oxytocin receptors mRNA 
transcription 
When comparing mRNA transcription of enzymes involved in endometrial prostaglandin 
biosynthesis, a reduction in PTGS2 (P < 0.05), PTGES and PTGIS (P < 0.01) was observed in 
OXT treated mares, while AKR1C3 was similar between groups (Fig. 3). Transcription levels 
of ESR1 (P < 0.05), ESR2 and PGR (P < 0.01) genes decreased, whereas OXTR increased (P 
< 0.05) in OXT-treated mares, when compared with control group (Fig. 3). 
 
Figure 3- Relative quantification of gene transcription by real-time PCR of proteins involved 
in prostaglandin biosynthesis and oxytocin and ovarian steroids receptors in endometrial 
biopsies of control and oxytocin treated mares. Endometrial biopsies were collected on day 10 
post-ovulation in control mares (n=4) and on day 24 in oxytocin treated mares (n=4). 
Expression of target genes was normalized against that of the housekeeping gene (RPL32).  
Bars represent mean ± SEM. AU: arbitrary units.  Asterisks indicate significant differences (* 
P < 0.05; ** P < 0.01). AKR1C3- aldo-keto reductase family 1, member C3; ESR1- estrogen 
receptor 1; ESR2- estrogen receptor 2; OXTR- oxytocin receptor; PGR- progesterone 
receptor; PTGES- microsomal prostaglandin E synthase 1; PTGIS- prostaglandin I2 synthase; 
PTGS2- prostaglandin-endoperoxide synthase.  
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1.4.3. Prostaglandin synthases, oxytocin and ovarian steroids receptors protein 
expression and immunolocalization 
Western blot and IHC analyses were performed to evaluate differences in biosynthesis of 
endometrial PG enzymes and receptors for OXT and ovarian steroids between control and 
OXT-treated prolonged CL mares.  
Protein expression analysis by western blot was performed for PTGS2, ESR1, ESR2 and 
OXT receptors. No significant differences were detected in band intensity of PTGS2 (70 kDa 
molecular weight–MW band) and ESR1 (52 kDa MW band) between control and OXT 
treated mares. However, there was a decrease in expression level of ESR2 (P < 0.05; 59 kDa 
MW band) and an increase of OXTR (P < 0.05; 66 kDa MW band) in OXT-treated mares 
compared to control mares (Fig. 4).  
 
Figure 4- Protein expression of PTGS2, oxytocin receptor (OXTR), and estrogen receptors 
(ESR1, ESR2) in endometrial biopsies of control and oxytocin treated mares. Endometrial 
biopsies were collected on day 10 post-ovulation in control mares (n=4) and on day 24 in 
oxytocin treated mares (n=4). Histograms show densitometric analysis of PTGS2, OXTR, 
ESR1 and ESR2 proteins normalized against β-actin. Upper panels illustrate representative 
western blots. The left lane of each blot is from control mares and the right from OXT treated 
mares. Data represent mean ± SEM. AU: arbitrary units. Asterisk indicates significant 
differences (* P < 0.05).  
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Results of IHC are shown in Fig. 5 and 6. PTGS2 was detected in surface epithelium and 
stromal cells, with occasional labeling of glandular epithelium. Immunostaining was the 
strongest in luminal surface epithelium for all mares (Fig. 5).  Immunolabeling for AKR1C3, 
PTGES and PTGIS was found in superficial and glandular epithelia in both control and OXT 
treated mares. While no differences were found in the intensity of immunostaining for 
AKR1C3 between groups, OXT-treated mares showed a tendency for a larger stained 
glandular area compared with the C-group (P = 0.06; Fig. 5). High immunolabeling of 
PTGES and PTGIS was detected in OXT-treated mares (P < 0.05; Fig. 5).  
 
Figure 5- Endometrial immunohistochemistry representative images of PTGS2, AKR1C3, 
PTGES and PTGIS protein in endometrial biopsies of control and oxytocin treated mares. 
Endometrial biopsies were collected on day 10 post-ovulation in control mares and on day 24 
in oxytocin treated mares (OXT). Positive staining is shown in brown. In negative controls, 
primary antibodies were replaced by the same concentration of rabbit or mouse IgG. 
 
Progesterone receptor was present in luminal and glandular epithelium, with more intense 
immunostaining in the OXT-treated group compared to the control (P < 0.05; Fig. 6). 
Immunostaining for OXTR was the strongest in stromal cells with scarce staining present in 
superficial glandular epithelium. Prolonged CL mares treated with OXT had increased OXTR 
expression compared with control mares (P < 0.05; Fig. 5). Immunolabeling for ESR1 and 
ESR2 was found in glandular epithelium in both groups. While no differences were observed 
in ESR1 immunostaining intensity between groups, OXT treated mares showed decreased 
endometrial ESR2 immunoexpression (P < 0.05; Fig. 6). 
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Figure 6- Endometrial immunohistochemistry representative images of PGR, OXTR, ESR1 
and ESR2 protein in endometrial biopsies of control and oxytocin treated mares. Endometrial 
biopsies were collected on day 10 post-ovulation in control mares and on day 24 in oxytocin 
treated mares (OXT). Positive staining is shown in brown. In negative controls, primary 
antibodies were replaced by the same concentration of rabbit or mouse IgG. 
 
1.5. Discussion  
Prevention of luteolysis in mares by administration of exogenous OXT on days 8 to 14 of 
estrous cycle has already been described (Stout et al., 1999; Vanderwall et al., 2007; 
Vanderwall et al., 2012; Gee et al., 2012; Keith et al., 2013), however, treatment outcome 
seemed to depend on OXT dose and route of administration. In the present study, twice daily 
im administration of 60 units of OXT prolonged the luteal phase in four of six (67%) mares. 
This dosage and route of administration was based on other studies that reported higher 
success rates: 6/6 mares (100%) (Vanderwall et al., 2007); 5/7 mares (71.4%) (Vanderwall et 
al., 2012); or 6/7 mares (86%) (Keith et al., 2013). In another study, continuous 
administration of 27.5 units/h of OXT by sc mini-pump on days 8-20 post ovulation abolished 
luteolysis in 4/5 mares (80%) (Stout et al., 1999). However, low doses of OXT (10 units/day) 
on days 7-14 post-ovulation did not increase the proportion of mares with prolonged diestrus 
when given im, but, iv administration of the same dose induced luteostasis in 5/6 animals 
(86%) (Gee et al., 2012). The iv route allows OXT to reach endometrial tissue before being 
metabolized (Keith et al., 2013). Thus, the amount of OXT getting to endometrial cells might 
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be crucial to induce luteal maintenance.  
A putative mechanism by which exogenous OXT might induce CL maintenance is by 
modifying the expression of the enzymes involved in PG synthesis. Pregnancy maintenance 
requires the inhibition of the luteolytic mechanism during late diestrus; this physiological 
state could perhaps serve as a model for the mechanism by which luteal maintenance is 
achieved in the absence of conception. PTGS2 expression was higher in endometrial surface 
epithelium during luteolysis (day 15) but not in 15-day pregnant mares (Boerboom et al., 
2004) and PTGS2 transcription was increased on day 15 in cyclic mares, while it was 
suppressed by pregnancy on days 15, 18, and 22 (Atli et al., 2010). Conversely, however, 
another study reported a marked increase in PTGS2 gene and protein expression between 
days 14 and 21 of pregnancy (Ruijter-Villani et al., 2015). 
Daily oxytocin administration during the mid-luteal phase stimulates luteal retention (Stout et 
al., 1999; Vanderwall et al., 2007; Vanderwall et al., 2012; Gee et al., 2012;  Keith et al., 
2013). In the present study, down-regulation of PTGS2 transcription was observed in OXT-
treated mares, while PTGS2 protein in endometrial luminal epithelia did not differ between 
control and OXT-groups. Gene and protein expression decrease of PTGS2 in OXT-treated 
mares at the time that they were presumed to be in the beginning of luteal maintenance was 
reported (Keith et al., 2013). In summary, PTGS2 seems to be up-regulated in luteolysis, but 
down-regulated during luteal maintenance and early pregnancy (Katila, 2011). Any form of 
endometrial irritation during the late luteal phase, through biopsy or sterile saline infusion, 
results in a consequent release of PGF2a and luteolysis (Baker et al., 1981; King et al., 2010). 
In these aforementioned studies, successful blocking of the luteolytic process using OXT 
could not be confirmed due to the timing of endometrial tissue procurement and its 
stimulation of luteolysis as a consequence.  Most prior studies report a majority, but not 
100%, of mares respond to OXT treatment with a prolonged CL.  Therefore, it can be 
assumed that the conditions assessed in the endometrial tissues collected during the late luteal 
phase from OXT-treated mares were not uniformly reflective of those leading to failure of 
luteolysis. 
In the present study, we sought to compare mid-luteal phase endometrial conditions prior to 
luteolysis with conditions following failed luteolysis induced by OXT administration.  Since 
OXT administration during diestrus is largely, but not always, successful in inhibiting 
luteolysis (Stout et al., 1999; Vanderwall et al., 2012; Gee et al., 2012), confirmation of the 
effectiveness of the treatment (prolongation of luteal function), and elimination of those 
mares from the analysis that did not respond was important.  Due to the confounding problem 
of endometrial biopsy stimulating luteolysis, creating a control and treatment group wherein 
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endometrial sampling was performed on the same day post-ovulation in both groups was not 
possible. Therefore, the comparisons presented in this study reflect mid-luteal phase 
endometrial conditions before luteolysis (controls) versus endometrial conditions following 
the inhibition of luteolysis, at a time presumed to be far removed from any luteolytic signal 
yet prior to normal cessation of spontaneously prolonged luteal activity. Comparing these 
results to those of others wherein endometrial sampling occurred at the time of typical 
luteolysis (and assuming that OXT treatment abolished this) could be very informative.  
Although the endometrial conditions in the 24-day prolonged CL endometrium are not 
comparable temporally to those of the 10–day mid-diestrus controls, they do reflect 
endometrial conditions stimulated by OXT to prolong diestrus.  How these conditions differ 
from those of a presumably normal-length diestrus are important to understand as the 
sequelae of failed luteolysis.  
As in mares with spontaneous prolonged CL during seasonal transitional to anestrus (King et 
al., 2010), P4 levels in OXT-treated mares were lower than control mares. The fact that 
endometrial biopsy at day 24 did not produce an immediate luteolysis as it did following 
biopsy on day 10, but resulted in a delayed luteal regression (6 days versus 3 days) indicates 
that the uterine environment at day 24 following OXT stimulated prolonged luteal function is 
not as poised for imminent luteolysis as it is on day 10 post-ovulation. 
Down-regulation of endometrial AKR1C3 and PTGES gene expression and increased protein 
expression of PTGES in OXT treated mares suggests that regulation of PTGES involved in 
OXT mediated luteal maintenance presumably occurs at protein rather than at transcription 
level. This may suggest that the mRNA signal for AKR1C3 and PTGES production occurred 
earlier than day 24 and was on the decline by day 24, while actual production of the protein 
was active at this time. These results disagree with previous studies where compared with 
non-pregnant controls, no differences were found in endometrial AKR1C3 and PTGES 
protein expression in 15-day pregnant mares (Boerboom et al., 2004), or in PTGES and 
AKR1C3 mRNA levels at days 8 and 12 of pregnancy (Merkl et al., 2010), when prolonged 
luteal function is physiologic. In contrast, in another study performed later in pregnancy (days 
18 and 22), PTGES and AKR1C3 transcription was up-regulated (Atli et al., 2010). Although 
OXT increased in vitro PGE2 secretion in mid-luteal phase mare endometrium (Galvão et al., 
2013), in early pregnant mares there were no changes in uterine flushing PGE2 concentrations 
(Stout  & Allen, 2002). In the present study, the high PTGES protein immunoexpression 
found in mares with prolonged luteal function may be due to a direct stimulus of OXT in 
endometrial cells. In several species other than the mare, binding of OXT to cell surface 
transmembrane OXTR, activates a downstream MAPK signaling cascade releasing 
 
     69 
Experimental Work 
arachidonic acid, the precursor of PG, via PTGS2 (Vrachnis et al., 2011). Luteal maintenance 
may depend on the balance between PGF2α, as a luteolytic signal, and PGE2 as a luteotrophic 
signal (Galvão et al., 2016). In bovine endometrial epithelial cells, P4 induced a higher in 
vitro basal secretion of PGE2 (+30.0%) than PGF2α (+22.2%), while OXT stimulated the 
production of PGE2 (9.1-fold, P < 0.0001) and PGF2α (6.7-fold, P < 0.0001) in epithelial, but 
not in stromal cells (Asselin et al., 1996). 
Although superficial and glandular endometrial epithelium immunolabeling for PTGIS was 
found in both control and OXT treated animals, the latter group exhibited decreased 
transcription and increased immunoexpression. Although the existence of endometrial PTGIS 
proteins has been documented in others species, their role in uterine function is unknown. To 
the best of our knowledge, this is the first work that shows the presence of PTGIS protein in 
equine mid-luteal phase endometrium. As plasma P4 levels in mares with OXT-induced 
prolonged luteal function were lower than in control mares, and as PTGIS expression in 
human endometrium was negatively correlated with decreased P4 levels (Catalano et al., 
2011), this may be a possible explanation for higher immunoexpression of PTGIS in OXT 
treated mares. Further studies are needed to elucidate the role of PTGIS in mare’s 
endometrium throughout the estrous cycle. 
The lower expression of ER1 and PGR in OXT-treated mares with prolonged luteal function 
in the present work is in agreement with other studies where luteal maintenance was achieved, 
as during gestation. Inhibition of these receptors has been ascribed to P4 (Hartt et al., 2005; 
Ruijter-Villani et al., 2015). In contrast, no difference was found in mRNA expression of 
ESR1 between control and OXT treated mares in the beginning of the luteal maintenance 
period (Keith et al., 2013). The decrease in ESR2 expression in OXT treated mares found in 
the present study contrasts with previous reports where the expression of endometrial ESR2 
mRNA did not differ throughout the estrous cycle (Silva et al., 2014; Ruijter-Villani et al., 
2015) or on days 54 and 66 of pregnancy (Silva et al., 2014). Others reported a 
downregulation of ESR2 on day 7 of pregnancy (Ruijter-Villani et al., 2015). Since the 
duration of P4 dominance affects ESR1 mRNA content in equine endometrium (McDowell et 
al., 1999), a long-term endometrial exposure to P4 may be responsible for the low ESR1 and 
ESR2 transcription found in OXT-treated mares. However, as exposure to P4 on day 7 
pregnant mares was not different from control mares in Ruijter-Villani et al. (2015) study, we 
hypothesized that the decrease in ESR2 expression observed in our study may be due to an 
additional mechanism, other than P4, and induced by OXT. 
The detection of PGR protein in luminal and glandular epithelium, with immunoexpression 
being the highest in the OXT-treated group differs from the results obtained in earlier studies 
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with prolonged luteal function in mares (Hartt et al., 2005; Wilsher et al., 2011; Silva et al., 
2014). In diestrus and early pregnancy, PGR mRNA and protein were not detected in luminal 
epithelium and were lower in stroma and deeper glandular epithelium (Hartt et al., 2005). 
Furthermore, during early pregnancy, mares lost PGR in endometrial epithelium, but not in 
stromal cells (Wilsher et al., 2011; Silva et al., 2014). The paracrine signaling and epithelium-
stroma cross-talk involved in the regulation of early pregnancy seems to be disrupted in OXT-
treated mares. In humans and mice, E2 rise stimulates PGR expression in stromal cells (Large 
& DeMayo; 2012). This E2 regulation of PGR expression may depend on stromal ESR1 in 
mouse uterine epithelium (Kurita et al., 2006). In addition, although ESR1 appears to be the 
dominant mediator of uterine reproductive functions, in the mouse uterus ESR2 acts as a 
modulator of ESR1-mediated gene transcription and is responsible for down-regulation of 
PGR in luminal epithelium (Weihua et al., 2000). In the mare, as in the mouse, decreased 
endometrial expression of ESR2 and ESR1 transcription might be responsible for the 
maintenance of PGR in luminal and glandular epithelium observed in OXT-treated mares.  
The up-regulation of OXTR gene and protein expression present in OXT-treated mares’ 
endometria contrasts with other studies where no differences were observed on endometrial 
OXT-binding capacity (Vanderwall et al., 2012) and on OXTR mRNA (Keith et al., 2013), 
between control and OXT-treated mares at the beginning of the luteal maintenance period. 
However, in pregnant mares, OXTR mRNA was slightly up regulated in equine endometrium 
at day 12 (Merkl et al., 2010), and the OXTR gene and protein in luminal and superficial 
glandular epithelia expression markedly increased between days 14 and 21 (Ruijter-Villani et 
al., 2015). We found protein localization of OXTR mainly in stromal cells, in all mares, 
although it was the strongest in OXT-group. In ruminants, an initial up-regulation of OXTR in 
the luminal epithelium triggers luteolysis. Binding of OXT to luminal and glandular 
epithelium OXTR initiates the pulsatile secretion of PGF2a and results in luteal regression 
(Robinson et al., 2001; Lee et al., 2013). In comparison to what has been described in 
ruminants, chronic OXT administration in mares might shift cell-specific expression of 
OXTR from luminal epithelium to stroma, leading to luteal maintenance.  
Prolonged exposure of the endometrium to P4 may decrease OXTR activity through 
desensitization of receptors since these receptors were up-regulated in OXT treated mares in 
the present work, as well as in 21 day pregnant mares (Ruijter-Villani et al., 2015). Non-
genomic action of P4 may be responsible for blocking OXT binding to OXTR with 
consequent inhibition of PGF2α luteolytic pulses resulting in prolonged luteal function. In 
isolated ovine endometrial plasma membranes, P4 was shown to inhibit OXT binding to its 
receptor by either competing with OXT for its receptor site or by binding to a closely 
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associated protein that alters OXTR conformation (Bishop & Stormshak, 2008). Indeed, the 
expression of P4 receptor membrane component 1 (PGRMC1) in mare endometrium is high 
during mid-luteal phase (Gebhardt et al., 2012), and early pregnancy (Ruijter-Villani et al., 
2015). Further studies are needed to investigate the presence of endometrial membrane-bound 
P4 receptors in OXT-induced luteostasis, as well as the direct or indirect action of OXT on 
luteal maintenance. 
In conclusion, administration of exogenous OXT on days 7 to 14 of the estrous cycle induced 
luteal maintenance in 67% of the mares. The different spatial expression of OXTR and PGR 
in the endometrium may be a mechanism by which chronic OXT enables luteal maintenance. 
The observed reduction of endometrial ESR2 may be responsible for the maintenance of PGR 
in luminal and glandular epithelium. Also, ESR2 may have a role in attenuating the 
transcriptional activity of ESR1 in mare endometrium. This study offers new knowledge on 
the endometrial expression of ovarian steroids and OXTR in OXT-induced luteal maintenance 
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2. Neutrophil extracellular traps formation by bacteria causing endometritis in the mare 
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2.1. Abstract 
Besides the classical functions, neutrophils (PMN) are able to release their DNA in response 
to infectious stimuli forming neutrophil extracellular traps (NETs) and killing pathogens. The 
pathogenesis of mare endometritis is still not completely understood. Therefore, the aim was 
to evaluate the in vitro capacity of equine PMN to secrete NETs by chemical activation, or 
stimulated with Streptococcus equi subspecies zooepidemicus (Szoo), Escherichia coli (Ecoli) 
or Staphylococcus capitis (Scap) strains obtained from mares endometritis. Besides, ex-vivo 
endometrial mucus samples obtained from mares with bacterial endometritis were evaluated 
for the presence of NETs. Equine blood PMN were used either without or with previous 
stimulation by phorbol-myristate-acetate (PMA), a strong NETs inducer, for 1, 2 or 3 h. To 
evaluate PMN ability to produce NETs when phagocytosis was impaired, the phagocytosis 
inhibitor cytochalasin (Cyt) was added after PMA. After bacteria addition, subsequent one-
hour incubation was as follows: (i) PMN (negative control); (ii) PMN+PMA (positive 
control); (iii) PMN+Cyt (iv) PMN+bacteria; (v) PMN+PMA+bacteria; (vi) 
PMN+Cyt+bacteria; (vii) PMN+PMA+Cyt+bacteria. NETs were visualized by DAPI and 
anti-histone. Immunostaining for myeloperoxidase and neutrophil elastase was also performed 
on ex-vivo samples. A 3h incubation of PMN+PMA increased NETs (P < 0.05). 
Bacteria+25nM PMA and bacteria+PMA+Cyt increased NETs (P < 0.05). Bacteria Szoo was 
the one that induced less NETs, when compared to Ecoli or Scap (P < 0.05). Presence of 
NETs in ex-vivo samples was confirmed in mares with endometritis. Scanning electron 
microscopy showed the widespread of NETs from PMN. Equine NETs are formed by smooth 
fibers and globules that can be aggregated in thick bundles. Formation of NETs and the 
subsequent entanglement of bacteria, suggest that equine NETs might be a complementary 
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2.2. Introduction  
In response to inflammatory stimuli, neutrophils (PMN) migrate from blood circulation and 
are recruited into sites of inflammation in different tissues. They are the first line of innate 
immune defense against the invading bacteria (Brinkmann, 2011). The PMN present in the 
blood stream firmly adhere to the endothelium cell barrier, cross it, and reach the tissue to the 
site of infection. There, chemokines released by mast cells and resident tissue macrophages 
activate the PMN (Souza et al., 2011). It is well established that once PMN get to the 
infection site they will attempt to kill bacteria by the use of diverse mechanisms (Brinkmann, 
2011; Souza et al., 2011). Even so, the exact mechanism involved in the pathophysiology of 
PMN hyperactivation, as the first line of defense against pathogenic bacteria, is not fully 
understood. The novel paradigm of innate immunity is that, besides the classical functions of 
extracellular release of lytic enzymes and phagocytosis, PMN by means of their enzymatic 
activity, surface receptors and cytoskeleton (Neeli et al., 2009), also have the capacity to 
release their DNA in response to infectious stimuli (Brinkmann et al., 2004). Thus, at the site 
of infection PMN form neutrophil extracellular traps (NETs) that have the ability to bind and 
kill pathogens outside the cell, such as bacteria (Fuchs et al., 2007; Pilsczek et al., 2010), 
protozoa (Guimarães-Costa et al., 2009; Wardini et al., 2010; Abdallah et al., 2012), or yeast 
(Urban et al., 2006; 2009). In addition, as reviewed by Brinkmann & Zychlinsky (2012), not 
only infectious agents, but also many physiologic inducers of NETs formation have been 
reported. Reactive oxygen species (ROS) generated at the phagosomal membrane (Fuchs et 
al., 2007), and antibody-antigen complexes (Garcia-Romo et al., 2011) are among those 
NETs inducers. In fact, at inflammatory sites, such as in spontaneous appendicitis in humans, 
NETs are also abundant (Brinkmann et al., 2004). Interleukin-8, lipopolysaccharide and 
phorbol-myristate-acetate (PMA) are also in vitro NETs inducers (Brinkmann et al., 2004). 
NETs are big DNA-associated molecule complexes that consist of nucleic and cytoplasmic 
proteins, each with strong antimicrobial and/or immunomodulating properties (Lögters et al., 
2009). The release of NETs by PMN with their death, when stimulated by pathogens, was 
called NETosis and, in contrast to necrosis and apoptosis, it may mediate antimicrobial and 
pro-inflammatory responses (Fuchs et al., 2007; Brinkmann and Zychlinski, 2012).  In the last 
stage of NETosis, the nuclear envelope of PMN ruptures and their granules decompose, 
allowing the chromatin to come into direct contact with most of the proteins present in the 
mature PMN (Brinkmann, 2011). Thus, histones and enzymes like elastase, proteinase 3, 
cathepsin G and myeloperoxidase, which are NETs components, are involved in 
microorganism killing (Weinrauch et al., 2002; Wartha et al., 2007; Brinkmann, 2011; Windt 
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et al., 2012; Marin-Esteban et al., 2012) or may be a host mechanism to confine the infection 
and prevent systemic spread of the infectious agent (Beiter et al., 2006).  
The etiology, diagnosis and pathogenesis of acute and chronic endometritis in the mare have 
been the subject of extensive research for a number of decades (Ferreira-Dias et al., 1994; 
Nielsen, 2005; Hoffmann et al. 2009; Szóstek et al., 2013; Woodward et al., 2013). Bacterial 
uterine infections occur in 25–60% of barren mares and inflict major pregnancy losses 
(LeBlanc et al., 2007). A number of bacteria such as Escherichia coli, β hemolytic 
Streptococcus, Pseudomonas aeruginosa, Klebsiella sp., Proteus and Corynebacterium 
among others, has been associated with equine endometritis (LeBlanc et al., 2007; 
Wittenbrink et al., 2008). The presence of these microorganisms in the mare uterus is usually 
simultaneous with the presence of PMN in the endometrium, and with cloudy or mucoid 
uterine effluxes (LeBlanc et al., 2007). Some of these bacteria are able to proliferate in the 
mare uterus, thus making infectious endometritis to prevail, while others are killed. Thus, we 
postulate that some mares might fight bacteria that cause endometritis by inducing NETs 
release. Therefore, the aim of this study was to evaluate in vitro the capacity of equine PMN 
to secrete NETs by chemical activation, or when stimulated with Streptococcus equi 
subspecies zooepidemicus (Szoo), Escherichia coli (Ecoli) or Staphylococcus capitis (Scap) 
strains obtained from mares with endometritis. 
 
2.3. Materials and methods 
2.3.1. Bacteria preparation  
Bacterial strains of Szoo, Ecoli and Scap were isolated from uterine swabs from mares with 
endometritis. Isolated bacteria were identified based on their biochemical profile (Api 
System, BioMérieux). All isolates were preserved at -70ºC in Buffered Peptone Water broth 
(Merck®) containing 20% glycerol. Bacterial isolates were plated on Columbia agar plates 
with 5% sheep blood and were prepared at the concentration of 5x107 CFU/mL in saline 
solution by correlating the optical density value with a standard curve. The presence of 
capsule was evaluated by Anthony’s method, by staining the bacteria placed on a glass slide, 
with crystal violet for 4 to 7 minutes, followed by rinsing with 20% copper sulfate and paper 
blotting. 
 
2.3.2. Isolation of neutrophils 
Venous blood was obtained by venipuncture of the jugular vein of adult healthy horses 
(40mL/horse; Faculty of Veterinary Medicine ethical committee approved) into heparinized 
 
     77 
Experimental Work 
tubes (monovettes®, Sarstedt). Isolation of PMN was performed according to Roberto da 
Costa et al. (2003) with some modifications as follows. Blood was distributed into centrifuge 
tubes and 15% v/v of 5% of dextran (Sigma-Aldrich, St. Louis, MO, USA) was added, and 
incubated for 10 to 15 min at 37ºC.  The obtained supernatant was gently pipette over 10mL 
of Ficoll separating solution (density=1.077; Biochrom), and centrifuged at 468g for 30 min. 
The supernatant was discarded and the pellet containing the neutrophils and red blood cells 
(RBC) was treated with double distilled water for 1 min to lyse the RBC. Equal volume of 
double concentrated phosphate-buffered saline (PBS) was used to restore isotonicity. The 
mixture was centrifuged at 532g at 4ºC for 10min and the PMN suspended in RPMI 1640 
(Sigma-Aldrich) medium, without serum. PMN cell viability was assessed by using Trypan 
blue dye exclusion, which was always higher than 97%. This entire procedure was carried out 
under sterile environment.  
 
2.3.3. In vitro neutrophil extracellular traps formation 
The equine PMN cell count was adjusted to a final concentration of 2x106/mL in RPMI 1640 
(Sigma-Aldrich), seeded on sterile 13mm round glass coverslips placed inside the wells of 24 
well culture plates (Nunc, Denmark) and incubated for 1h, at 37ºC in 5% CO2 humidified 
atmosphere, as described (Brinkmann et al., 2010). To test the capacity of horse PMN to 
produce NETs without bacterial stimulation, PMN were used either without previous 
stimulation or stimulated by 25 or 100nM PMA (Sigma-Aldrich), a strong NETs inducer, for 
1, 2 or 3h. Besides, to evaluate PMN ability to produce NETs when phagocytosis was 
impaired, cytochalasin (Cyt, 10µg/ml; Sigma-Aldrich), a phagocytosis inhibitor, was added 
15min after PMA and further incubated. Bacteria was added to horse PMN, at the 
concentration of 2x107/mL, previously incubated with or without Cyt or PMA and further 
incubated for 1h, as follows: (i) PMN; (ii) PMN+PMA; (iii) PMN+Cyt (iv) PMN+bacteria; 
(v) PMN+PMA+bacteria; (vi) PMN+Cyt+bacteria; (vii) PMN+PMA+Cyt+bacteria. The 
positive control consisted of PMN that were previously stimulated for 30min with PMA, 
while the negative control consisted of equine PMN alone and without any treatment. Bacteria 
strains added to horse PMN were Szoo, Ecoli and Scap. Each treatment was performed in four 
replicates and each assay was run in triplicate. From each bacterium incubation, 12 samples 
were analyzed. After incubation, glass coverslips with the attached PMN were carefully 
washed three times in PBS and incubated in 0.5% Triton X-100 (Sigma-Aldrich) to 
permeabilize the cells. In order to fix NETs, 4% paraformaldehyde was added to the wells for 
2h. Further on, they were stained with DAPI (Vectashield with DAPI; Vector Laboratories, 
USA) and observed under fluorescence microscope (DM5000B, Leica). Images were captured 
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with a digital camera (DC350F, Leica, Germany) at random. NETs filamentous structures 
present per microscopic field were manually counted (Wartha et al., 2007). For each 
coverslip, ten microscopic fields were viewed at a magnification of 200x. 
2.3.4. Ex-vivo neutrophil extracellular traps  
Endometria were obtained post mortem from cyclic mares (n=10) at a local abattoir. The 
mares were euthanized after stunning according to the European Legislation concerning 
welfare aspects of animal stunning and killing methods (EFSA, AHAW/04-027) and to the 
Portuguese legislation (DL 98/96, Art. 1º), and approved by the Faculty of Veterinary 
Medicine Ethics Committee.   
Uterine horns were opened and signs of endometritis, like increased mucus production and 
altered surface epithelial color were searched. Uterine swabs were collected for bacteria 
isolation and cytology evaluation. Glass coverslips and glass slides (ref 4951 Plus, 
Superfrost® plus, Thermo Scientific) were placed on the endometrial surface and left for 30 
minutes, in order to adhere to it (Manzenreiter et al., 2012). Uterine inflammation was 
confirmed by cytology (presence of more than 3 PMNs per five fields at 400x magnification; 
LeBlanc et al, 2007) and infection was assessed by positive bacterial growth. Slides were 
washed in PBS and incubated in 0.5% Triton X-100. Further on, they were fixed in methanol 
for 10 min, stained with DAPI and observed under a fluorescence microscope. NETs images 
were captured with a digital camera. 	
 
2.3.5. Histone, myeloperoxidase (MPO) and neutrophil elastase (NE) markers assays 
In another assays, DNA histone present in in vitro and ex-vivo NETs was immunostained with 
polyclonal anti-histone H2B (Lys 15) rabbit antibody (ref 5435S, Cell Signaling Technology, 
Isaza, Portugal) diluted at 1:100 in PBS and incubated overnight at 4ºC. This was followed by 
1h incubation at room temperature with anti-rabbit IgG secondary antibody (A21206, 
Invitrogen, USA) diluted at 1:300. Further on, NETs were stained with DAPI (Vectashield) 
and observed under fluorescence microscope (DM5000B, Leica).  
In order to visualize myeloperoxidase (MPO) and neutrophil elastase (NE), ex-vivo samples 
were incubated overnight at 4ºC with rabbit myeloperoxidase antibody (1:100; orb16003, 
Biorbyt, UK) and neutrophil elastase antibody (1:200; ab68672, Abcam, Cambridge, UK), 
respectively. After, they were incubated for 1hour with anti-rabbit IgG secondary antibody 
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2.3.6. Scanning electron microscopy 
Scanning electron microscopy (SEM) of NETs was performed. Neutrophils were stimulated 
in vitro with 25nM of PMA and with bacteria for 1h to induce NETs formation as described 
above. Coverslips from both in vitro and ex-vivo samples were fixed with 2.5% 
glutaraldehyde (AppliChem, Germany) in 0.1 M sodium cacodylate buffer for 2h, at 4°C. The 
samples were subsequently dehydrated in a graded ethanol series. Samples were dried using 
the critical point drying method and sputter coated with gold palladium, mounted on stubs, 
observed in a scanning electronic microscope (SEM; JEOL5200-LV) and photographed. 
 
2.3.7. Statistical analysis 
Data regarding in vitro NETs count were analyzed by one-way ANOVA followed by the 
Bonferroni multiple comparison test (GraphPad Software version 5, San Diego, USA). 
Significance was defined as P<0.05.  
2.4. Results 
In the absence of PMN stimulation and when PMN were incubated alone, without bacteria 
(negative control; Fig. 7A) no NETs were formed. However, when PMN were stimulated with 
25nM PMA, a strong NETs inducer, they were able to release their DNA, as well as their 
nuclear and cytoplasmic proteins (Fig. 7B-D). This was noted at all incubation times (1h, 2h, 
3h), even though NETs formation was the highest after 3h incubation (p<0.05; Fig. 7B-D).  
However, PMA at 100nM induced PMN necrosis and few NETs were released. Therefore, 
PMA was used at 25nM in all other assays. When PMN were previously treated with PMA 
and further incubated with bacteria (Szoo, Ecoli, or Scap) they also produced NETs (Fig. 7E-
F).  
Histone marker assay was performed to confirm that the extruded material forming in vitro 
NETs was PMN derived and of nucleic origin. Thus, the positive staining of equine NETs, 
when in the presence of the anti-histone antibody, confirmed the presence of this major 
protein component of chromatin in NETs (Fig.7G). 
Out of the 10 endometria obtained from mares immediately after euthanasia, 4 showed signs 
of endometritis and had positive cytology and bacteriology. S. equi spp zooepidemicus was 
isolated from two endometria, E. coli from one mare, while a mixed culture of S. equi spp 
zooepidemicus and E. coli was obtained from the other mare. NETs were visualized in the 
samples obtained from the infected endometria, regardless bacteria species (Fig. 7H-P). In ex-
vivo samples, presence of histone, MPO and NE in NETs was confirmed (Fig. 7I, L and O). 
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Figure 7- In vitro and ex-vivo NETs released by equine PMN. In vitro (A-G) and ex-vivo (H-
P). NETs (yellow arrows) induced after in vitro PMN stimulation with PMA and mare 
endometritis bacteria: A: PMN alone (negative control); B-D: After 1h (B), 2h (C) or 3h (D) 
incubations with 25nM PMA (Mag=200x); E: PMN (thick arrow) stimulated with 25nM 
PMA and Staphylococcus capitis (dashed arrow); F: PMN stimulated with 25 nM PMA and 
cytochalasin, a phagocytosis inhibitor, and S. capitis (dashed arrow; Mag=1000x). A-F: NETs 
were stained with DAPI. G: Histone H2B positive immunostaining of equine in vitro NETs 
(white arrow) confirms the nuclear origin of extruded material (Mag=400x). H-P: ex-vivo 
NETs obtained from equine endometrium with endometritis stained with DAPI (H, K, N) and 
immunostaining for histone H2B (I; Mag=400x), myeloperoxidase (L; Mag=200x) and 
neutrophil elastase (O; Mag=200x); Right panels (J,M,P): merged.  
 
When PMN were in vitro incubated with bacteria (Szoo, Ecoli, or Scap), without previous 
treatment with PMA, they also produced NETs (Fig. 8A-C). In fact, soon after incubation 
(1h), all tested bacteria were already able to induce NETs, trapping them, although Szoo was 
the tested microorganism that stimulated the least NETs (p<0.05; Fig. 8A). In contrast, Scap 
was the bacterium that induced the most NETs (P < 0.05; Fig. 8C).  
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Figure 8- NETs (arrow) induced by equine PMN, without previous PMA incubation, and after 
1h stimulation with S. zooepidemicus (Szoo; A), E. coli (Ecoli; B) or S. capitis (Scap; C). 
(Mag=200x). Scap was the bacteria that induced most NETs (p<0.05). Bars represent 
mean±SEM. Different letters indicate significant differences (P < 0.05). A-C: NETs stained 
with DAPI. 
 
An increase in NETs was observed when bacteria were incubated with PMN previously 
stimulated by PMA, in comparison to PMA treated PMN incubated without bacteria (P < 
0.05; Fig. 9). Nevertheless, bacteria phagocytosis inhibition by cytochalasin did not contribute 
for a raise in NETs formation (Fig. 9). All the bacterial strains used in these experiments were 
non-encapsulated as evaluated by Anthony’s method. 
 
Figure 9- NETs release by horse neutrophils when incubated with PMA alone or with bacteria 
S. zooepidemicus (Szoo), E. coli (Ecoli) or S. capitis (Scap) in the presence or absence of 
cytochalasin, a phagocytosis inhibitor. Bars represent mean±SEM. Different letters indicate 
significant differences (P < 0.05). 
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Upon stimulation by 25nM PMA, the PMN flattened, made protrusions, depicted granules 
and formed NETs, as confirmed by scanning electron microscopy (SEM; Fig. 10 A-B).  
 
 
Figure 10- Scanning electron microscopy of the interaction between equine neutrophils and 
bacteria that cause mare endometritis. Neutrophils were incubated with: A-B- PMA (positive 
control); C-D- Streptococcus equi ssp. zooepidemicus; E-F- Escherichia coli; G-H- 
Staphylococcus capitis; A, C, E and G- Ultrastructure of initial phases of NETs release by 
PMNs that depicts many membrane protrusions with extrusion of smooth fibers and globular 
domains. Bacteria trapped by fibers and neutrophil granules are already visualized in C, E and 
G (arrows); B, D, F and H- The characteristic appearance of NETs, extended smooth fibers 
that intersect and bundle with each other resembling a three-dimensional network garnished 
with multiple spherical globules of different sizes is seen. Fibers organized in thick bundles 
are present. Bacteria attached to NET fibers (arrows) and neutrophil granules are depicted; I 
and J- Densely interlinked meshwork structures with a very similar appearance to in vitro 
NETs, obtained from endometrial mucus of mares with endometritis. J. Escherichia coli 
attached to fibers (arrow) can be observed.  
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The analysis of these NETs shows the widespread of NETs from PMN that suffered 
destruction throughout this process. NETs are formed by smooth fibers and globular domains 
that can be aggregated to thick bundles of fibers (Fig. 10 C-H). Besides, formation of NETs 
and the subsequent entanglement of Szoo, Ecoli or Scap, as well as the interaction between 
PMN and bacteria, showed that bacteria were trapped by NETs. Ex-vivo assays performed 
with endometrial mucus showed a densely-interlinked meshwork of fibers, which resemble in 
vitro NETs (Fig. 10 I-J). 
 
2.5. Discussion  
To the best of our knowledge this study shows for the first time that stimulated equine PMN 
have in vitro NETs formation capacity when in the presence of selected bacteria causing 
uterine infection in the mare, such as Ecoli, Szoo or Scap. Besides, in vivo capacity of NETs 
formation by PMN present in the uterus of mares with Szoo and Ecoli endometritis was also 
described as a novelty. Besides, the capacity of equine PMN to release NETs when in contact 
with equine spermatozoa was already reported (Alghamdi  & Foster, 2005, Alghamdi et al., 
2009). Those findings show that NETs produced by horse PMN can disarm Gram-positive 
and Gram-negative pathogens, as for other PMN species and bacteria (Brinkman et al. 2004). 
In the present work, even in the absence of bacteria, horse stimulated PMN with 25nM PMA 
had the ability to form NETs, as shown in the pig (500 nM PMA), even though at a 
deleterious dose for equine PMN (Bréa et al., 2012). In fact, the amount of NETs formation, 
depends on the degree of stimulation, and varies with the type and concentration of the 
stimulus (Brinkmann et al., 2013). Nevertheless, untreated equine PMN did not release NETs, 
as reported for humans (Pilsczek et al., 2010). Besides, when activated horse PMN were 
incubated with cytochalasin, NETs persisted, as shown for other bacteria (Brinkman et al., 
2004). Thus, the present study may suggest that besides the classic mechanism of 
phagocytosis already showed for the horse (Roberto da Costa et al., 2003; Gardner et al., 
2007), NETosis might be an alternative and a complementary mechanism for mares to fight 
endometritis. 
It is well established that the main microorganisms responsible for endometritis in the mare 
are Szoo and Ecoli, (Wittenbrink et al., 2008), which were the ones that induced less NETs.  
In contrast, Scap that is not a common equine endometritis pathogen was the bacterium that 
showed the highest NETs inducing capacity. In cows, when blood PMNs were stimulated by 
E. coli lipopolysaccharide or pathogenic mammary E. coli, an increase in NETs formation, 
ROS production, and a bactericidal effect were observed (Grinberg et al., 2008; Revelo & 
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Waldrom, 2012). Also, in response to a human E. coli strain, NETs were able to capture, 
immobilize, and kill bacteria (Marin-Esteban et al., 2012).  
Whereas PMN have the ability to induce NETs formation when in the presence of 
microorganisms, some bacteria have developed a novel mechanism of innate immune evasion 
(Uchiyama et al., 2012). Only most recently the importance of their extracellular nucleases in 
virulence was uncovered, with the finding that they can disrupt the DNA matrix in NETs 
(Brinkmann & Zychlinsky, 2012; Derré-Bobillot et al., 2013). In fact, some Streptococci, 
which are opportunistic pathogens, have developed DNase virulence factors responsible for 
DNA-based degradation of NETs allowing the pathogens to escape extracellular killing 
(Uchiyama et al., 2012; Derré-Bobillot et al., 2013). Also, in vivo susceptibility to 
polymicrobial infection has been ascribed to NETs depletion (Meng et al., 2012). An 
extracellular nuclease of Streptococcus agalactiae, attacks NETs, which is needed for in vivo 
full virulence expression (Derré-Bobillot et al., 2013). Although Streptococcus 
polysaccharide capsule is an important virulence factor, non-encapsulated S. pneumonia are 
more resistant to extracellular human neutrophil elastase and cathepsin G-mediated killing 
than isogenic encapsulated bacteria (Windt et al., 2012). This resistance might be very 
important on mucosal surfaces and be the cause of mucosal infections (Windt et al., 2012). 
Nevertheless, in an early study, a non-encapsulated strain of Streptococcus equi showed no 
resistance to phagocytosis by equine PMN, (Anzai et al., 1999). Since the strain of Szoo used 
in this in vitro study was non-encapsulated, this might be related to the low NETs response 
observed by us. Most likely, in the mare, PMN phagocytosis is the mechanism of choice in 
the defense against Szoo, when compared to NETs. Besides, NETs might facilitate other 
immune processes, such as phagocytosis, and may play a role in disease pathogenesis (Cooper 
et al., 2013). The same rationale might hold true for the results regarding NETs induction 
with non-encapsulated Ecoli in the present study, since their behavior was similar to Szoo. In 
fact, non-encapsulated strains of E. coli from mastitis cows, were less resistant than 
encapsulated strains to phagocytosis by bovine PMN (Hill et al., 1983). 
 The level of NETs trapping, and the ability of microorganisms to degrade NETs or to resist to 
their antimicrobial components are likely to be determinant if bacterial infection will result in 
severe invasive disease (Wartha et al., 2007; Berends et al., 2010).  In our in vitro study, 
equine PMN responded to Scap by releasing NETs, as reported for human PMN in contact 
with Staphylococcus aureus (Pilsczek et al., 2010). The nuclease production by S. aureus 
promotes resistance against NET-mediated bacterial clearance and contributes to disease 
pathogenesis (Berends et al., 2010). Nevertheless, similar conclusions cannot be withdrawn 
from the present study with respect to Scap. Based on these data we are unable to tell if the 
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highest number of NETs observed after incubation of equine PMN with Scap, could be 
ascribed to a high NETs production or to a low capacity to degrade NETs or to resist to 
antimicrobial components. 
Histones are basic DNA-binding proteins that organize chromatin in the cell nucleus and 
within NETs (Neeli & Radic, 2012). The presence of histone 2B in the NETs produced by 
equine PMN confirmed NETs nature. Besides, the H2B immunostaining of ex-vivo NETs, 
combined with the characteristic appearance of DNA fibers, provides evidence that the 
observed web-like structures in endometrial mucus, obtained from equine endometrium with 
endometritis, corresponded to NETs and are not fibrillar structures (Krautgartner et al., 2010). 
In addition, the expression of myeloperoxidase and neutrophil elastase in ex-vivo NETs, 
suggest that they may have antimicrobial activity. Whereas bacteria and parasites probably 
are killed by histones, myeloperoxidase and neutrophil elastase (Brinkmann et al., 2004), their 
presence in equine NETs might suggest a similar role. 
The in vitro NETs observed in the present work by SEM, resembled flattened three dimension 
meshworks, as described for in vitro induced NETs by PMA in humans (Manzenreiter et al., 
2012). As reported for equine spermatozoa and PMN binding (Alghamdi et al., 2009), SEM 
studies showed that bacteria causing mare endometritis are ensnared by NETs showing a 
direct contact between NETs and bacteria. These NETs are formed by DNA smooth fibers 
decorated with globules that can be aggregated to thick bundles of fibers (Brinkman et al., 
2004), similar to those found in sputum of humans with cystic fibrosis (Manzenreiter et al., 
2012). The spherical shape of globular fractions of NETs, also seen in the present study, may 
represent lipid membrane vesicles, possibly neutrophil ectosomes (Urban et al., 2009; 
Manzenreiter et al., 2012). The ectosomes are vesicles released by PMN, when activated in 
vitro and in vivo, expressing a strict selection of proteins (Gasser et al., 2003; Urban et al., 
2009). In purulent crevicular exudates, in humans, no discrimination between fibrin and NETs 
based on morphological criteria in SEM was possible (Krautgartner et al., 2010). In the 
present study, no DNAse treatment was performed in ex-vivo samples for SEM to overrule the 
presence of fibrin instead of NETs (Krautgartner et al., 2010). However, immunostaining 
assays with histone, myeloperoxidase and elastase proved the existence of NETs produced in 
vivo in the uterus of mares with endometritis. 
In conclusion, a phagocytosis independent mechanism to kill bacteria responsible for 
endometritis in the mare by means of NETs formation might be a novel approach to 
understand this pathologic condition. Besides, further knowledge on signaling pathways that 
lead to NETs release should be unraveled and might be considered for future therapeutic 
targets.   
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3.1. Abstract 
Neutrophil extracellular traps (NETs) are DNA complexes carrying nuclear and cytoplasmic 
proteins, such as elastase (ELA), cathepsin-G (CAT) and myeloperoxidase (MPO). Mare 
endometrosis is a chronic degenerative process characterized by excessive collagen in 
endometrium. While NETs fight bacteria that cause endometritis, they may trigger 
endometrial fibrogenesis. The aim was to evaluate the in vitro effect of some NETs 
components on mare endometrial fibrogenesis and determine its relationship with endometrial 
histopathology or estrous cycle. Endometrial explants were incubated with NETs components 
(ELA, CAT, MPO or oxytocin).  Collagen type I (COL1) protein and COL1 and COL3 genes 
transcription were evaluated in follicular and mid-luteal phases endometria (Kenney and Doig 
type I/IIA and IIB/III). Increased COL1 occurred with all NETs proteins, although 
endometrial response to each NETs protease depended on estrous cycle and/or endometrial 
category. Since ELA enhanced COL1 production, NETs persistence might be linked to mare 
endometrosis. Estrous cycle phase influenced endometrial fibrogenesis, suggesting that 
follicular phase conditions may favor endometrial collagen production. However, luteal phase 
endometria with moderate or severe pathological alterations may be also susceptible to 
fibrotic effects of NETs constituents. These data propose that NETs involvement in chronic 
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3.2. Introduction  
It has been long established that polymorphonuclear neutrophils (PMN) play a pivotal role in 
innate immunity, by representing the first line of defense against invading pathogens (Kazzaz 
et al., 2016; Nakazawa et al., 2017). These inflammatory cells move to the infection site 
where they attempt to kill bacteria by the use of diverse classic mechanisms like extracellular 
release of antimicrobial peptides, lytic enzymes and phagocytosis (Brinkmann 2011). In 
addition, PMN also have the ability to release their own DNA, histones, and enzymes, 
including elastase (ELA), cathepsin G (CAT) and myeloperoxidase (MPO), in response to 
infectious stimuli forming neutrophil extracellular traps (NETs) that ensnare, bind and kill 
pathogens outside the cell (Brinkmann et al., 2004; Fuchs et al., 2007; Wardini et al., 2010; 
Rebordão et al., 2014; Pisanu et al., 2015; Nakazawa et al., 2017). The physical barrier 
created by NETs prevent further dissemination of microorganisms by ensnaring them at the 
infection site, thus limiting bacterial spread or locally confining tissue infection (Beiter et al., 
2006; O’Brien et al., 2017). The majority of bacteria bound to NETs were alive when 
liberated by DNase treatment (Menegazzi et al., 2012), indicating that NETs trap rather than 
kill microbes. NETs persistence and intensity (acute versus chronic process) can ultimately 
either fight disease or cause disease themselves (Brinkmann et al., 2012). The extracellular 
presence of PMN serine-proteases in tissues may be one of the mechanisms leading to an 
exaggerated inflammatory response, tissue-specific injury (Saffarzadeh et al., 2012), and 
finally to the development of fibrosis in lung (Korkmaz et al., 2008; Cantin et al., 2015), 
cardiovascular system (Rudolph et al., 2010; Friedrichs et al., 2012), liver (Pulli et al., 2015) 
and kidney (Shimoda et al., 2007).  
Repair of damaged tissues is a fundamental biological mechanism that allows for the 
replacement of dead or damaged cells after injury, a process critically important for survival 
(Wynn, 2007; Oliveira et al., 2016). However, irrespective to the initial causes, if this process 
becomes dysregulated or when the tissue damaging stimulus persists, it can lead to the 
development of a permanent fibrotic “scar” at the site of tissue injury. This is characterized by 
excessive accumulation of extracellular matrix (ECM) components - e.g., hyaluronic acid, 
fibronectin, proteoglycans, and interstitial collagens, mainly collagen I (COL1) (Wynn, 
2007). In humans, fibrosis formation as a result of chronic inflammation has been reported in 
different tissues, like kidney (Torres et al., 2014), lung (Cantin et al., 2015), intestine, liver 
(Seki & Schwabe 2015; Rieder et al., 2016), and pancreas (Zechner et al., 2014), among 
others. In the mare endometrium, a fibrotic condition known as endometrosis is a chronic 
degenerative process mainly characterized by extensive periglandular collagen fiber 
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deposition in the stroma. This pathology is responsible for infertility in this species (Kenney 
& Doig 1986; Lehmann et al., 2011). Endometrosis is a very complex pathological process 
whose etiology is still unclear.  
As fibrosis is often a consequence of chronic low-level inflammation, we have hypothesized 
that endometrosis might be a sequela to persistent/chronic endometritis in the mare, resulting 
from persistent low-grade inflammatory processes and consequent uterine influx of PMN.  
We have documented PMN ability to form NETs in mare endometrium when in the presence 
of some pathogenic bacteria (Rebordão et al., 2014). Thus, we postulate that NETs may play 
a dual and contradictory role in mare endometrium. While NETs may have a beneficial action 
by fighting bacteria causing endometritis (Rebordão et al., 2014), when inflammation is 
chronic and sustained, NETs components may trigger a harmful effect on the endometrium 
leading to fibrosis establishment (endometrosis). Therefore, the objective of this study was to 
evaluate the effect of some NETs components on mare’s endometrial capacity to form 
fibrosis. The influence of endometrial inflammatory/fibrotic lesions and estrous cycle phase 
on endometrial fibrotic stimulation was also considered. Our results suggest that persistence 
of NETs components might be linked to the pathophysiology of mare endometrial fibrosis, 
since increased collagen type I production by endometrial tissues, characteristic of fibrosis 
was observed with all studied NETs proteins, although endometrial response to each specific 
NETs protease was different regarding the estrous cycle phase and/or with endometrial 
category. In the mare, estrous cycle phase appears to influence endometrial fibrogenesis, 
being the follicular phase, the phase with increased risk of developing this pathology. 
 
3.3. Materials and methods 
3.3.1. Biological samples collection and study design 
Reproductive tracts and venous blood were collected at an abattoir from mature mares of 
unknown history during the breeding season. Animal handling and slaughter conformed to 
European welfare (EFSA, AHAW/04–027) and Portuguese (DL 98/96, Art. 18) mandates. 
Plasma was obtained from centrifugation of heparinized blood (Monovettes; Sarstedt, 
Numbrecht, Germany) and kept frozen at -20ºC for progesterone (P4) concentrations analysis 
according to previously detailed procedures (Roberto da Costa et al., 2007). Estrous cycle 
stage of each mare was determined as follicular phase (FLP; n=10), or the mid-luteal phase 
(MLP; n=10) through a combination of ovarian and uterine condition as previously reported 
(Roberto da Costa et al., 2007) and P4 concentrations. FLP was characterized by the presence 
of a follicle >35mm, absence of an active corpus luteum (CL) and P4 <1ng/mL. The MLP 
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was defined by a fully developed CL, follicles 15–20mm in diameter and P4 concentrations 
>6ng/mL. Immediately after ovary collection, uterine horns were opened and signs of 
endometritis, like increased mucus production and altered color of the surface epithelium 
were searched for. A sterile swab was used to quickly evaluate the presence of PMN and 
bacteria by routine Diff-Quick staining. Thus, only endometria, not presenting bacteria, and 
having in average less than two PMN per light microscopic field at 400 magnification (Riddle 
et al., 2007) were considered as healthy uteri and were used. Immediately after ovary 
collection, endometrial samples from the uterine horn ipsilateral to the ovary presenting either 
a CL characteristic of MLP or a pre-ovulatory follicle, were separated from the myometrium 
and washed in sterile phosphate-buffered saline (PBS) with antibiotics (100 mg/mL 
streptomycin -S9137; Sigma, St Louis, MO, USA), 100 IU/mL penicillin (P3032; Sigma). 
Endometrial samples were immersed in either: (i) RNAlater (AM7020; Ambion, Applied 
Biosystems, Foster, CA, USA) for quantification of mRNA and protein expression; (ii) 4% 
buffered formaldehyde for histologic evaluation and further endometrial classification; or (iii) 
chilled (4ºC) Dulbecco’s modified Eagle’s medium (DMEM) and F-12 Ham medium (D/F 
medium; 1:1 (v/v); D-8900; Sigma) supplemented with 100 mg/mL streptomycin (S9137; 
Sigma, St Louis, MO, USA), 100 IU/mL penicillin (P3032; Sigma) and 2mg/mL amphotericin 
(A2942; Sigma) for in vitro explant culture studies.  
A total of 20 equine endometria, from FLP (n=10) and MLP (n=10), were used in the present 
study. Each estrous cycle phase evaluated included samples from group I/IIA (n=5) and group 
IIB/III (n=5) endometria. In in vitro explant culture studies, endometrial tissues were 
challenged with different concentrations of ELA, MPO or CAT for 24h, as described in 
section 3.3.3. The concentrations of NETs proteins used in our study were chosen based on 
qualitative and quantitative protein composition of NETs and on the activities of those NETs 
proteases. ELA, CAT and MPO are the most abundant non-histone NETs proteins 
representing 5.84%, 2.47% and 1.01% of total NET protein content, respectively (Urban et 
al., 2009). Concentrations used in this study were similar to those used in other in vitro 
assays, as well as similar to concentrations reported in physiologic and inflammatory 
conditions, as follows: ELA in chronic bronchitis, cystic fibrosis, and asthma (Voynow et al., 
2008); MPO range in blood: 0.1–2.5 ug/mL (Boudjeltia et al., 2004); CAT - activated PMN in 
sites of injury or inflammation can express up to 160 ng of catalytically active CAT per 106 
cells (Glusa et al., 2001). The MPO concentrations used in our in vitro studies are within the 
range of those detected in the uterine lumen of mares (Parrilla-Hernandez et al., 2014). 
Concentrations of each protease was determined by a prior dose response experiment (data 
not shown) wherein transforming growth factor beta-ß1 (TGF-b1) production by endometrial 
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explants (as a putative fibrotic marker) was evaluated in response to three concentrations of 
each protein; MPO (0.1, 0.5 or 1 µg/mL), CAT (0.1, 1 or 2.5 µg/mL) or ELA (0.1, 0.5 or 1 
µg/mL).  The highest dose of MPO and CAT did not lead to a further increase in TGF-b1 
production. The lowest concentration of ELA did not induce a high secretion of TGF-b1. 
Bovine and horse skin collected at an abattoir was used as antigen and animal species positive 
controls in western-blot analysis. Endometria, skin and blood were transported on ice to the 
laboratory within 1h. 
 
3.3.2. Endometrial histological analysis and classification 
Formaldehyde-fixed endometrial sections (5 µm) were stained with hematoxylin (05-06014E; 
Bio-Optica) and eosin (HT1103128; Sigma-Aldrich) and examined under light microscope 
(Leica DM500). Endometria were classified by the extent of inflammation and/or fibrosis 
(Kenney & Doig, 1986), as category I, IIA, IIB or III, corresponding to minimum, mild, 
moderate or severe lesion of endometrial fibrosis, respectively. For the in vitro studies, 
endometrial samples were clustered into two groups; type I and IIA endometria (group I/IIA) 
or type IIB and III endometria (group IIB/III). 
 
3.3.3. In vitro endometrial explant culture 
For tissue culture, endometrial strips were cut, immersed in a Petri dish with PBS and 
antibiotics, washed thoroughly, and this procedure repeated 3 times. Individual pieces of 
endometria were blotted in filter paper, weighed, rinsed, and approximately 20-30mg placed 
in a single well of a sterile 24-well cell culture plate (Eppendorf, #0030 722.116) in 1 mL of 
cell culture medium, for 1h, at 37ºC in a humidified atmosphere (Biosafe Eco-Integra 
Biosciences, Chur, Switzerland; 5% CO2, 95% air) with gentle shaking (Titertek, Huntsville, 
AL, USA; 150 r.p.m.). Culture medium consisted of DME/F-12 Ham Medium (D/F medium; 
1:1 (v/v); D-8900; Sigma) and 0.1% (w/v) bovine serum albumin (BSA; 735078; Roche 
Diagnostics, Mannheim, Germany), supplemented with 100µg/mL streptomycin (S9137; 
Sigma, St Louis, MO, USA), 100 IU/mL penicillin (P3032; Sigma) and 2mg/mL amphotericin 
(A2942; Sigma). 
After 1h pre-incubation, medium was changed and endometrial explants were cultured for 
24h with: (i) medium only (control); or (ii) elastase (A6959, AppliChem GmbH; ELA; 0.5, 
1µg/mL); (iii) cathepsin (A6942, AppliChem GmbH; CAT; 0.1, 1µg/mL); (iv) 
myeloperoxidase (A6969, AppliChem GmbH; MPO; 0.1, 0.5µg/mL); or (v) positive control 
oxytocin (OXT; 10-7 M) (Nash et al., 2008). Each treatment was performed in quadruplicate, 
and explants incubated under the same conditions as pre-incubation. After incubation, tissues 
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were maintained in cryotubes at -80ºC, with RNAlater, for mRNA level and protein 
determination of specific genes involved in fibrosis. Conditioned culture medium was 
collected and immediately used for alamarBlueâ assay, and also stored at -80ºC, for further 
prostaglandin F2α and E2 determinations. Prior to freezing, in order to prevent prostaglandins 
degradation during storage, 1% stabilizer (0.3 M ethylenediaminetetraacetic acid (EDTA) and 
1% aspirin, No. A2093; Sigma) was added to tissue conditioned culture medium (Szóstek et 
al., 2014). 
 
3.3.4. Viability of endometrial explants  
In order to confirm that the endometrial samples were still viable, metabolic viability of the 
explants was assessed by alamarBlueâ(AB) (DAL1100; ThermoFisher Scientific) as 
previously described (Carranza-Torres et al., 2014). Following each incubation time, each 
explant and its tissue culture medium were incubated for an additional 4 h with 10% AB, at 
37°C. Afterwards, 100 µL were collected from each sample and transferred to a 96-well 
microplate. Fluorescence values were read using a fluorometer microplate reader (Synergy H1 
Hybrid Reader, BioTek; Gene 5 software) at 560 nm excitation/590 nm emission 
wavelengths. The percentage viability was obtained by calculating the percentage of AB 
reduction per cell (Carranza-Torres et al., 2014).  
 
3.3.5. Hormone determinations 
Circulating concentrations of P4 were assayed in duplicate and measured by a validated solid-
phase Radioimmunoassay (RIA), without extraction, using a commercial kit (Coat-A-Count; 
Diagnostic Product Corporation, Los Angeles, CA, USA), and a Wallac (wizard 1470) 
counter. All samples were run in a single assay. The limit of detection of the assay was 0.02 
ng/mL and the intra-assay coefficient of variation was 3.4%.  
Culture medium was analyzed by direct enzyme immunoassay (EIA) for PGF2𝛼 as previously 
described (Szóstek et al., 2014). The standard curve for PGF2𝛼 ranged from 0.19ng/mL to 
50ng/mL and the intra- and inter-assay coefficient of variation (CV) were on average 8.5% 
and 10.7% respectively. Concentration of PGE2 was determined using a Prostaglandin E2 EIA 
kit (PGE high sensitivity ELISA kit; Catalog nº ADI-931-001; Enzo Life Sciences), according 
to the manufacturer procedures. According to the manufacturer, the detection limit of PGE2 
was 8.26 pg/mL. For PGE2, the standard curve ranged from 0.039 pg/mL to 100 pg/mL, and 
the concentration at 50% binding (ED50) was 6.25 pg/mL. The intra- and inter-assay CV 
were 6.1% and 12.8%, respectively. Hormone concentrations in culture media were 
normalized for mg of endometrium. 
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3.3.6. Quantitative Real-Time polymerase chain reaction (qPCR) 
For qPCR studies, RNA isolation and cDNA synthesis were performed as previously 
described (Galvão et al., 2010). Briefly, RNA was extracted from endometria using the Total 
RNA Extraction and Purification kit (28704; Qiagen, Hilden, Germany), including a DNA-
digestion step with an RNase-free DNase kit (50979254; Qiagen), according to the 
manufacturer’s instructions. The RNA was quantified using the Nanodrop system (ND200C; 
Fisher Scientific, Hampton, PA, USA) and its quality assessed by visualization of 28S and 
18S rRNA bands after electrophoresis through a 1.5% agarose gel and gel red staining 
(41003; Biotium, Hayward, CA, USA). Reverse transcription was performed using Reverse 
Transcriptase Superscript III enzyme (18080093; Invitrogen, GIBCO BRL, Carlsbad, CA, 
USA) from 1 mg total RNA in a 20 µL reaction volume using oligo (dT) primer (27-7858-01; 
GE Healthcare, Buckinghamshire, UK). Specific primers were designed, as well as the 
reference gene, using the Internet-based program Primer-3 (Untergasser et al., 2012) and 
Primer Premier software (Premier Biosoft Interpairs, Palo Alto, CA, USA).  
Real time PCR was used for assessment of mRNA transcription of collagen genes such as 
types I and III alpha collagen (COL1, COL3). The primers used in the present study are listed 
in Table 3. Before running the assay, the reference gene was validated. To determine the most 
stable internal control gene, four potential reference genes were initially considered, as 
follows: glyceraldehyde 3-phosphate dehydrogenase (GAPDH), succinate dehydrogenase A 
complex, subunit A, flavoprotein (SDHA), beta-2-microglobulin (B2M) and ribosomal protein 
L32 (RPL32). For validation, samples from different stages of the estrous cycle or subjected 
to different treatments were run in parallel with the tested genes. RPL32 was the most stable 
internal control gene (less than 2-fold changes between different biological conditions (Dheda 
et al., 2004). Primer concentrations were optimized to the minimum concentration: lowest 
cycle threshold ratio. This was performed in a StepOnePlus™ Real-Time PCR System 
(Applied Biosystems, Warrington, UK) using the default thermocycler program for all genes: 
a 10-min pre-incubation period at 95ºC was followed by 40 cycles of 15 s at 95ºC and 1 min 
at 60ºC, followed by a dissociation step (15 s at 95ºC, 30 s at 60ºC and 15 s at 95ºC). Both the 
target and reference genes were run simultaneously and all reactions were performed in 
duplicate wells on a 96-well optical reaction plate (4306737; Applied Biosystems) in 13 µL 
reaction volume containing 3.5 µL water, 1µL forward primer, 1 µL reverse primer, 6.5 µL 
Power SYBER Green Master Mix (4367659; Applied Biosystems) and 1 µL cDNA. In order 
to confirm specificity, all polymerase chain reaction (PCR) products were run on a 2.5% 
agarose gel (BIO-41025; Bioline, Luckenwalde, Germany). Data on relative mRNA 
quantification were then analyzed with the real-time PCR miner algorithm (Zhao & Fernald 
 
     95 
Experimental Work 
2005), namely, after average cyclic threshold (Cq) and primer efficiency determinations for 
each sample, all Cq levels were related with primer efficiency level (E) using the equation 
[1/(1þE)Cq] (Zhao & Fernald 2005). Expression level of the target genes was normalized 
against that of the reference gene. 
Table 3- Primer sequences used for type I and III collagens real time PCR analysis of mare 
endometrial explants. 
 
 COL1A2- collagen, type I, alpha 2; COL3A1- collagen, type III, alpha 1; RPL32- ribosomal protein 
L32. 
 
3.3.7. Western blot analysis 
Protein expression of type I collagen fibers was evaluated by western blotting on equine 
endometrial tissue explants after incubation. Even though a number of different antibodies for 
COL3 was tested, we were unable to detect type III collagen protein in mare endometrium. 
Since the primary antibody used in immunoblotting was raised against collagen type 1 of 
bovine origin, samples of bovine and horse skin were used as antigen and animal species 
positive controls, respectively. Endometrium and skin samples were minced and placed in ice-
cold RIPA buffer (50 mM Tris-Hcl, pH 8; 150 mM NaCl; 1% Triton X-100; 0.5% sodium 
deoxycholate; 0.1% sodium dodecyl sulphate) with protease inhibitors (Complete Mini 
Protease Inhibitor Cocktail Tablets, Roche) and disrupted using mechanical (TissueLyser, 
Qiagen GmbH; Hilden, Germany) and ultrasonic homogenizer (Bandelin Sonopuls; Berlin, 
Germany).  Protein was extracted and its concentration determined with Bradford reagent 
(500-0006; Bio-Rad, Hercules, CA, USA) (Ferreira-Dias et al., 2007). Protein (40 µg) was 
then loaded onto 8% acrylamide gel (161-0155; Bio-Rad, Hercules, CA, USA), and 
transferred to nitrocellulose membranes (Ref. 10401396, Whatman; GE Healthcare Europe 
GmbH, Lisbon, Portugal). Protein levels were assessed using diluted specific primary 
antibody against collagen type I (20121; Novotec, Lyon, France; 1:1000 diluted). After 
overnight membrane incubation at 4ºC with the primary antibody, the density of samples on 
multiple gels was analyzed.  A standard sample (40 µg total protein of a mix of incubated 
endometria samples) was loaded in a single lane of each gel in all gels (Miller 2010). This 
standard sample was used to normalize all bands on that same blot, and then compare them 
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Forward: CAAGGGCATTAGGGGACACA 196 
 Reverse: ACCCACACTTCCATCGCTTC 
COL3A1 
(AF117954.1) 




Forward: AGCCATCTACTCGGCGTCA 144 
Reverse: GTCAATGCCTCTGGGTTTCC 
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across multiple blots. To normalize for protein loading, a mouse monoclonal antibody against 
β-actin (A5441; Sigma; RRID: AB_476744) was used at a dilution if 1:10,000 and incubated 
for 2 h, at room temperature. Membranes were incubated for 1.5 h at room temperature with 
horseradish peroxidase (HRP)-conjugated anti-rabbit (1:20,000 dilution; P0448; 
DakoCytomation, Carpinteria, CA, USA). In the case of β-actin, the secondary antibody was 
HRP-conjugated goat anti-mouse (1:5,000 dilution; A2554; Sigma). After 1h incubation at 
room temperature, protein expression was visualized using luminol enhanced 
chemiluminescence (Super Signal West Pico, 34077; Thermo Scientific, Waltham, MA, 
USA). Chemiluminescence detection and image acquisition was performed by ChemiDoc 
XRS+ system (Bio-Rad Laboratories, Inc.). Densitometry signal evaluation was assessed 
using Image LabTM software. Dividing the units of arbitrary densitometry by standard sample 
density for each band normalized target protein expression, and values were expressed in 
terms of Relative Density. Sample Relative Density of each lane was further divided by β-
actin loading-control Relative Density for that same lane.  
 
3.3.8. Validation of collagen type I antibody 
For detecting the effects of NETs components on endometrial type I collagen protein 
expression, western-blot analysis under denatured and reduced conditions was conducted. 
Since the primary antibody used in immunoblotting was raised against collagen type I of 
bovine origin, one assay was performed with different concentrations of bovine skin, horse 
skin and horse endometrium samples, to verify that the antibody was able to detect horse type 
I collagen (Fig. 11). Collagen type I consists of two collagen α1 (I) and one collagen α2
 
(I) 
polypeptide chains. In horse, predicted molecular weight of collagen alpha-1(I) chain is 
126kDa (Protein Database, NCBI, 2017). In all types of tested samples a molecular weight 
band around 126 kDa was evident (Fig. 11) corresponding to Col1 α1 (I) polypeptide.  Band 
intensity was visualized in a concentration-dependent fashion. 
 
Figure 11- Collagen type I immunoblotting assay with different concentrations of bovine skin, 
horse skin or endometrial protein samples. Data demonstrates that the primary antibody used 
was able to detect horse type I collagen. Lanes: a- endometrial sample (40 µg); b, c, d -40 µg, 
20 µg or 80 µg of horse skin, respectively; e, f - 20 µg or 40 µg of bovine skin, respectively. 
Rebordão et al. 


















     97 
Experimental Work 
3.3.9. Statistical analysis 
Data are presented as mean ± S.D. Unpaired Student t-test was used to compare the data of 
endometrial explant viability and prostaglandin secretion data of non-treated endometrial 
explant viability. One-way analysis of variance (ANOVA) followed by Dunnett post-hoc test 
was used to compare the results between control and treated explants.  Two-way ANOVA, 
followed by Bonferroni multiple comparison test among means, was used to determine 
whether any change was the result of the interaction between the type of treatment and (i) 
group of endometrium categories or (ii) estrous cycle phase. Statistical analyses were 
performed using GraphPAD PRISM (Version 5.00, GraphPad Software, San Diego, CA, 
USA). Results were considered significant at P < 0.05.  
 
3.4. Results 
3.4.1. Viability of Endometrial Explants 
Endometrial explants cultured for 24h maintained high metabolic activity throughout the 
incubation period. No significant difference in mean viability was observed between fresh 
tissues (non-incubated-0h; 98.1± 1.2%) and after incubation (94.94± 3.9%); (P > 0.05). 
Explants were also capable of maintaining their secretory capacity throughout the incubation 
period, by producing PGF2α and PGE2 into the culture medium. PGF2α and PGE2 secretion 
of non-treated endometria after 24h incubation was 4.4±2.7 ng/mg endometria and 5.6±2.9 
pg/mg, respectively. Those values increased in endometrial explants challenged for 24h with 
OXT (PGF2α: 9.882 ± 4.6 ng/mg; PGE2: 13.65±5.6 pg/mg) (P < 0.05). These results were 
independent of estrous cycle phase (data not shown). The initial pink color appearance of the 
explants and the secretion of PG throughout the 24h experimental period may be taken as a 
sign of their viability (Nash et al., 2008).  
 
3.4.2. NETs components induce high endometrial collagen expression	
To determine if NETs components could have a stimulatory role in collagen deposition on 
mare endometrium and if that effect could be dependent on the presence of endometrial 
inflammatory lesions and/or on estrous cycle phase, collagen type I protein (COL1) and 
collagen genes transcription were evaluated in type I/IIA and IIB/III endometrial explants 
obtained during FLP and MLP.  
Increased COL1 production resulted after incubation of FLP endometrium with the highest 
concentration of ELA or MPO and both doses of CAT (P<0.05; Fig. 12.1; 12.2). These effects 
were observed regardless of endometrium classification (Fig. 12.1; 12.2). Collagen type I 
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gene transcription in FLP type I/IIA endometria was unchanged (P > 0.05) after incubation 
regardless of the type or concentrations of NETs proteins (Fig. 12.3). However, in type IIB/III 
tissues obtained in the FLP, up-regulation of COL1 occurred after incubation with the highest 
concentration of ELA (P < 0.05; Fig. 12.4).  
Endometria obtained in the FLP responded to NETs proteases by enhancing COL3 transcripts. 
In FLP type I/IIA, an up-regulation of COL3 was observed with MPO (0.5 µg/mL, P < 0.05) 
and CAT (0.1 µg/mL, P < 0.001; Fig. 12.5). Likewise, in FLP type IIB/III tissues, COL3 gene 
transcription increased with all concentrations of both ELA (0.5 µg/mL, P < 0.001; 1 µg/mL, 
P < 0.01) and CAT (0.1 µg/mL, P < 0.01; 1 µg/mL, P < 0.05) (Fig. 12.6).  
 
 
Figure 12- Relative collagen type I (COL1) protein (1, 2, 7 ,8) and transcription of COL1 (3, 
4, 9 ,10) or COL3 (5, 6, 11 ,12) genes, by type I/IIA or IIB/III follicular or mid-luteal phase 
endometrial explants after incubation with different concentrations of NETs components. N=5 
samples from each group- I/IIA and IIB/III, for each estrous cycle phase. Bars represent 
mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 0.01; *** P < 
0.001). CAT- cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 
or 1 µg/mL); FLP- follicular phase; MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 
0.5 µg/mL); OXT- oxytocin. 
 
Representative COL1 western blot images in FLP type I/IIA and type IIB/III endometria are 
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Figure 13- Panels representative of type I collagen western blotting in follicular phase. A- in 
type I/IIA endometria explants (n=5); B- in type IIB/III endometria explants (n=5).  A 
standard protein (c) was used to compare the density of samples on multiple gels. Data were 
normalized against b-actin density values. a- CONT 24h; b- OXT 24h; c- standard protein; d- 
ELA 0.5 µg/mL 24h; e- ELA 1 µg/mL 24h; f- MPO 0.1 µg/mL 24h; g- MPO 0.5 µg/mL 24h; 
h- CAT 0.1 µg/mL 24h; i- CAT 1 µg/mL 24h. COL1- type I collagen; FLP- follicular phase. 
 
 
During the MLP, type I/IIA endometrial explants incubated with 1µg/mL of ELA or CAT 
induced COL1 protein expression (P < 0.05; Fig. 12.7). In type IIB/III endometria, COL1 
protein was elevated in explants subjected to all concentrations of ELA (0.5 µg/mL- P < 0.05; 
1 µg/mL- P < 0.01) and low MPO doses (P < 0.05; Fig. 12.8).  
Collagen gene transcription in type I/IIA MLP endometria, responded to incubation with the 
lowest concentration of MPO (0.1 µg/mL) and CAT (0.1 µg/mL) by down-regulating COL1 
(P < 0.05; Fig. 12.9). In contrast, in the type IIB/III explants exposed to the same 
concentration of MPO and to the highest tested dose of ELA, COL1 was up-regulated (P < 
0.05; Fig. 12.10). However, despite no differences in COL3 transcripts by type I/IIA 
endometria (P > 0.05; Fig. 12.11), down-regulation of COL3 gene transcription occurred after 
incubation of type IIB/III tissues with the highest concentration of MPO (P < 0.05; Fig. 
12.12). Representative COL1 immunoblotting images in MLP type I/IIA and type IIB/IIB 
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FLP Type I/IIA endometria explant FLP Type IIB/III endometria explant 
β-Actin 42 kDa 
a b c 
COL1 126kDa 
d e c 
β-Actin 42 kDa 
COL1 126kDa 
f g c 





β-Actin 42 kDa 
COL1 126kDa 
β-Actin 42 kDa 
a b c 
COL1 126kDa 
d e c 
β-Actin 42 kDa 
COL1 126kDa 
f g c 
β-Actin 42 kDa 
COL1 126kDa 
h i c 




     100 
Experimental Work 
 
Figure 14- Panels representative of type I collagen western blotting in mid-luteal phase. A- in 
type I/IIA endometria explants (n=5); B- in type IIB/III endometria explants (n=5). A 
standard protein (c) was used to compare the density of samples on multiple gels. Data were 
normalized against b-actin density values. a- CONT 24h; b- OXT 24h; c- standard protein; d- 
ELA 0.5 µg/mL 24h; e- ELA 1 µg/mL 24h; f- MPO 0.1 µg/mL 24h; g- MPO 0.5 µg/mL 24h; 




3.4.2.1. Endometrium classification affected collagen expression 
 
Comparison between collagen expression by endometrial category (I/IIA vs. IIB/III) obtained 
in the FLP, showed no differences in COL1 production and COL1 gene expression, 
throughout the experimental period (data not shown). In contrast, in MLP endometria, 
comparison of fibrosis indicators between groups I/IIA vs. IIB/III, showed higher COL1 
production in IIB/III tissues compared with I/IIA after incubation with the lowest 
concentrations of ELA (P < 0.01) or MPO (P < 0.05) (Fig 15.1).  Transcription of the COL1 
gene was also up-regulated in the IIB/III group compared with I/IIA when endometrial 
explants were subjected to ELA (1µg/mL, P < 0.05) or MPO (0.1µg/mL; P < 0.001) (Fig. 
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Figure 15- Effect of endometrial category (I/IIA vs. IIB/III) on collagen type I protein (COL1) 
or COL1 gene expression by mid-luteal phase endometrial explants incubated with different 
concentrations of NETs components. N=5 samples from each group- I/IIA and IIB/III in 
MLP. Bars represent mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 
0.01; *** P < 0.001). CAT- cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- 
elastase (0.5 or 1 µg/mL); FLP- follicular phase; MLP- mid-luteal phase; MPO- 
myeloperoxidase (0.1 or 0.5 µg/mL); OXT- oxytocin. 
 
3.4.2.2. Estrous cycle phase affected collagen expression 
Comparison between endometria obtained during different estrous cycle phases (FLP vs. 
MLP), on endometrial response to fibrotic mediators revealed in FLP type I/IIA group, an 
increase in COL1 protein expression after CAT treatment (0.1 µg/ml) (P < 0.05; Fig. 16.1). 
Likewise, increased COL1 mRNA transcription (P < 0.05; Fig. 16.2) with the lowest studied 
dose of CAT (0.1 µg/mL; P < 0.001) and the highest concentration of ELA (P < 0.05) was 
observed in FLP when compared with MLP. With respect to COL3 gene, in FLP, a high 
transcription was observed with MPO (0.5µg/mL; P < 0.01) or CAT (0.1 µg/mL; P < 0.05) in 
treated explants (Fig. 16.3), compared to MLP.  
Mid-luteal phase type IIB/III endometrial explants showed an enhanced COL1 production 
after incubation with ELA (0.5 µg/mL; P < 0.001) or with MPO (0.1 µg/mL; P < 0.01) 
(Fig.16.4), compared with the same treatments and endometria types during the FLP. 
Regarding COL1 gene transcription an increase in its expression was depicted when MLP 
explants were incubated with the lowest studied concentration of MPO (P < 0.01) (Fig. 16.5) 
compared to FLP. Yet, with respect to COL3 gene, increased transcription was observed in 
FLP type IIB/III group (Fig. 16.6) after incubation with ELA (0.5µg/mL; P < 0.001) or CAT 
(0.1 µg/mL; P < 0.05), when compared with the same treatments and endometria types during 
the MLP.  
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Figure 16- Effect of estrous cycle phase (follicular phase vs. mid-luteal phase) on collagen 
type I protein (COL1) (1, 4) and COL1 (2, 5) or COL3 (3, 6) genes expression by type I/IIA 
or IIA/III endometrial explants incubated with different concentrations of NETs components. 
N=5 samples from each group- I/IIA and IIB/III of each estrous cycle phase. Bars represent 
mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 0.01). CAT- 
cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 or 1 µg/mL); 
FLP- follicular phase; MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 0.5 µg/mL); 
OXT- oxytocin. 
 
3.5. Discussion  
The initiating factors of endometrosis are still uncertain and may be associated to hormonal 
imbalances, endometrium inflammation or be a spontaneous condition of unknown etiology, 
particularly in old mares (Schoon et al., 1999; Hoffmann et al., 2009; Reilas et al., 2016; 
Schöniger et al., 2017). To the best of our knowledge this is the first study that has 
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investigated the potential ability of NETs components to induce in vitro endometrial fibrosis 
by examining the expression of collagen genes and protein in mare endometrium.  
In the mare endometrium, an insult like semen or pathogenic microorganisms provokes an 
inflammatory response, with PMN uterine infiltration that phagocytize bacteria and debris 
(LeBlanc & Causey 2009; Woodward et al., 2013; Cadario, 2014). Previous in vitro studies 
have shown equine PMN ability to release NETs in vitro, when in the presence of sperm cells 
(Alghamdi & Foster 2005). Also in mares with infectious endometritis, the presence of ex-
vivo NETs decorated with ELA and MPO in uterine secretions was confirmed (Rebordão et 
al., 2014). Besides, MPO values have been detected in uterine lumen of mares throughout the 
estrous cycle and they greatly increased in the presence of endometritis (Parrilla-Hernandez et 
al., 2014). In our study, in response to MPO, endometrial explants augmented COL1 in vitro 
production, which might suggest MPO role on endometrosis establishment. Even though 
physiologic and pathologic concentrations of MPO in mare uterus are known (Parrilla-
Hernandez et al., 2014), the concentrations of ELA and CAT have not yet been reported. In 
susceptible mares, ELA and CAT released from peripheral blood PMN were initially lower at 
parturition, when compared to resistant mares, but further increased in the course of foal-heat 
post-breeding endometritis (Wessely-Szponder et al., 2014). Since deficient uterine clearance 
in mare post-breeding endometritis increases the likelihood of cell damage (LeBlanc & 
Causey, 2009), and may result in secondary bacterial infection and PMN infiltration (Cadario, 
2014), we propose that NETs persistence in the mare uterus perpetuates the inflammatory 
process and may lead to fibrosis development. 
In endometrosis, type III collagen (predominant in healthy endometrium) is gradually 
replaced by type I collagen, with increasing endometrial fibrotic changes (Masseno, 2012; 
Costa, 2015). The exact mechanisms of excessive collagen fiber accumulation, which alter 
endometrial structure and results in reproductive failure, have not been elucidated. Increased 
collagen type I production by endometrial tissues, characteristic of fibrosis, was observed in 
mare endometria in the presence of all NETs proteins studied, although endometrial response 
to specific NETs proteases varied with the estrous cycle phase and/or with endometrial 
category. Our results are in agreement with those obtained by others, in which increased 
collagen production was observed when lung fibroblasts were treated in vitro with NETs 
(Chrysanthopoulou et al., 2014). In cystic fibrosis secretions, uncontrolled NETs proteases 
released by PMN contribute to the destruction of lung tissue (Dubois et al., 2012).  
In a study on phorbol myristate acetate (PMA)-induced NETs generated by healthy human 
donor PMN, the dominant proteolytic activity in NETs was attributed to neutrophil ELA, but 
when ELA was immune-depleted, the remaining activity was attributed to CAT (O’Donoghue 
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et al., 2013). This is in accord with our data since among all NETs components tested, ELA 
(high concentration) enhanced COL1 production in all endometrial groups, regardless of 
estrous cycle phase. The association of ELA with fibrosis development has been 
demonstrated in several tissues, for example, neutrophil ELA promotes myofibroblast 
differentiation in lung fibrosis (Gregory et al., 2015) and atheromatous plaques in 
cardiovascular diseases (Sharony et al., 2010). 
Fibrotic conditions like renal fibrosis (Shimoda et al., 2007) and cystic fibrosis (Twigg et al., 
2015) have been associated with CAT. In our study, endometrial response to CAT profibrotic 
effects was dependent not only on endometrial category, but also appeared to be hormone-
dependent. In type IIB/III tissues, elevated COL1 production in the follicular phase estrogen-
primed endometrium was observed after incubation with CAT, whereas in MLP tissues the 
same effect was not seen.  
Atrial (Rudolph et al., 2010; Friedrichs et al., 2012) and liver fibrosis (Pulli et al., 2015) have 
been linked to MPO tissue damage. MPO-activated hepatic stellate cells, the main source of 
collagen production in the liver, up-regulated in vitro COL1 and α-smooth muscle actin 
myofibroblasts, via TGF-β (Pulli et al., 2015). In our study, the MPO profibrotic pathway in 
type I/IIA endometria seems to be hormone-dependent, since enhanced COL1 production and 
increased COL3 gene transcription only occurred in the FLP. However, MPO effects in type 
IIB/III endometria were noticed in both estrous cycle phases. It appears that fibrotic 
endometrium becomes independent of the uterine endocrine control mechanisms, due to 
ovarian steroid receptors reduction, as previously reported (Hoffmann et al., 2009; Lehmann 
et al., 2011). 
The increase in COL1 output after stimulation with NETs proteins was not always associated 
with an increase in COL1 gene transcription, regardless of estrous cycle phase or endometrial 
type. This may suggest that the mRNA signal for COL1 production occurred before the end of 
the incubation period jeopardizing the detection of its raise in endometrial explants. It is 
known that mRNAs are less stable than proteins with a maximum half-life of approximately 
7h, compared to 46h for proteins (Vogel & Marcotte 2013). Thus, protein abundance mainly 
depends on a dynamic balance amongst transcription, mRNA processing and damage, 
translation, modification and destruction of the resulting proteins (Vogel & Marcotte 2013).  
In this study, we investigated whether NETs effect on collagen deposition in mare 
endometrium could be dependent on the presence of endometrial inflammatory lesions. 
During the FLP, endometrial susceptibility to NETs does not seem to be influenced by the 
inflammatory lesions already present, as evidenced by NETs proteases ability to stimulate 
COL1 production equally in type I/IIA and type IIB/III tissues. In the luteal phase, the type of 
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endometrium seems to influence the response to NETs. Only the highest doses of ELA and 
CAT caused an increase in fibrosis in tissues with minimum or mild lesions (type I/IIA), 
whereas in endometrium with moderate to severe lesions, low concentrations of these pro-
fibrotic mediators (ELA and MPO) were sufficient to induce a fibrogenic response.  
The possible hormonal influence on endometrial response to NETs proteases was addressed 
through evaluation of tissue response during the follicular versus the luteal estrous cycle 
phases. During the follicular phase, both types of endometria increased their transcription of 
the COL3 gene when stimulated with NETs proteins. It is possible that increased transcription 
of this gene is accompanied by an increased production of this type of collagen fiber. 
However, COL3 protein production was not evaluated in this study, so this remains to be 
determined. Type III collagen fibers are considered to be the ones that are synthesized earlier 
in the development of fibrosis (Masseno, 2012; Lunelli et al., 2013; Costa 2015); the ability 
of NETs proteins to stimulate a COL3 reaction in all follicular endometrial types may be 
reflective of this. During the luteal phase, enhanced transcription of COL3 did not occur in 
either endometria type. We suggest that estrous cycle may influence the type of collagen 
fibers that will predominate when endometrial tissue is subjected to injury. Such differences 
may be hormone-dependent and mediated by tissue specific catabolic or anabolic enzymes 
involved in collagen synthesis. Previous studies on steroid regulation of collagen synthesis in 
genital organs support our hypothesis. In the human uterus after estrogen (E2) stimulation, 
stromal endometrial proliferation associated with extensive deposition of COL3 was 
observed, while P4 stimulation caused an increase in COL3 breakdown (Stenback 1989). The 
ratio of type III to type I collagen in the proliferative-phase human endometrium was 
significantly higher than the ratios in the secretory-phase endometrium (Iwahashi et al., 
1996). Under the influence of high estrogen levels during late estrus, mare ovarian stroma 
showed an increase in COL3 while COL1 decreased. During diestrus, COL1 predominated in 
the stroma (Smok & Rojas 2010). Our results are in accord with Smok & Rojas (2010) 
suggesting that in mare reproductive tissues, E2 may be related to COL3 production whereas 
P4 appears associated with increased COL1.  
Even though our in vitro data suggest that NETs components might contribute for 
endometrosis development as a follow up of PMN influx during endometritis, this might be 
questioned by some authors. After experimentally induced bacterial endometritis in mares, 
despite a transient activation of fibrotic cells in stroma, presumably caused by pro-fibrotic 
growth factors and cytokines released by inflammatory cells, and despite repeated 
inflammations, endometrosis was not exacerbated during the 2-year experimental period 
(Hoffmann et al., 2009a). Regardless of the presence of inflammation prior to endometrial 
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fibrosis, a low correlation between inflammation and endometrosis grade suggests that 
progression of endometrium fibrogenesis in the mare, becomes independent of inflammation 
after a critical point (Aresu et al., 2012).  In contrast, in a recent study, mares with closed 
cervix developed a marked endometritis, with intense PMN infiltration, large fluid 
accumulation, and permanent pathologic endometrium changes, including fibrosis (Reilas et 
al., 2016). The incidence of endometrosis increases in older mares, related to ovarian 
inactivity, and independent of parity (Ebert et al., 2014; Kilgenstein et al., 2015). In fact, 
maiden mares often have high grade endometrosis, which may be ascribed to cervical-
dysfunction, poor myometrial contractility and intrauterine fluid accumulation (Pycock 2006).  
Therefore, even though unknown factors may be involved in endometrosis progression 
(Hoffmann et al., 2009a), endometritis might be one of the triggers for endometrium 
fibrogenesis.  
In conclusion, even though NETs might be a complementary mechanism to fight some 
bacteria responsible for endometritis in the mare (Rebordão et al., 2014), they may also pose a 
threat to the health of the endometrium due to their protease action. Although ELA enhanced 
COL1 production, regardless of endometrial category or estrous cycle phase, endometrial 
collagen production response to each specific NETs protease depended on estrous cycle phase 
and/or on endometrial category. Nevertheless, further studies are required to unravel the 
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4.1 Abstract 
Endometrosis is a pathological fibrotic disease of mare endometrium that impairs uterine 
function, but its leading mechanisms remain largely obscure. Prostaglandins (PG), like PGF2α 
play an important role in reproductive physiology and have been implicated in fibrogenesis in 
several organs. Signaling through their respective receptor (PGF2α-FP) mediates fibrotic 
actions. Persistence of neutrophil extracellular traps (NETs) may favor mare endometrial 
fibrogenesis, as in vitro endometrial explants incubation with NETs proteases induced high 
collagen type I production. The aim was to investigate the involvement of PGF2α pathways in 
collagen deposition on mare endometrium, challenged with NETs proteases. Kenney and 
Doig´s type I/IIA and IIB/III mare endometria, from follicular (FLP) and mid-luteal (MLP) 
phases, were cultured for 24h with NETs components (elastase, cathepsin-G, 
myeloperoxidase or oxytocin, as positive control). Expression of PGF2α protein and its 
synthases (PTGS2, AKR1C3) and FP gene transcription were evaluated. Enhanced PGF2a 
production and FP transcripts were present. Fibrogenic output was influenced by endometrial 
type and estrous cycle phases. In FLP and MLP type IIB/III endometria, enhanced synthesis 
of PGF2a or of its receptor was likely involved in mare endometrosis. Endocrine 
microenvironment in healthy or in pathological endometrial tissues, might modulate fibrotic 
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4.2. Introduction 
Neutrophil extracellular traps (NETs) are big DNA-associated molecule complexes of nucleic 
and cytoplasmic proteins, each one of them with strong antimicrobial and/or 
immunomodulating/pro-inflammatory properties, responsible for bacteria killing (Fuchs et al., 
2007; Lögters et al., 2009; Brinkmann & Zychlinski, 2012).  At the end of this active process 
called NETosis, polymorphonuclear neutrophil (PMN) nuclear membrane ruptures and their 
granules decompose, allowing the chromatin to directly contact with most PMN proteins 
(Steinberg & Grinstein, 2007).  
As a paradox, in spite of PMN being the first line of defense against the invading pathogenic 
bacteria, they may also be responsible for deleterious effects leading to a number of 
pathophysiological processes (review by Segel et al., 2011).  The release of proteases, such as 
elastase (ELA), cathepsin-G (CAT) or myeloperoxidase (MPO) may be one of the 
mechanisms by which PMN may contribute for a magnified inflammatory response and to 
tissue-specific injury with subsequent fibrosis formation (Sharoni et al., 2010; Ikegame et al., 
2010; Segel et al.., 2011; Cantin et al., 2015; Pulli et al., 2015). In fact, NETs induced 
activation and differentiation of lung fibroblasts into myofibroblast and collagen production 
has been shown (Chrysanthopoulou et al., 2014). 
The pathogenesis of tissue fibrosis is extremely complex and regulated in the inflamed tissues 
by intricate interactions of pro-fibrotic cytokines, extracellular matrix (ECM) components, 
inflammatory cells, hormones and fibroblasts (Atamas, 2002). The cytokine transforming 
growth factor-β1 (TGF-β1), secreted by the inflammatory cells recruited for wound healing, is 
generally considered one of the most potent pro-fibrotic cytokines involved in fibrosis 
(Atamas, 2002; Yu et al., 2003; Leask & Abraham, 2004; Wynn, 2011). In fact, TGF-β1 
plays a central role in fibrogenesis through a dual effect: on fibroblast activation and 
fibroblast-to-myofibroblast differentiation; and on collagen production by inducing the 
expression of genes for ECM deposition (Atamas, 2002; Ueha et al., 2012; Maroni & Davis, 
2012)  
Additional pathways, other than fibrotic cytokine TGF-β1, such as prostaglandins (PG), have 
been considered in fibrogenesis (Oga et al., 2009). Prostaglandins are lipid autacoids derived 
from arachidonic acid (AA) that sustain homeostatic functions and mediate several 
pathogenic mechanisms, including the inflammatory response (Ricciotti & FitzGerald, 2011). 
These mediators act locally, through specific receptors, due to their extremely short half-life 
in blood (Oga et al., 2009). Release of AA from membrane glycerophospholipids is catalyzed 
by phospholipase A2 (PLA2) enzymes, and AA is sequentially metabolized to prostaglandin 
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G2 (PGG2) and then to PGH2 by prostaglandin-endoperoxide synthase 1 (PTGS1) and/or 
PTGS2. PTGS1 is constitutively expressed in most tissues and responsible for housekeeping 
functions, while PTGS2 is regulated by several factors such as cytokines and supports 
sustained production of PG (Fortier et al.; 2008). Prostaglandin H2 is then converted to 
various bioactive PGs (thromboxane A2, PGD2, PGE2, PGF2α and PGI2) (Ueno et al., 
2005).  The PG produced by a given cell largely depends on the expression profile of each 
prostaglandin synthase enzymes (Hata & Breyer, 2004). Prostaglandin F2α is produced 
through the reduction of PGH2, by aldoketoreductase 1C synthases (AKR1C3) (Fortier et al.; 
2008). Prostaglandins are ubiquitously produced and act locally in an autocrine or juxtacrine 
manner to elicit a diverse set of effects that modulate many physiological systems, like 
reproductive ones, but also have been implicated in a broad array of diseases (Hata & Breyer, 
2004). Activation of a given PG receptor by its associated ligand might elicit varying 
responses in different cell types and tissues. 
Prostaglandin F2α acting on its receptor (FP) was recently linked to fibrosis formation in 
other tissues, like lung (Oga et al., 2009; Aihara et al., 2013; Oga et al., 2013), heart (Ding et 
al., 2012; Ding et al., 2014), skin (Kanno et al., 2013) and synovia (Bastiaansen-Jenniskens et 
al., 2013). Nevertheless, whether TGF-β1 and PGF2α stimulate fibrogenesis through 
independent pathways or not has been questioned. Some authors have referred that PGF2α 
stimulates TGF-β1 production and plays a central role in fibrosis establishment (Hou et al., 
2008; Kanno et al., 2013). Yet, in some systems, PGF2α-FP signaling facilitates fibrosis 
independently from TGF-β (Oga et al., 2009; Olman, 2009; Ding et al., 2012; Bastiaansen-
Jenniskens et al., 2013)  
Mare endometrial fibrosis (endometrosis) is the consequence of diverse insults that provoke 
degenerative changes of endometrial glands and surrounding stroma, characterized by 
periglandular arrangement of myofibroblasts and deposition of ECM, mainly collagen type I 
(Masseno, 2012; Costa, 2015). Knowledge of the exact mechanisms behind endometrial 
fibrosis is lacking. Since we have found the presence of NETs in the uterus of mares with 
infectious endometritis (Rebordão et al., 2014), persistence of NETs may pose a threat to 
health of the endometria ultimately leading to fibrosis development. As profuse PG synthesis 
occurs in the endometrium and in other tissues that are linked to inflammatory and fibrotic 
conditions, we hypothesized that PG may also be involved in mare endometrial fibrosis. In 
our previous work, in vitro incubation of mare endometrial explants with some NETs 
proteases induced high collagen production, suggesting that NETs components could have a 
pathogenic role in fibrosis formation (Rebordão et al., 2018). Therefore, the aim of the 
present study was to evaluate PGF2a pathway involvement on collagen deposition in mare 
 
     112 
Experimental Work 
endometrium after incubation with NETs proteases, by examining the expression of PGF2α 
protein and its synthases and receptor gene. The influence of endometrial 
inflammatory/fibrotic lesions and of estrous cycle phase was also studied.  
4.3. Materials and Methods 
4.3.1. Collection of mare’s uteri and blood and experimental design 
Mare internal genitalia were collected postmortem from randomly designated cyclic mares, at 
the abattoir, during reproductive season (May-September). Animal handling and slaughter 
conformed to European welfare (EFSA, AHAW/04–027) and Portuguese (DL 98/96, Art. 18) 
mandates. Since reproductive status of the mares was unknown, blood samples were collected 
for progesterone (P4) determination in plasma. 
Immediately after uteri collection, endometrial samples from the uterine horn ipsilateral to the 
ovary presenting either a growing follicle or a corpus luteum (CL) were carefully separated 
from the myometrium and washed in sterile phosphate-buffered saline (PBS) with antibiotics 
(100 mg/mL streptomycin- S9137; Sigma, St Louis, MO, USA and 100 IU/mL penicillin- 
P3032; Sigma). The macroscopic analysis of the ovaries and uteri, were used to assign a 
phase of the estrous cycle to each animal and to confirm the absence of signs of endometritis, 
such as altered surface epithelial color, increased mucus production. The presence of PMN or 
bacteria in uteri was evaluated microscopically on endometrial smears collected with sterile 
swabs and stained by Diff-Quick. The follicular phase (FLP) was characterized by the 
presence of a follicle >35mm diameter and the absence of an active CL, while in the mid 
luteal phase (MLP) a developed CL could also be associated with follicles 15–20mm in 
diameter (Roberto da Costa et al., 2008). The healthy uteri collected were thus classified as 
belonging to the FLP (n=10) or to the MLP (n=10). Endometrial samples were then placed in 
either 4% buffered formaldehyde, for endometrial histologic evaluation and classification; 
RNAlater (AM7020; Ambion, Applied Biosystems, Foster, CA, USA), for quantification of 
mRNA expression; or kept intact in chilled (4ºC) Dulbecco’s modified Eagle’s medium 
(DMEM) and F-12 Ham medium (D/F medium; 1:1 (v/v); D-8900; Sigma) supplemented 
with antibiotics (100 mg/mL streptomycin, 100 IU/mL penicillin and 2mg/mL amphotericin- 
A2942; Sigma) for in vitro explant culture studies.  Endometrial samples and blood were 
transported on ice to the laboratory within 1h.  
Ten endometrial samples from each estrous cycle phase (as described in section 4.3.2; n=5 
samples from each I/IIA or IIB/III group, from FLP and MLP), were further incubated with 
NETs proteases (see section 4.3.3). Qualitative and quantitative protein composition of NETs 
and the activities of those NETs proteases were the criteria used to select NETs proteins 
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concentrations for in vitro explant incubations. ELA, CAT and MPO were identified as the 
most abundant non-histone NETs proteins (Urban et al., 2009) and their activities were 
between 10 nM (0.3 µg/mL) to 100 nM (3.2 µg/mL) (Dubois et al., 2012). Selection of NETs 
proteases concentration was also based on previously published reports (Voynow et al., 1999; 
Glusa & Adam, 2001; Boudjeltia et al., 2004). The MPO concentrations used in our in vitro 
studies are within the range of those detected in the uterine lumen of mares (Parrilla-
Hernandez et al., 2014). In addition, concentrations of each protease were determined by a 
preliminary dose response experiment (data not shown) performed in our laboratory, where 
endometrial explants TGF-b1 production (as a putative fibrotic marker) was evaluated in 
response to three concentrations of each protein: MPO (0.1, 0.5 or 1 µg/mL), CAT (0.1, 1 or 
2.5 µg/mL) or ELA (0.1, 0.5 or 1 µg/mL).  Since the highest dose of MPO and CAT did not 
induce a further increase in TGF-b1 production and the lowest concentration of ELA did not 
stimulate a high secretion of TGF-β1, further endometrial incubations with those NETs 
proteins were performed with the other two tested concentrations. 
In our previous work, with this same experimental design and endometrial samples, we were 
able to assess altered collagen deposition in mare endometrium after incubation with NETs 
proteases (Rebordão et al., 2018). The relative fold increase of collagen type I protein by type 
I/IIA or IIA/III follicular phase or mid-luteal phase endometrial explants after being 
challenged by ELA, MPO and CAT (Rebordão et al., 2018), are shown in table 4.   
 
Table 4- Relative fold increase of collagen type I protein in follicular phase and mid-luteal 
phase endometrial explants by categories I/IIA or IIA/III, after 24h incubation with different 
concentrations of NETs components, compared to their own negative controls (non-treated 
tissues). 
 
Values represent mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 0.01). 
ELA- elastase; MPO- myeloperoxidase; CAT- cathepsin G. 
 
4.3.2. Mare endometrial histologic evaluation and classification  
Histologic sections of 5 µm formaldehyde fixed endometrial samples were stained with 
hematoxylin (05-06014E; Bio-Optica) and eosin (HT1103128; Sigma-Aldrich). Each sample 
Table 1: Relative fold increase of collagen type I protein (mean±SD) in follicular phase and mid-luteal 
phase endometrial explants by categories I/IIA (n=5 per each estrous cycle phase; I/IIA group) or IIA/III 
(n=5 per each estrous cycle phase; IIB/III group), after 24h incubation with different concentrations of 
elastase (ELA- 0.5 or 1 µg/mL), myeloperoxidase (MPO- 0.1 or 0.5 µg/mL) or cathepsin G (CAT- 0.1 or 
1 µg/mL), compared to their own negative controls (non-treated tissues). N=5 samples from each group- 
I/IIA and IIB/III of each estrous cy le phase. Values represent mean±S.D. Asterisks indicate significant 




  Follicular phase Mid-luteal phase 







ELA 0.5 1.46±0.28 1.09±0.21 1.29±0.24 3.02±0.30* 
1 2.96±0.79* 1.95±0.29* 2.24±0.36* 3.04±0.06** 
MPO 0.1 0.99±0.15 0.96±0.15 1.50±0.07 2.73±0.84* 0.5 2.87±0.35* 1.99±0.36* 1.61±0.08 1.28±0.28 
CAT 0.1 3.18±0.76* 2.10±0.25* 1.10±0.30 1.99±0.20 1 2.83±0.48* 2.40±0.34* 2.05±0.46* 1.84±0.19 
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was examined for the presence of inflammatory cells, periglandular fibrosis, glandular 
distribution and lymphatic lacunae, under light microscope (Leica DM500). Less than one 
PMN per field at 400x magnification (in 5 random fields) was a further basis for considering 
that the uteri were free of inflammation (Nielsen, 2005).  Endometrial samples were classified 
according to Kenney & Doig (1986), in category I, IIA, IIB or III, corresponding to minimum, 
mild, moderate or severe lesions of endometrial fibrosis, respectively. All subsequent studies 
were done after clustering the endometrial samples into 2 groups, as follows: I/IIA group 
(included all type I and IIA endometria), and IIB/III group (comprised type IIB and type III 
tissues). 
 
4.3.3. Endometrial explants and NETS components in vitro culture 
Tissue culture was performed using strips of endometrium (n=5 samples from each group- 
I/IIA and IIB/III) collected from each estrous cycle phase (FLP and MLP). After being 
carefully washed with PBS and antibiotics (rinsed 4 times in 4 different petri dishes), small 
pieces of tissues were blotted in filter paper, and approximately 20-30 mg of endometria were 
placed in cell culture medium of each well of a sterile 24 well cell culture plate (Eppendorf, 
#0030 722.116), for 1h, at 37ºC in a humidified atmosphere (Biosafe Eco-Integra 
Biosciences, Chur, Switzerland; 5% CO2, 95% air) with gentle shaking (Titertek, Huntsville, 
AL, USA; 150 r.p.m.). Culture medium consisted of DME/F-12 Ham Medium (D/F medium; 
1:1 (v/v); D-8900; Sigma) supplemented with bovine serum albumin (BSA; 0.1% (w/v); 
735078; Roche Diagnostics, Mannheim, Germany), streptomycin (100 mg/mL), penicillin 
(100 IU/mL) and amphotericin (2mg/mL). 
Medium was changed after 1h pre-incubation and endometrial explants were cultured for 
further 24h with: (i) medium – control; or (ii) elastase (ELA; 0.5, 1µg/mL); (iii) cathepsin G 
(CAT; 0.1, 1µg/mL); (iv) myeloperoxidase (MPO; 0.1, 0.5µg/mL); or (v) oxytocin (OXT) as 
positive control (10-7 M) (Nash et al., 2008). Explants were incubated under the same 
conditions as pre-incubation and each treatment was performed in quadruplicate. When 
incubation time was over, culture medium was immediately used for alamarBlueâ explant 
metabolic viability assessment and the remaining part collected to eppendorfs with 1% of a 
prostaglandin stabilizer (0.3 M ethylenediaminetetraacetic acid (EDTA) and 1% aspirin, No. 
A2093; Sigma) and kept at -80ºC for further PGF2α determinations (Szóstek et al., 2014). 
Conditioned explants were maintained in cryotubes with RNAlaterâ at -80ºC, for the 
assessment of specific genes involved in fibrosis. 
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4.3.4. Assessment of endometrial explants viability  
Metabolic viability of the explants was evaluated by alamarBlueâ(AB) (DAL1100; 
ThermoFisher Scientific), as previously explained (Carranza-Torres et al., 2015). Briefly, 
fresh (non-incubated), treated and non-treated control explants and culture medium were 
incubated in the same conditions described in 2.3 section for additional 4 h with 10% AB, 
after 24h incubation. Fluorescence values of medium (100 µL) from each of those samples 
were read in duplicate against a blank (medium with AB) using a fluorometer microplate 
reader (Synergy H1 Hybrid Reader, BioTek; Gene 5 software) at 560 nm excitation/590 nm 
emission wavelengths. Percentage of endometrial explants viability was obtained by 
calculating the percentage (%) of AB reduction per cell (Carranza-Torres et al., 2015). 
In addition, since PGF2α response of non-treated and oxytocin treated explants suggests that 
the endometrial explants contain functional endometrial cells (Nash et al., 2008) this was also 
used as criteria of its functionality and consequent viability. 
 
4.3.5. Hormones assays  
Plasma P4 concentrations were measured in duplicate by a validated solid-phase 
Radioimmunoassay (RIA), without extraction, using a commercial kit (Coat-A-Count; 
Diagnostic Product Corporation, Los Angeles, CA, USA), and a Wallac (wizard 1470) 
counter, as previously described (Rebordão et al., 2017a). All samples were run in a single 
assay. The limit of detection of the assay was 0.02 ng/mL and the intra-assay coefficient of 
variation for all samples was 3.4%. Circulating P4 concentrations were used to help determine 
estrous cycle phase of the mares. Mares with plasma P4 concentrations >6ng/mL were 
considered in MLP, while P4 values <1ng/mL were indicative of FLP (Roberto da Costa et al. 
2007). 
Culture medium PGF2a was measured by direct enzyme immunoassay (EIA) as previously 
described (Szóstek et al., 2014). Standard curve for PGF2𝛼 ranged from 0.19ng/mL to 
50ng/mL and the intra- and inter-assay coefficients of variation were on average 8.5% and 
10.7%, respectively. Hormone concentrations in culture media were normalized for mg of 
endometrium.  
 
4.3.6. Quantitative Real-Time polymerase chain reaction (qPCR) 
 For qPCR studies, total RNA extraction from the endometrium was done with Total 
RNA Extraction and Purification kit (28704; Qiagen, Hilden, Germany), with a DNA-
digestion step included (RNase-free DNase Set; 50979254; Qiagen), according to the 
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manufacturer instructions (Galvão et al., 2010). After RNA quantification with Nanodrop 
system (ND200C; Fisher Scientific, Hampton, PA, USA), its quality was assessed by 
visualization of 28S and 18S rRNA bands by electrophoresis across a 1.5% agarose gel plus 
gel red staining (41003; Biotium, Hayward, CA, USA). Synthesis of cDNA was performed 
using Reverse Transcriptase Superscript III enzyme (18080093; Invitrogen, GIBCO BRL, 
Carlsbad, CA, USA) from 1 mg total RNA in a 20 µL reaction volume using oligo(dT) primer 
(27-7858-01; GE Healthcare, Buckinghamshire, UK). Internet-based program Primer-3 
(Untergasser et al., 2012) and Primer Premier software (Premier Biosoft Interpairs, Palo Alto, 
CA, USA) were used to design specific primers and the reference gene, which are shown in 
table 5. To validate the reference gene, samples from different stages of the estrous cycle or 
different treatments were run in parallel for the following genes: glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), succinate dehydrogenase A complex, subunit A, flavoprotein 
(SDHA), beta-2-microglobulin (B2M) and ribosomal protein L32 (RPL32). The last one was 
found to be the most stable internal control gene (less than 2-fold changes between different 
biological conditions; Dheda et al.; 2004). 
 
Table 5- Primer sequences used for AKR1C3, FP and PTGS2 real time PCR analysis of mare 
endometrial explant. 
 
AKR1C3- aldo-keto reductase family 1, member C3; FP- prostaglandin F2α receptor; PTGS2- 
prostaglandin-endoperoxide synthase; RPL32- ribosomal protein L32. 
 
Primer concentrations were optimized to the minimum concentration: lowest cycle threshold 
ratio. Transcription of mRNA of genes involved in PGF2α pathway, like prostaglandin 
endoperoxide synthase 2 (PTGS2), F2α synthase (AKR1C3-aldo-keto reductase C3), PGF2α 
receptor (FP) was assessed by Real time PCR. In StepOnePlus™ Real-Time PCR System 
(Applied Biosystems, Warrington, UK), the following thermocycler program was performed 
for all genes: 10 min pre-incubation period at 95ºC; 15 s at 95ºC for 40 cycles and 1 min at 
60ºC, followed by a dissociation step (15 s at 95ºC, 30 s at 60ºC and 15 s at 95ºC). Both the 
target and reference genes were run simultaneously in duplicate 13 µL reaction volume (3.5 
µL water, 1 µL cDNA; 1µL forward primer, 1 µL reverse primer and 6.5 µL Power SYBER 
 
Rebordão et al.  
 
Table 1. Primer sequences used in real time PCR analysis of mare endometrial explant. 
 
  Gene 
(Acession number) 
















144 Reverse: GTCAATGCCTCTGGGTTTCC 
AKR1C3- aldo-keto reductase family 1, member C3; FP- prostaglandin F receptor; PTGS2- 
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Green Master Mix- 4367659; Applied Biosystems) on a 96-well optical reaction plate 
(4306737; Applied Biosystems).  To confirm specificity, all polymerase chain reaction (PCR) 
products were run on a 2.5% agarose gel (BIO-41025; Bioline, Luckenwalde, Germany). 
Real-time PCR miner algorithm (Zhao & Fernald 2005) was used to quantify relative mRNA 
data; for each sample, average cyclic threshold (Ct) was related to the primer efficiency level 
(E) using the equation [1/(1þE)Ct] (Zhao & Fernald 2005). Target genes expression was then 
normalized against that of the reference gene and relative expression values were calculated. 
Relative mRNA transcription of control samples was compared with treated explants data. 
 
4.3.7. Statistical analysis  
Statistical analysis of the data was performed using GraphPAD PRISM (Version 5.00, 
GraphPad Software, San Diego, CA, USA). Prostaglandin F2α secretion data of non-treated 
and oxytocin-treated endometrial explants was evaluated by Student t-test. Results of 
endometrial explants viability and data concerning relative mRNA and prostaglandin output 
of control and treated explants was analyzed by One-way analysis of variance (ANOVA) 
followed by Dunnett post-hoc test. To determine if any difference was due to the existence of 
interaction between the type of treatment and (i) group of endometrium categories; or (ii) 
estrous cycle phases, Two-way ANOVA, followed by Bonferroni multiple comparison test 
among means, was used. Data are presented as mean ± S.D. A P value less than 0.05 was 
considered statistically significant.  
 
4.4. Results 
4.4.1. Viability of Endometrial Explants  
Endometrial explants showed high metabolic activity and no differences in % of AB 
reduction were observed between fresh (non-incubated; 98.1± 1.2%) and 24h incubated 
control (non-treated) tissues (94.94± 3.9%) (P > 0.05). After incubation of mare endometrial 
explants with ELA, MPO and CAT, the % of difference in AB reduction between treated and 
non-treated control samples was not different (ELA 0.5µg/mL= 94.62%±7.1; ELA 1µg/mL = 
95.05%±7.5; MPO 0.1µg/mL= 97.79%±14.7; MPO 0.5µg/mL= 97.26%±12.3; CAT 
0.1µg/mL= 95.52%±7.1; CAT 1 µg/mL= 98.7%±10.6) (P > 0.05). Besides, the PGF2α 
response of explants to oxytocin treatment suggests that the endometrial explants contain 
functional endometrial cells (Nash et al., 2008). PGF2α secretion by endometrial explants 
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after incubation with OXT (9.882 ± 4.6 ng/mg) was increased when compared with incubated 
non-treated tissues (4.4±2.7 ng/mg) (P < 0.05).  
 
4.4.2. PGF2α pathway is involved in fibrogenesis of mare endometrium  
 
Increased collagen type I production by mare endometria, characteristic of fibrosis, in the 
presence of NETs proteins was observed in our previous study (Rebordão et al., 2018; table 
4), using the same endometrial samples evaluated in this follow-up work. Thus, transcription 
of genes involved in endometrial PG secretory function, like prostaglandin endoperoxide 
synthase (PTGS2), AKR1C3 and FP, as well as PGF2a output were studied, in order to 
determine if the enhanced collagen type I protein detected after incubation of endometrial 




4.4.2.1. Follicular phase type I/IIA mare endometrium explants  
 
In type I/IIA mare endometrium explants obtained from FLP, increased COL1 protein and 
PTGS2 transcripts (P < 0.05; Fig. 17.1), was observed at 24h incubation with the highest 
tested concentration of MPO with no further changes in the other studied parameters. No 
differences were found in AKR1C3 transcripts throughout the incubation period, regardless of 
NETs proteins (P > 0.05; Fig. 17.2). Enhanced COL1 after 24h incubation with the lowest 
concentration of CAT was related with high transcription of PTGS2 (P < 0.05; Fig. 17.1) and 
of FP gene (P < 0.05; Fig. 17.3). Further increase in COL1 production and PGF2a production 
(Fig. 17.4) was observed at 24h incubation with the highest tested concentrations ELA (P < 
0.001) and CAT (P < 0.05).  
 




Figure 17- Transcription of prostaglandin-endoperoxide synthase 2 (PTGS2) (1, 5), PGF2α 
synthase (AKR1C3) (2, 6) or PGF2α receptor (FP) (3, 7), genes and PGF2α production (4, 8), 
by follicular phase endometrial explants after incubation with different concentrations of 
NETs components. N=5 samples from each group- I/IIA and IIB/III in FLP. Bars represent 
mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 0.01; *** P < 
0.001). CAT- cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 




4.4.2.2. Follicular phase type IIB/III mare endometrium explants  
In FLP type IIB/III mare endometrium explants, no changes in COL1 production, was related 
to decreased PTGS2 (P < 0.05; Fig. 17.5) and FP genes transcription after incubation with the 
lowest concentration of MPO (P < 0.05; Fig. 17.7). However, tissue incubation with the 
highest concentration of ELA enhanced COL1 production and AKR1C3 (P < 0.05; Fig. 17.6). 
Also, after 24h incubation with the highest concentration of CAT increased COL1 production 
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and FP transcripts (P < 0.05; Fig. 17.7) were noted. PGF2a production remained unchanged 
throughout the incubation period regardless of NETs components, but it was up-regulated 
with OXT (P < 0.01; Fig. 17.8). No differences were observed in any of PGF2a-pathway 
mediators when tissues were challenged with the highest doses of MPO or with the lowest of 
CAT, although enhanced production of COL1 was observed after 24h. 
 
4.4.2.3. Mid-luteal phase type I/IIA mare endometrium explants  
In MLP type I/IIA mare endometrium, no changes in COL1 production was related to 
increased PTGS2 gene transcription (P < 0.05; Fig. 18.1) after incubation with both 
concentrations of MPO.  Yet, the same type of endometrium, responded to 24h incubation 
with highest concentrations of ELA and CAT by up-regulating COL1 protein and down-
regulating AKR1C3 (P < 0.05; Fig. 18.2), and FP (P < 0.05; Fig. 18.3) genes transcription.  
Decreased transcription of AKR1C3 was also observed with the lowest concentrations of ELA 
and CAT (P < 0.05; Fig. 18.2), while down-regulation of FP transcripts also occurred with 
the lowest doses of ELA and MPO (P < 0.05; Fig. 18.3). None of those effects were linked to 
an increase in collagen production.  
No differences were found in PGF2a production after 24h incubation, regardless of NETs 
proteins (P > 0.05), although it increased with OXT (P < 0.05; Fig. 18.4). 
 
4.4.2.4. Mid-luteal phase type IIB/III mare endometrium explants  
In MLP type IIB/III mare endometrium explants, decreased PTGS2 transcripts were observed 
at 24h incubation with the highest concentration of MPO and the lowest dose of CAT with no 
changes in COL1 production (P < 0.05; Fig. 18.5). The highest concentration of ELA (P < 
0.01) and the lowest dose of MPO (P < 0.05) up-regulated COL1 protein, AKR1C3 (ELA- P < 
0.05; MPO- P < 0.01) (Fig. 18.6) and FP (ELA- P < 0.05; MPO-P < 0.001) (Fig.18.7) gene 
transcription. However, increased COL1 production after 24h incubation with the lowest 
concentration of ELA was associated with decreased transcription of FP gene (P < 0.05; Fig. 
18.7). In contrast, tissue incubation with both concentrations of CAT induced FP gene 
transcription (P < 0.05; Fig. 18.7), although no increase in COL1 protein was noted. No 
changes were seen in PGF2a output when tissues were subjected to all tested NETs proteases, 
although it was increased after incubation with OXT (P < 0.05; Fig. 18.8). 
 




Figure 18- Transcription of prostaglandin-endoperoxide synthase 2 (PTGS2) (1, 5), PGF2α 
synthase (AKR1C3) (2, 6) or PGF2α receptor (FP) (3, 7), genes and PGF2α production (4, 8) 
by mid-luteal phase endometrial explants after incubation with different concentrations of 
NETs components. N=5 samples from each group- I/IIA and IIB/III in MLP. Bars represent 
mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 0.01; *** P < 
0.001). CAT- cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 
or 1 µg/mL); MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 0.5 µg/mL); OXT- 
oxytocin. 
 
4.4.3. Endometrial category influences the putative PGF2a fibrogenic pathway  
The influence of endometria type groups (I/IIA vs. IIB/III) on the effect of NETs components 
in putative PGF2a fibrogenic pathway was evaluated. This analysis was performed 
comparing the same treatments, within the same estrous cycle phase (FLP or MLP).  
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4.4.3.1. Type I/IIA vs. IIB/III mare endometrium in follicular phase  
 
Type IIB/III endometrial explants obtained in FLP exhibited an increased transcription of FP 
gene after 24h incubation with the highest concentration of CAT (P < 0.05; Fig. 19.1) when 
compared to type I/IIA tissues. Higher PGF2α production was noted in type I/IIA explants 
incubated with the highest concentration of ELA, after 24h (P < 0.01; Fig. 19.2), in 
comparison to type IIB/III group.  
 
Figure 19- Effect of endometrial category (type I/IIA vs. type IIB/III) on PGF2α receptor (FP) 
(1, 3) gene transcription or PGF2α production (2, 4) by endometrial explants incubated with 
different concentrations of NETs components. N=5 samples from each group- I/IIA and 
IIB/III for each estrous cycle phase. Bars represent mean±S.D. Asterisks indicate significant 
differences (* P < 0.05; ** P < 0.01; *** P < 0.001). CAT- cathepsin G (0.1 or 1 µg/mL); 
CONT- non-treated tissues; ELA- elastase (0.5 or 1 µg/mL); FLP- follicular phase; MLP- 
mid-luteal phase; MPO- myeloperoxidase (0.1 or 0.5 µg/mL); OXT- oxytocin. 
 
 
The most elevated PTGS2 gene expression was detected in I/IIA group with both tested 
concentrations of MPO (MPO 0.1µg/mL - P < 0.001; MPO 0.5µg/mL - P < 0.05) and the 
lowest dose of CAT (P < 0.01) after a 24h incubation (Fig. 20.1). In contrast, up-regulation of 
AKR1C3 transcripts were only detected in type IIB/III endometrial explants, after incubation 
with the highest concentration of ELA and with the lowest dose of CAT (P < 0.05; Fig. 20.2). 
Rebordão et al. 
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Figure 20- Effect of endometrial category (type I/IIA vs. type IIB/III) on the transcription of 
prostaglandin-endoperoxide synthase 2 (PTGS2) (1, 3) or PGF2α synthase (AKR1C3) (2, 4) 
genes by endometrial explants incubated with different concentrations of NETs components. 
N=5 samples from each group- I/IIA and IIB/III for each estrous cycle phase. Bars represent 
mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 0.01; *** P < 
0.001). CAT- cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 
or 1 µg/mL); FLP- follicular phase; MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 
0.5 µg/mL); OXT- oxytocin. 
 
 
4.4.3.2. Type I/IIA vs. IIB/III mare endometrium in mid-luteal phase  
 
In type IIB/III endometrial explants obtained in MLP, higher FP transcripts resulted after 
incubation with the highest dose of ELA (P < 0.001), the lowest dose of MPO (P < 0.001) and 
both concentrations of CAT (P < 0.01), compared to type I/IIA tissues (Fig. 19.3). 
Nevertheless, no differences were detected in PGF2α production between endometrial 
categories in MLP explants (Fig. 19.4). 
In type I/IIA endometria, after 24h incubation, greater PTGS2 gene expression was noted with 
both tested concentrations of MPO (P < 0.05; Fig. 20.3). In contrast, higher AKR1C3 gene 
transcription was only detected in type IIB/III endometrial explants, with the highest 
concentration of ELA (P < 0.01) and with the lowest MPO dose (P < 0.001) at 24h (Fig. 
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4.4.4. Estrous cycle phase affected putative fibrogenic mediators of PGF2α via 
The influence of different phases of mare estrous cycle (FLP vs. MLP) on the effect of NETs 
components in putative PGF2a fibrogenic pathway was also analyzed. This evaluation was 
done in the same endometria type (I/IIA or IIB/III), comparing the same treatments at 
different incubation times. 
 
4.4.4.1. Follicular phase vs. mid-luteal phase in type I/IIA endometria 
Regarding FP gene transcription, increased levels were found in FLP explants, when 
compared to MLP incubated with ELA (1 µg/mL) or CAT (0.1 µg/mL) (P < 0.001; Fig. 21.1). 
A marked increase in PGF2a production was observed in FLP endometria incubated with the 
highest concentration of ELA, (P < 0.001; Fig. 21.2) compared with MLP endometria.  
 
Figure 21- Effect of estrous cycle phase (follicular phase vs. mid-luteal phase) on PGF2α 
receptor (FP) (1, 3) gene transcription or PGF2α production (2, 4) by endometrial explants 
incubated with different concentrations of NETs components. N=5 samples from each group- 
I/IIA and IIB/III of each estrous cycle phase. Bars represent mean±S.D. Asterisks indicate 
significant differences (* P < 0.05; ** P < 0.01; *** P < 0.001). CAT- cathepsin G (0.1 or 1 
µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 or 1 µg/mL); FLP- follicular phase; 
MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 0.5 µg/mL); OXT- oxytocin. 
 
 
No differences between estrous cycles phases were noted in PTGS2 or AKR1C3 genes 
transcription after incubation (P > 0.05; Fig. 22.1; 22.2).  
 
 




























































































































































































Figure 22- Effect of estrous cycle phase (follicular phase vs. mid-luteal phase) on 
prostaglandin-endoperoxide synthase 2 (PTGS2) (1, 3) or PGF2α synthase (AKR1C3) (2, 4) 
genes transcription by endometrial explants incubated with different concentrations of NETs 
components. N=5 samples from each group- I/IIA and IIB/III of each estrous cycle phase. 
Bars represent mean±S.D. Asterisk indicate significant differences (*** P < 0.001). CAT- 
cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 or 1 µg/mL); 
FLP- follicular phase; MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 0.5 µg/mL); 
OXT- oxytocin. 
 
4.4.4.2. Follicular phase vs. mid-luteal phase in type IIB/III endometria 
Mid-luteal phase explants showed increased levels of FP (P < 0.01) (Fig. 21.3) and AKR1C3 
(P < 0.001; Fig. 22.4) genes transcription than FLP tissues, after 24h incubation with the 
lowest MPO dose, compared with the same treatment and endometria type during the FLP. 
No differences in PGF2a production (Fig. 21.4) and in PTGS2 transcripts (Fig. 22.3) were 
noticed between estrous cycle phases throughout the experiment. 
 
4.5. Discussion  
In our previous work, we were able to show that NETs components could have a pathogenic 
role in fibrosis formation on mare endometrium, as in vitro incubation of endometrial explants 
with some NETs proteases induced high COL1 production (Rebordão et al., 2018). Since 





































































































































































































     126 
Experimental Work 
been implicated in the development of fibrosis in other tissues, we have decided to investigate 
some mediators of PGF2a pathway, to unravel the mechanisms behind NETs proteases-
induced fibrosis. Our in vitro results have revealed novel changes in PGF2a pathway 
mediators induced by NETs proteases that may predispose to mare endometrial fibrosis 
establishment: (i) enhanced synthesis of PGF2a; (ii) and increased FP gene transcription. The 
type of effect that prevails was influenced not only by the type of endometrium, but also by 
estrous cycle phases. Those different effects may be partially explained by sex steroid 
hormones modulated expression of PG receptors during the reproductive cycles (Blesson & 
Sahlin, 2014). 
Endometrosis is defined as periglandular and/or stromal endometrial fibrosis characterized by 
large number of smooth-muscle-actin containing myofibroblasts, pronounced epithelial 
vimentin expression, excessive ECM accumulation, progressive cystic glandular dilation with 
mechanical destruction of the uterine glands and presence of glandular nests (Hoffmann et al., 
2009). The exact etiology and pathological mechanisms leading to endometrial destruction 
and progressive reproductive failure have not been fully elucidated. In fact, this pathology 
may somewhat result from a host defense defect that impairs bacterial killing, enhances PMN 
recruitment and NETs release. In the lung, when extracellular concentration of free ELA 
released by PMN exceeds the buffering capacity provided by endogenous inhibitors, ELA 
starts to drive uncontrolled inflammatory processes (Hogg  & Senior, 2002). Likewise, the 
same may occur in the uterus of mares with NETs persistence.  
It was recently reported that PGF2α acting on its receptor (FP) is capable to induce 
fibrogenesis in several systems. Abundant PGF2α in broncho-alveolar lavage fluid of mice 
with induced pulmonary fibrosis stimulated the proliferation of lung fibroblasts and COL 
production via FP (Oga et al., 2009). Also, in a bleomycin-induced pulmonary fibrosis model, 
plasma PGF2α metabolites were associated to disease severity and prognosis (Aihara et al., 
2013). Increased collagen type I and III via a FP receptor/protein kinase C/Rho kinase 
cascade was reported in myocardial fibrosis (Ding et al., 2012; Ding et al., 2014). In mice 
dermal sclerosis fibroblasts, alpha2-antiplasmin (2AP), a serpin elevated in fibrotic diseases, 
induced PGF2α synthesis that in turn promoted fibrosis (Kanno et al., 2013). Also, synovial 
fibrosis establishment was positively associated with PGF2α levels (Bastiaansen-Jenniskens 
et al.; 2013).  
PGF2α pathway likely involved in mare endometrium fibrogenesis induced by NETs 
persistence was up-regulated in all studied types of endometria, except in MLP I/IIA 
endometria. In FLP type I/IIA tissues after 24h of NETs components insult, COL1 increase 
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(with the highest concentration of ELA or both doses of CAT) was associated to enhanced 
synthesis of PGF2a or of its receptor.  
In FLP type IIB/III endometria (challenged with CAT for 24h), increased COL1 production 
and high transcription of FP gene linked PGF2a pathway to fibrosis development. Moreover, 
no changes in COL1 production in this same group of explants incubated with the lowest 
concentration of MPO, together with low FP gene transcription, were in agreement with the 
reduced COL deposition in other tissues, like in lungs (Oga et al., 2009).  
In contrast, in MLP type I/IIA mare endometrium, PGF2α pathway does not seem to be 
involved in mare endometrium fibrogenesis induced by NETs persistence. Other vias besides 
PGF2α pathway may be involved, since high COL1 production, induced by ELA and CAT in 
this type of endometrial tissues, was linked to low AKR1C3 or FP gene expression. 
Nevertheless, in MLP type IIB/III endometrium activation of PGF2α pathway appears to be 
essential for fibrogenesis. All NETs proteins that induced COL1 production showed high 
relative transcription of FP or AKR1C3 genes, except with the lowest concentration of ELA.  
In this study, we investigated whether NETs effect on PGF2α pathway in mare endometrium 
could be dependent on the presence of endometrial fibrotic lesions. Endometrial category 
appears to influence the PG secretion, as enhanced PTGS2 mRNA transcription was observed 
in I/IIA groups, throughout the incubation period. Although in mare endometrium no 
differences between endometrial categories were found in PTGS2 mRNA transcription during 
the follicular and mid-luteal phases (Szóstek et al., 2012), our results are in agreement with 
previous studies in lung fibroblasts. Diminished ability of lung fibrotic cells upregulated 
PTGS2 mRNA level and fibrogenesis capacity (Keerthisingam et al., 2001). Besides, 
increased PGF2α production after ELA treatment was only noted in I/IIA groups in FLP. A 
former study in which the highest concentration of PGF2α was found in healthy endometria 
of the mare during the follicular phase, with decreased PGF2α production in categories II and 
III endometria in both follicular and mid-luteal phases (Szóstek et al., 2012) agrees with the 
present work. In contrast, type IIB/III endometria were able to respond to NETs proteases 
with higher AKRC1 gene transcription, regardless of estrous cycle phase. Also, in the mid 
luteal phase, the type of endometrium seems to influence the levels of FP transcription 
response to NETs. In MLP type IIB/III explants higher FP transcripts were noted throughout 
the experimental period.  
The putative endocrine influence on endometrial response to NETs proteases was addressed 
through the assessment of PGF2α mediators in tissues during FLP and MLP. In our study, 
increased levels of PGF2α synthesis (after ELA and CAT treatment) were only detected in 
FLP endometria. Such differences may be hormone-dependent and mediated by tissue 
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specific catabolic or anabolic enzymes involved in PG synthesis. Previous studies on steroid 
regulation of PG synthesis support our hypothesis. In the mare endometrium after in vitro 
exposure to estrogen (E2), a dose-dependent stimulation of PGF2α production was observed, 
while exposure of tissues to P4 failed to alter PGF2α secretion (Vernon et al., 1981). 
Likewise, explants collected from mares during the follicular phase exhibited a higher basal 
concentration of PGF2a secretion than explants collected during the luteal phase after 24h 
and 72h incubation (Nash et al., 2008). Also, in equine endometrial epithelial cells, E2 
appears to be a strong stimulator of PG secretion, increasing production of both PGE2 and 
PGF2α (Szóstek et al., 2014). In fact, a high level of PGF2α was found during the follicular 
phase in equine endometrium (Szóstek et al., 2014). Taken together, these effects suggest that 
in face of a stimulus, a higher production of both PG will occur in FLP endometria, rather 
than in MLP tissues, since endometrial PG synthesis mechanisms are activated. In the mare, 
following the entrance of bacteria or semen into the uterus, recruitment of PMNs triggers the 
release of PGF2α that induces uterine contractions (Woodward  & Troedsson, 2013). 
Although this is a crucial mechanism for clearance of the uterine fluid produced by an initial 
inflammatory response (Katila, 1995), we postulate that sustained high levels of PGF2α due 
to the persistence of NETs-proteases may trigger endometrial fibrosis formation. Indeed, in 
mares predisposed to develop persistent endometritis (susceptible mares) have an increased 
number of PMN in the endometrium after breeding when compared with resistant mares 
(Woodward et al., 2013). Also, increased presence of PGF2α in susceptible mares might be 
due to the sustained inflammatory uterine environment in these mares (Cadario et al., 1999). 
Indeed, PGF2α has been proposed as suitable marker of uterine inflammation during mating-
induced endometritis in vivo in the horse (Nash et al., 2010).  Since in the mare target tissues 
seems to be exposed to higher concentrations of PGF2α for longer periods (Shrestha et al., 
2012) and an endometrial PGF2α auto-amplification system seems to exist, in which PGF2α 
can stimulate its own production (Kozai et al., 2016), this may contribute to sustained high 
levels of PGF2α in the uterus.  So, we propose that in the presence of an insult in mare 
endometrium, like NETs persistence, it will induce a raise in PGF2α, strengthening the pro-
fibrotic effect that will prevail.  
In the present work, estrous cycle influence was not noted in FP gene transcription. Previous 
studies have suggested that sex steroid hormones that regulate the reproductive cycles, 
modulate the expression of PG receptors like PGE2 receptors (EPs) and FP (Blesson & 
Sahlin, 2014). In the uterus of ovariectomized rat, FP mRNA expression was decreased by 
estradiol (E2) treatment (Blesson & Sahlin, 2014). Nevertheless, in the mare, FP transcripts 
do not seem to be influenced by the endocrine cyclic change, since FP gene transcription was 
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similar at day 7 (MLP), 14 (late-LP) and 21 (estrus) of estrous cycle (Ruijter-Villani et al. 
2014), although other studies have referred that the highest FP transcripts were observed in 
late luteal phase (Atli et al., 2010; Kozai et al., 2016). As in physiologic conditions, our 
results suggest that the mechanisms involved in FP gene transcription do not seem to be 
estrous cycle phase-dependent, since enhanced FP transcripts occurred both in FLP and MLP 
endometrial tissues under the action of NETs proteases. 
Although our results suggest that PGF2α may be involved in NETs protease-induced COL1 
formation in mare endometrium, as fibrosis is an extremely complex pathologic process other 
vias, besides the PGF2α pathway, such as PGE2 pathway and pro-fibrotic cytokines may be 
involved. Indeed, it has been questioned if PGF2α stimulates fibrogenesis through 
independent TGF-β1 pathways (Oga et al., 2009; Olman, 2009; Ding et al., 2012; 
Bastiaansen-Jenniskens et al., 2013) or not (Kanno et al., 2013). 
In conclusion, our results indicate that FLP endometrium seems to be less protected from pro-
fibrotic mediators since it is at this stage that we have observed both high PGF2a production 
and FP gene transcription under NETs proteases action, both associated with fibrogenesis. 
Transcription of FP gene does not appear to be hormone-dependent, although its transcription 
seems to be dependent of endometrial category in mid luteal phase shaping fibrosis outcome. 
Although other pro-fibrotic cytokines may be involved, injury induced-changes on PGF2α 
mediators by NETs components may instigate this via to become an additional pathway with 
key roles in mare endometrial fibrogenesis. Besides, endocrine microenvironment and healthy 
or pathological conditions of endometrial tissues play an important role in fibrogenesis. In 
addition, further studies are needed to elucidate if putative fibrogenic PGF2α may act in vivo 
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5. Impairment of anti-fibrotic PGE2 pathway might influence neutrophil extracellular 
traps-induced fibrosis in mare endometrium 
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5.1. Abstract 
In spite of being long recognized as a major cause of infertility in the mare, the pathogenesis 
of chronic endometrium fibrosis (endometrosis) is not completely understood. Prostaglandin 
E2 (PGE2) has several biological contradictory effects in many organs, such as pro- or anti-
inflammatory actions, depending on the activation of its respective four subtype prostanoid 
receptors. By signaling through its receptors EP2 and EP4, PGE2 mediates both anti-
inflammatory and anti-fibrotic actions.  We have shown that when the in vitro contact of 
neutrophil extracellular traps (NETs) proteases with mare endometrium persists, it may favor 
mare endometrial collagen type I production and stimulate fibrogenesis. Therefore, the 
objective of this study was to investigate the involvement of PGE2 pathway in collagen 
deposition on mare endometrium, challenged in vitro with NETs proteases. Mare endometria 
(Kenney and Doig categories I/IIA and IIB/III), obtained in the follicular (FLP) and mid-
luteal (MLP) phases, were incubated for 24h with NETs components (elastase, cathepsin-G, 
myeloperoxidase or oxytocin, as positive control). Expression of PGE2 protein and 
transcription of its synthase (PTGES) and receptors (EP2, EP4) genes were evaluated. 
Impaired PGE2 production and low EP2 transcripts were noted. Endometrial category and 
estrous cycle phases influenced collagen fibrogenic output. Impairment of PGE2 pathway 
might play a role in FLP (category IIB/III) and MLP (I/IIA) endometrial fibrosis, due to the 
suppression of its anti-fibrotic capacity. In conclusion, ovarian steroid endogenous priming of 
the endometrium might differently modulate the anti-fibrotic PGE2 pathway in healthy or 




Keywords: Neutrophil extracellular traps, fibrosis, endometrium, endometrosis, estrous 
cycle, mare, PGE2; PGE2 receptors, endometrial pathology 
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5.2. Introduction 
Endometrosis is a chronic, degenerative condition that affects mare endometrium.  It is 
characterized by excessive deposition of extracellular-matrix (ECM), like type I (COL1) 
collagen and fibronectin, around the endometrial glands and stroma that leads to the 
destruction of tissue architecture and impairment of endometrium function (Kenney, 1978; 
Kenney & Doig, 1986; Hoffmann et al., 2009; Costa et al., 2015). It has been referred that 
persistent endometritis, as a consequence of different insults associated with breeding, foaling 
and veterinary interventions, can be involved in chronic degenerative changes of mare 
endometrium and may be related with fibrosis formation (Kenney, 1978; Ricketts & 
Troeddsson 2007; LeBlanc & Causey, 2009; Hoffmann et al., 2009). 
Inflammation seems to be linked to fibrosis in a paracrine way, in which injured and 
inflammatory cells secrete pro-fibrotic chemokines, cytokines and growth factors that act on 
resident cells, like fibroblasts, and ultimately trigger fibrogenesis (Liu Y, 2011; Zeisberg & 
Kalluri, 2013). Prostaglandin E2 (PGE2) seems to prevent the pro-fibrotic transforming 
growth factor β1 (TGF-β1) to induce fibroblast differentiation to myofibroblast, thereby 
playing a protective role against fibrosis (Bozyk & Moore; 2011). In fibrotic lung, impaired 
PGE2 production and PGE2 signaling have been described (Bozyk & Moore; 2011). This 
eicosanoid has several biological effects in many organs, such as pro- and anti-inflammatory 
actions, which depend on the activation of its four subtypes prostanoid receptors (EP1, EP2, 
EP3 or EP4) (Kalinski, 2012). The anti-fibrotic action of this hormone is linked to either EP2 
or EP4 signaling, although the subtype of receptor that is involved on this action seems to be 
tissue-dependent (Huang et al., 2010; Ishiwata, et al., 2013; Kach et al., 2014; Wei et al., 
2014; Wang et al., 2017). PGE2 is a metabolite of arachidonic acid formed via the 
prostaglandin-endoperoxide synthase 1 (PTGS1) and /or PTGS2 enzymatic pathway. The 
enzyme PTGS2 is considered to be rate-limiting for PG production. Three types of PTGE 
synthases (PTGES) controlling PTGE2 production in cells have been identified. Two are 
membrane-associated (mPTGES-1 and mPTGES-2) and the third one is cytosolic (cPTGES). 
Expression of mPTGES-1 is responsible for sustained production of PGE2 (Fortier et al., 
2008) and is induced in response to inflammation (Stichtenoth et al., 2001).  
Polymorphonuclear neutrophils (PMN) are able to kill microorganisms not only by 
intracellular pathways, but also by extracellular killing mechanisms, like extracellular netlike 
structures called neutrophil extracellular traps (NETs) (Brinkmann et al., 2004; Brinkmann & 
Zychlinsky, 2007). Although NETs have potent antimicrobial functions and may act as a 
physical barrier to prevent further spread of microorganisms (Fuchs et al., 2007; Lögters et 
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al., 2009; Brinkmann & Zychlinski, 2012; O'Brien et al., 2017), persistence of NETs has been 
linked to the development of several non-fibrotic and fibrotic diseases (Jorch & Kubes, 2017; 
Nakazawa et al., 2017). In addition, it has been proposed that fibroblast activation mediated 
by NETs components, like histones, antimicrobial peptides, proteases, and cytokines, may 
contribute to disease progression towards fibrosis (Chrysanthopoulou et al., 2014). Several 
proteins have been identified in NETs and the most abundant non-histone NETs proteins are 
elastase (ELA), cathepsin G (CAT) and myeloperoxidase (MPO) (Urban et al., 2009), that 
have been related with fibrogenesis in different organs (Voynow et al., 2008; Dubois et al., 
2012; Sharoni et al., 2010; Ikegame et al., 2010; Segel et al., 2011; Cantin et al., 2015; Pulli 
et al., 2015). 
Since NETs are present in endometrial secretions obtained from mares with bacteria 
endometritis (Rebordão et al., 2014), and in vitro collagen production was enhanced after 
challenge of mare endometrial explants with some NETs proteases, we have proposed that 
persistence of NETs may be involved in the development of endometrial fibrosis (Rebordão et 
al., 2018). Since PG are abundantly produced in the endometrium, modulating several 
physiological reproductive events (Weems et al., 2006) and PGE2 might hinder fibrotic 
conditions in several organs and species (Bozyk & Moore; 2011), we hypothesized that PGE2 
might play a protective role against endometrosis in the mare. In this study, the effects of 
NETs proteases on the putative anti-fibrotic PGE2 pathway were analyzed by evaluating the 
expression of PGE2 protein and its synthases and receptor genes. The influence of 
endometrial inflammatory/fibrotic lesions present, as well as estrous cycle phase was also 
studied.  
 
5.3. Materials and methods 
5.3.1. Endometrial and blood sampling and study design  
During the reproductive season (May-September), ovaries, uteri and blood from cyclic mares 
were collected post-mortem at the abattoir. Management and slaughter of mares were 
performed following European welfare (EFSA, AHAW/04–027) and Portuguese (DL 98/96, 
Art. 18) mandates. 
By macroscopic evaluation of the ovaries (presence of a growing follicle or corpus luteum) 
uteri were identified as fitting to the follicular phase (FLP; n=10) or to the mid luteal phase 
(MLP; n=10). (Roberto da Costa et al., 2008). Uterine horns were opened and signs of 
endometritis, like increased mucus production and altered color of surface epithelium were 
criteria to discard those genitalia. Also, uterine swabs were collected for bacteria isolation and 
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cytology evaluation (section 5.3.2.). None of the uteri collected were considered to be 
undergoing active inflammation. Immediately after uteri collection, endometrial pieces were 
obtained and placed in: (i) 4% buffered formaldehyde, for histopathological examination and 
further endometrial classification (section 5.3.2.) (ii) chilled (4ºC) Dulbecco’s modified 
Eagle’s medium (DMEM) and F-12 Ham medium (D/F medium; 1:1 (v/v); D-8900; Sigma) 
supplemented with antibiotics (100 mg/mL streptomycin, 100 IU/mL penicillin and 2mg/mL 
amphotericin- A2942; Sigma) for explant culture assays (section 5.3.3); or (iii) RNAlater 
(AM7020; Ambion, Applied Biosystems, Foster, CA, USA), for further mRNA (section 
5.3.5) assays. Blood samples were collected for further progesterone (P4) determination in 
plasma, to confirm mares´ estrous cycle phases (section 5.3.6). All samples were transported 
on ice to the laboratory within 1h.  
For in vitro culture studies (section 5.3.3), concentrations of ELA, MPO or CAT were chosen 
based in previous in vitro assays (Glusa & Adam, 2001; Boudjeltia et al., 2004; Voynow et 
al., 2008) and on qualitative and quantitative protein composition of NETs (Urban et al., 
2009; Dubois et al., 2012). Besides, a preliminary dose-response trial was done to determine 
the concentrations of each protease that should be used. Endometrial explants were 
challenged with three concentrations of each protein: MPO (0.1, 0.5 or 1 µg/mL), CAT (0.1, 1 
or 2.5 µg/mL) or ELA (0.1, 0.5 or 1 µg/mL) and TGF-b1 production (as a putative fibrotic 
marker) was assessed.  Two of those tested concentrations of each protease were chosen, 
since the highest dose of MPO and CAT did not induce a further increase in TGF-b1 
production, and the lowest concentration of ELA did not provoke a high secretion of TGF-b1, 
either (data not shown). In the present work, the concentrations of NETs proteases used were 
within the range of their levels referred in physiologic and inflammatory conditions in tissues 
and species other than the mare endometrium (Glusa & Adam, 2001; Boudjeltia et al., 2004; 
Voynow et al., 2008). In addition, MPO concentrations used were similar to those found in 
mare uterine lumen (Parrilla-Hernandez et al., 2014). 
 
This same experimental design and endometrial samples were used in our previous work that 
showed enhanced collagen type I production by these tissues when challenged with NETs 
proteases (Rebordão et al., 2018). Fig. 23 summarizes COL1 protein increase that resulted 
after stimulation of type I/IIA or IIA/III follicular phase or mid-luteal phase endometrial 
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Figure 23- Summary of collagen type I protein data, in endometrial explants after incubation 
with different concentrations of NETs components, relative to their own negative controls 
(non-treated tissues). N=5 samples from each group- I/IIA and IIB/III, for each estrous cycle 
phase. CAT- cathepsin G (0.1 or 1 µg/mL); COL1- collagen type I; ELA- elastase (0.5 or 1 
µg/mL); FLP- follicular phase; MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 0.5 
µg/mL); OXT- oxytocin. 
 
5.3.2. Cytological and histopathological analysis of mare endometrium  
Light microscopic evaluation of Diff-Quick stained endometrial smears collected with sterile 
swabs was used to discard the presence of inflammation and/or bacteria. Presence of acute 
inflammation was considered if more than two neutrophils per four microscopic fields 
(Mag=400X) were counted (Riddle et al., 2007). 
Histopathological analysis was performed on formaldehyde fixed endometrial slices (5 µm) 
stained with hematoxylin (05-06014E; Bio-Optica) and eosin (HT1103128; Sigma-Aldrich), 
(Leica DM500). Endometria evaluation were assessed to establish whether the endometrium 
had undergone pathological degenerative changes (Kenney & Doig 1986). Endometria were 
classified as belonging to category I, IIA, IIB or III, according to the degree of inflammation 
and/or fibrosis (Kenney & Doig 1986). Endometrial samples were then gathered into two 
groups for further studies. Categories I and IIA tissues were included in I/IIA group, while 
IIB/III group enclosed categories IIB and III endometria.  
 
5.3.3. In vitro culture studies  
Endometrial tissue culture was performed as previous reported (Rebordão et al., 2018). 
Briefly, strips of endometrium (n=5 samples from each group- I/IIA and IIB/III from FLP or 
MLP) were cut in small pieces, slightly dried, weighed (20-30mg) and placed into each well 
of a sterile 24 well cell culture plate, with 1ml of DME/F-12 Ham Medium (D-8900; Sigma) 
containing 0.1% bovine serum albumin (735078; Roche Diagnostics, Mannheim, Germany), 
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streptomycin (100 mg/mL), penicillin (100 IU/mL) and amphotericin (2mg/mL). After 1h of 
pre-incubation, at 37ºC in a humidified atmosphere (5% CO2, 95% air) with gentle shaking, 
medium was changed and endometrial explants were cultured, under the same conditions, for 
further 24h with: (i) medium – control; or (ii) elastase (A6959, AppliChem GmbH; ELA; 0.5, 
1µg/mL); (iii) cathepsin G (A6942, AppliChem GmbH; CAT; 0.1, 1µg/mL); (iv) 
myeloperoxidase (A6969, AppliChem GmbH; MPO; 0.1, 0.5µg/mL); or (v) oxytocin (OXT) 
as positive control (10-7 M; Nash et al., 2008). Each treatment was performed in 
quadruplicate. After, culture medium was used for explant metabolic viability assessment, 
using  alamarBlueâ or  kept  at -80ºC with a 1% prostaglandin stabilizer (0.3 M 
ethylenediaminetetraacetic acid (EDTA) and 1% aspirin, No. A2093; Sigma) (Szóstek et al., 
2014) for further prostaglandins analysis. Endometrial explants were maintained in cryotubes 
with RNAlaterâ at -80ºC, for gene transcription studies. 
 
5.3.4. Endometrial tissues viability assay  
AlamarBlueâ(AB) (DAL1100; ThermoFisher Scientific) was used to assess endometrial 
explants metabolic viability, as described (Carranza-Torres et al., 2015). Briefly, 10% of AB 
was added to fresh (non-incubated), to 24h incubated explants treated with NETs proteases or 
to not treated (negative control), as well as to culture medium. They were further incubated 
for 4 h in the same conditions described in 5.3.3. From each of those samples, 100 µL of 
medium was harvested and fluorescence values analyzed under a fluorometer microplate 
reader (Synergy H1 Hybrid Reader, BioTek; Gene 5 software) at 560 nm excitation/590 nm 
emission wavelengths. Viability of endometrial explants was obtained by calculating the 
percentage (%) of AB reduction per cell (Carranza-Torres et al., 2015).  
In addition, since PGF2a response of non-treated and OXT-treated endometrial explants 
suggests that the endometrial explants contain functional cells (Nash et al., 2008), PGF2a out-
put was used to assess functional capacity of incubated tissues (Nash et al., 2008). In addition, 
PGE2 secretion response of non-treated and OXT-treated explants was also used as its 
functional capacity, as described in mare endometrial cells (Szóstek et al., 2014). 
 
5.3.5. Gene transcription study  
Real time PCR studies of endometrial explants were performed as previously described 
(Rebordão et al., 2017a). Total RNA was isolated with Total RNA Extraction and Purification 
kit (28704; Qiagen, Hilden, Germany), with a DNA-digestion step included (RNase-free 
DNase Set; 50979254; Qiagen), according to the manufacturer instructions. Its quality was 
assessed by visualization of 28S and 18S rRNA bands by electrophoresis on 1,5% agarose gel, 
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after RNA quantification with Nanodrop system (ND200C; Fisher Scientific, Hampton, PA, 
USA). Using a Reverse Transcriptase Superscript III enzyme (18080093; Invitrogen, GIBCO 
BRL, Carlsbad, CA, USA) from 1 mg total RNA in a 20 µL reaction volume using oligo(dT) 
primer (27-7858-01; GE Healthcare, Buckinghamshire, UK) cDNA was generated. The 
sequences for equine microsomal prostaglandin E synthase (PTGES), PGE2 receptor 2 
(EP2), PGE2 receptor 4 (EP4) and ribosomal protein L32 (RPL32) primers were design using 
program Primer-3 (Untergasser et al., 2012) and Primer Premier software (Premier Biosoft 
Interpairs, Palo Alto, CA, USA), which are shown in table 6. In a preliminary study RPL32 
has been found to be the most stable internal control gene and was used as reference gene 
(Rebordão et al., 2018). Transcription of mRNA of both target and reference genes, was 
performed simultaneously in duplicate 13 µL reaction volume (3.5 µL water, 1 µL cDNA; 
1µL forward primer, 1 µL reverse primer and 6.5 µL Power SYBER Green Master Mix- 
4367659; Applied Biosystems), in StepOnePlus™ Real-Time PCR System (Applied 
Biosystems, Warrington, UK). Thermocycler program was run for all genes as follows: initial 
denaturation (10 min at 95ºC), followed by 40 cycles of denaturation (15 s at 95ºC) and 
annealing (1 min at 60ºC), followed by a dissociation step (15 s at 95ºC, 30 s at 60ºC and 15 s 
at 95ºC). An electrophoresis on 2,5% agarose gel was run to confirm the specificity of the 
product. Quantification of relative mRNA data was done by real-time PCR miner algorithm 
(Zhao & Fernald 2005). Relative mRNA transcription of control samples was compared with 
treated explants data. 
 
Table 6- Primer sequences used for EP2, EP4 and PTGES real time PCR analysis of mare 
endometrial explants. 
 
EP2- prostaglandin E receptor 2; EP4- prostaglandin E receptor 4; PTGES-microsomal prostaglandin 
E synthase1; RPL32- ribosomal protein L32. 
 
5.3.6. Progesterone and prostaglandins analysis  
The concentrations of P4 in plasma were determined by solid-phase Radioimmunoassay 
(RIA), without extraction, as previously described (Rebordão et al., 2017a). Using a 
 
Rebordão et al.  
 












Forward: CTCCCTGGTGGTGCTCATCT 219 Reverse: CGGCAGAAGAGGCATTTGAT 
PTGES  
 (NM_001081935.1) 





144 Reverse: GTCAATGCCTCTGGGTTTCC 
EP2- prostaglandin E receptor 2; EP4- prostaglandin E receptor 4; PTGES-microsomal prostaglandin 
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commercial kit (Coat-A-Count; Diagnostic Product Corporation, Los Angeles, CA, USA), 
duplicate plasma P4 samples were measured under a Wallac (wizard 1470) counter, in a 
single assay. The limit of detection of the assay was 0.02 ng/mL and the intra-assay 
coefficient of variation for all samples was 3.4%. To help identify estrous cycle phase of the 
mares, plasma P4 concentrations were used. Were considered to be in the MLP all mares with 
plasma P4 values >6ng/mL, and in the FLP, mares with P4 concentrations <1ng/mL (Roberto 
da Costa et al., 2007). 
Prostaglandin F2a in culture medium as a means to assess functional capacity of incubated 
tissues (Nash et al., 2008) was measured by direct enzyme immunoassay (EIA), as previously 
described (Szóstek et al., 2014). Standard curve for PGF2𝛼 ranged from 0.19ng/mL to 
50ng/mL and the intra- and inter-assay coefficients of variation were on average 8.5% and 
10.7%, respectively.  
The concentration of PGE2 in conditioned culture medium of each sample was measured in 
duplicate using Prostaglandin E2 EIA kit (PGE high sensitivity ELISA kit; Catalog nº ADI-
931-001; Enzo Life Sciences), according to the manufacturer instructions. The detection limit 
of PGE2 was 8.26 pg/mL. Standard curve for PGE2 ranged from 0.039 pg/mL to 100 pg/mL, 
and the concentration at 50% binding (ED50) was 6.25 pg/mL. The intra- and inter-assay CV 
were 6.1% and 12.8%, respectively. Hormone concentrations in culture media were 
normalized for mg of endometrium. 
 
 
5.3.7. Statistical analysis  
 
GraphPAD PRISM (Version 5.00, GraphPad Software, San Diego, CA, USA) was used to 
analyze data. Statistical tests included Student’s t-test for PGF2α or PGE2 secretion data of 
non-treated and oxytocin-treated endometrial explants data. One-way analysis of variance 
(ANOVA) followed by Dunnett post-hoc test was used to compare the results of endometrial 
explants viability and data regarding relative mRNA transcription and prostaglandin 
production of control and treated explants. Group of endometrium categories or estrous cycle 
phases influence was analyzed by Two-way ANOVA, followed by Bonferroni multiple 
comparison test among means. Results were expressed as mean ± S.D. A P value less than 
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5.4. Results 
5.4.1. Viability of endometrial explants  
Endometrial explants persisted viable after 24h incubation, since no differences were noted in 
% of AB reduction between fresh tissues (non-incubated; 98.1± 1.2%) and incubated control 
(non-treated) explants (94.94± 3.9%) (P > 0.05). Similar results were found in the % of 
difference in AB reduction between explants subjected to different concentrations of ELA 
(0.5 µg/mL= 94.62% or 1 µg/mL= 95.05%±7.5), MPO (0.1 µg/mL = 97.79%±14.7 or 0.5 
µg/mL= 97.26%±12.3) or CAT (0.1 µg/mL= 95.52%±7.1 or 1 µg/mL = 98.7%±10.6) and 
non-treated control tissues after 24h incubation (P > 0.05). In addition, PGF2α and PGE2 
secretion by endometrial explants after incubation with OXT (PGF2α: 9.882±4.6 ng/mg; 
PGE2: 8.6±5.7 pg/mg) was increased when compared with incubated non-treated tissues 
(PGF2α: 4.4±2.7 ng/mg; PGE2: 4.0±3.1pg/mg) (P < 0.05), which confirms that the 
endometrial explants contain functional endometrial cells. Thus, these results indicate that 
viability of endometrial explants was maintained in the first 24h of culture, since sustained 
high metabolic activity and enhanced prostaglandin secretion were observed during this time 
period.  
 
5.4.2. NETs proteases on PGE2 pathway in mare endometrium  
Since PGE2 is known to be an anti-fibrotic mediator exerting this effect mainly via two types 
of prostanoid receptors, we have investigated if NETs proteins could be related to PGE2 
pathway, by studying PGE2 production and gene expression of PTGES and its EP2 and EP4 
receptors. 
 
5.4.2.1. Follicular phase type I/IIA endometrium explants  
In type I/IIA mare endometrial explants obtained from FLP, no effects were noted in PTGES 
transcripts for any of the treatments (Fig. 24.1). However, after incubation with the lowest 
concentration of ELA, an up-regulation of EP2 gene transcription was noted (P < 0.05; Fig. 
24.2). Moreover, increased EP4 gene transcription resulted after incubation of this same type 
of tissue with the highest concentrations of ELA (P < 0.01) or CAT (P < 0.05) (Fig. 24.3). 
Although PGE2 production increased with the positive control OXT (P < 0.01), no differences 
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5.4.2.2. Follicular phase type IIB/III endometrium explants  
In FLP type IIB/III mare endometrium explants, PTGES transcripts did not change with any 
of NETs proteases treatments, but increased with OXT (P < 0.01; Fig. 24.5). In respect to 
EP2 gene, incubation with the highest concentration of ELA, lowered its gene transcription (P 
< 0.05; Fig. 24.6). However, an up-regulation of EP4 transcripts was observed with both 
concentrations of ELA (P < 0.05), MPO (0.5 µg/mL, P < 0.05) and CAT (0.1 µg/mL, P < 
0.05) (Fig. 24.7). Impaired PGE2 production was observed, throughout the whole 
experimental period (Fig. 24.8), regardless of NETs proteins, except with OXT that increased 
PGE2 synthesis (P < 0.05). 
 
 
Figure 24- Relative transcription of PGE2 synthase (PGES) (1, 5, 9, 13), PGE2 receptors 2 
(EP2) (2, 6, 10, 14), or 4 (EP4) (3, 7, 11, 15) genes or PGE2 production (4, 8, 12, 16), by 
endometrial explants after incubation with different concentrations of NETs components. N=5 
samples from each group- I/IIA and IIB/III, for each estrous cycle phase. Bars represent 
mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P < 0.01; *** P < 
0.001). CAT- cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 
or 1 µg/mL); FLP- follicular phase; MLP- mid-luteal phase; MPO- myeloperoxidase (0.1 or 
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5.4.2.3. Mid-luteal phase type I/IIA endometrium explants  
Incubation of MLP type I/IIA endometrial explants with the lowest doses of ELA and MPO, 
was associated with up-regulation of PTGES gene transcription (P < 0.05; Fig. 24.9). While 
there were no differences in EP2 gene transcription (Fig. 24.10), decreased EP4 transcripts 
were seen in explants incubated with the lowest studied concentrations of MPO (P < 0.05; 
Fig. 24.11).  Likewise, the highest concentrations of ELA or CAT were associated with 
diminished PGE2 production (P < 0.05; Fig. 24.12). 
 
5.4.2.4. Mid-luteal phase type IIB/III endometrium explants  
 
In MLP type IIB/III endometrium decreased PTGES occurred after incubation with both 
concentrations of ELA (P < 0.05; Fig. 24.13). Exposure to the highest concentration of ELA, 
the lowest concentration of MPO and both doses of CAT, up-regulated EP2 (P < 0.05; Fig. 
24.14). Both tested doses of ELA or CAT increased EP4 genes transcription (P < 0.05; Fig. 
24.15). Nevertheless, decreased PGE2 synthesis was seen in the presence of all NETs proteins 
(P < 0.05), except with the highest tested concentration of ELA (Fig. 24.16). 
 
5.4.3. Endometrial category influences PGE2 pathway 
 
The influence of endometria type groups (I/IIA vs. IIB/III) on the effect of NETs components 
in putative PGE2 pathway was evaluated. This analysis was performed comparing the same 
treatments in the same estrous cycle phase (FLP or MLP).  
 
5.4.3.1. Type I/IIA vs. IIB/III endometrium in follicular phase  
 
No differences between endometrial categories in the follicular phase, on PTGES, EP2 or 
EP4 transcripts and PGE2 production were detected, regardless of the type or concentrations 
of NETs proteases (data not shown). 
 
5.4.3.2. Type I/IIA vs. IIB/III endometrium in mid-luteal phase  
Up-regulation of PTGES transcripts was observed in type I/IIA endometria after incubation 
with the lowest concentrations of ELA and MPO (P < 0.05; Fig. 25.1). In contrast, in type 
IIB/III endometria, higher EP2 (P < 0.05; Fig. 25.2) or EP4 gene expression was observed 
when tissues were incubated, for 24h, with the highest dose of ELA (P < 0.001), the lowest 
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concentration of MPO (P < 0.05) and CAT (P < 0.01; Fig. 25.3), compared with type I/IIA 
group. No differences between endometria type groups were observed in PGE2 synthesis, 
regardless of NETs proteins tested (Fig. 25.4). 
 
Figure 25- Effect of endometrial category (type I/IIA vs. type IIB/III) on PGE2 synthase 
(PGES), PGE2 receptors 2 or 4 (EP2; EP4) genes transcription or PGE2 production by 
endometrial explants incubated with different concentrations of NETs components. N=5 
samples from each group- I/IIA and IIB/III in MLP. Bars represent mean±S.D. Asterisks 
indicate significant differences (* P < 0.05; ** P < 0.01; *** P < 0.001). CAT- cathepsin G 
(0.1 or 1 µg/mL); CONT- non-treated tissues; ELA- elastase (0.5 or 1 µg/mL); FLP- follicular 
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5.4.4. Estrous cycle phase influences PGE2 putative anti-fibrotic pathway  
The influence of different phases of mare estrous cycle (FLP vs. MLP), on the effect of NETs 
components in PGE2 pathway was also analyzed. This evaluation was done in the same 
endometria types (I/IIA or IIB/III), comparing the same treatments. 
5.4.4.1. Follicular phase vs. mid-luteal phase in type I/IIA endometria 
Estrous cycle phases had no effect on PTGES or EP2 mRNA gene expression, regardless of 
NETs proteins tested (Fig. 26.1; 26.2). However, enhanced gene transcription of EP4 was 
detected in FLP endometria, treated with the highest concentrations of ELA (P < 0.01) and 
CAT (P < 0.05); (Fig. 26.3), compared to MLP tissues. In addition, no differences between 
estrous cycle phases were noted in PGE2 synthesis, regardless of NETs proteins tested (Fig. 
26.4). 
 
Figure 26- Effect of estrous cycle phase (follicular phase vs. mid-luteal phase) on PGE2 
synthase (PGES) (1, 5), PGE2 receptors 2 (EP2) (2, 6), or 4 (EP4) (3, 7) genes transcription 
or PGE2 production (4, 8), by endometrial explants incubated with different concentrations of 
NETs components. N=5 samples from each group- I/IIA and IIB/III of each estrous cycle 
phase. Bars represent mean±S.D. Asterisks indicate significant differences (* P < 0.05; ** P 
< 0.01; *** P < 0.001). CAT- cathepsin G (0.1 or 1 µg/mL); CONT- non-treated tissues; 
ELA- elastase (0.5 or 1 µg/mL); FLP- follicular phase; MLP- mid-luteal phase; MPO- 
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5.4.4.2. Follicular phase vs. mid-luteal phase in type IIB/III endometria 
When comparing FLP with MLP in tissues with severe fibrotic lesions, no difference was 
detected in PTGES gene transcription when challenged with any of NETs proteases tested 
(Fig. 26.5). However, in MLP, increased EP2 transcripts were seen when endometria were 
challenged with the highest concentration of ELA (P < 0.001) and CAT (P < 0.05), compared 
to FLP (Fig. 26.6). Likewise, increased EP4 transcripts was seen in MLP endometria treated 
with the highest concentration of ELA (P < 0.05) or with the lowest concentration of MPO 
with respect to FLP (P < 0.05; Fig. 26.7). No differences between estrous cycle phases were 
observed in PGE2 synthesis, regardless of NETs proteins (Fig. 26.8). 
5.5. Discussion  
To the best of our knowledge, this is the first report that describes the in vitro effect of NETs 
proteases on equine endometrium PGE2 production. Presence of bacteria or semen within the 
mare uterus stimulates in loco production of PGE2 and other arachidonic acid metabolites, 
which is followed by increased vascular permeability that enables PMN infiltration into the 
uterine lumen (LeBlanc & Causey, 2009). In the present study, a putative involvement of 
PGE2 pathway as a protective mechanism against fibrogenesis should be considered. In FLP 
type I/IIA endometria subjected to the lowest concentration of ELA, enhanced EP2 gene 
transcription was simultaneous with no differences in COL1 production (Rebordão et al., 
2018), suggesting that EP2 might have an anti-fibrotic effect. Nevertheless, in endometria 
with severe fibrotic changes (type IIB/III), NETs proteases, mainly ELA and CAT, impaired 
PGE2 production in both phases of the estrous cycle. Likewise, a decrease in in vitro basal 
secretion of PGE2 in equine category III endometrium compared to category I has been 
referred (Szóstek et al., 2012). This might be a favorable condition for endometrosis 
establishment in mares considered susceptible to endometritis.  
Interestingly, three recent reports recognized PGE2 as an endogenous physiological inhibitor 
of NETs release through EP2 signaling (Marey et al., 2014; Shishikura et al., 2015; Domingo-
Gonzalez et al., 2016). It was proposed that PMN have a universal feature that consists of 
NETs inhibition by PGE2 signaling, and that PGE2 can inhibit NETs production itself 
(Domingo-Gonzalez et al., 2016). Therefore, this role of PGE2 appears to be directly related 
to its EP2-EP4 mediated anti-inflammatory and anti-fibrotic effects and might be a 
mechanism of protection against chronic diseases development. In the mare, based on our 
data, PGE2 anti-fibrotic effect appears to be mediated by EP2 receptor. This is in agreement 
with work on lung fibrosis where EP2 has been shown to be responsible for PGE2 anti-
fibrotic effects (Huang et al., 2010; Kach et al., 2014; Wei et al., 2014). Our results suggest 
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that in mare endometrium, EP4 does not seem to have a protective effect against fibrosis. This 
is in contrast with the protective roles of endogenous PGE2-EP4 signaling against cardiac 
fibrosis (Ishiwata et al., 2013; Wang et al., 2017) and renal fibrosis (Nakagawa et al., 2012). 
Down-regulation of EP4 gene transcription was detected in FLP type IIB/III and MLP type 
I/IIA groups, without any change in COL1 production (Rebordão et al., 2018). Furthermore, 
enhanced COL1 protein (Rebordão et al., 2018) was associated with up-regulation of EP4 
transcripts in FLP type I/IIA groups. Besides, EP4 gene transcription does not appear to be 
estrous cycle phase-dependent, since increased EP4 transcripts were detected in all studied 
endometrial types under NETs proteases action. This effect is probably related to EP4 
physiological expression during the estrous cycle, since its gene expression is not affected by 
endocrine cyclic changes (Atli et al., 2010). 
As increased COL1 formation in severe endometrosis (Rebordão et al., 2018), and low EP2 
transcripts were only seen in FLP endometria challenged with the highest dose of ELA, this 
may be involved in the mechanism of fibrogenesis in this type of endometrium.  Under 
physiological conditions, it is in the mid-luteal phase that there is an increase of EP2 
transcripts in mare endometrium (Atli et al., 2010; Gebhart et al., 2012). Thus, this may be 
the reason why decreased endometrial EP2 gene expression was only detected in follicular 
phase. So, under physiological conditions, FLP endometrium may be more prone to develop 
fibrosis in the presence of a pro-fibrotic injury, due to a diminished capacity to synthetize this 
anti-fibrotic mediator. Also, in MLP endometrium with minimum or mild pathological 
alterations (type I/IIA), PGE2 pathway might trigger fibrogenesis, due to the suppression of 
PGE2 anti-fibrotic action. High COL1 production induced by ELA and CAT in these types of 
tissues (Rebordão et al., 2018) was associated with impaired PGE2 production throughout the 
experimental period, without any changes in the other PGE2 pathway mediators studied. 
Since PGE2 might prevent fibroblast differentiation through TGF-β1 inhibition (Bozyk & 
Moore; 2011), we hypothesize that impaired PGE2 synthesis may provoke mare endometrial 
fibrogenesis. 
In mare endometrium explants, stimulated with NETs proteases, a decrease in PGE2 
production was observed. Exposure of human bronchial epithelial cells (HAEC) to ELA, 
increased PGE2 release within 10 min of incubation and peaked at 3 h, starting to decline 
thereafter (Perng et al., 2003).  It was suggested that this might represent a natural defense 
mechanism of the airways to regulate local inflammation (Perng et al., 2003). Also in the 
mare, in inflamed uteri, increased secretion of PGE2 has been reported (Gajos et al., 2014). 
Since increase of PGE2 may inhibit PMN phagocytosis and NETs release (Marey et al., 2014; 
Shishikura et al., 2015; Domingo-Gonzalez et al., 2016), this might lead to persistence of 
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both inflammation and NETs. Nevertheless, despite an initial release of PGE2 with local anti-
inflammatory properties, a later impairment in PGE2 release occurs in fibrotic lungs (Bozyk 
& Moore, 2011). This is in agreement with our in vitro data on mare endometrial explants 
where a fall in PGE2 was detected. In the fibrotic lung, multiple mechanisms are responsible 
for PGE2 loss, like soluble mediators and epigenetics (Bozyk & Moore, 2011). Injury to lung 
epithelial cells by pro-fibrotic mediators provokes the release of chemokine CCL2 and 
diminished PGE2 production, triggering fibrogenesis (Moore et al., 2003).  
In the mare, the intrauterine administration of PGE2 causes an increase in uterine tone and 
contractility (Troedsson et al., 1995; Volkmann et al., 1995; Gastal et al.,1998). Based on our 
in vitro results, with impaired PGE2 release by endometrial explants challenged with NETs 
proteases, we might speculate that in vivo NETs persistence in mare uterine lumen may lead 
to impaired PGE2 production. This possibly contributes for impaired physical clearance, 
which is the main factor involved in susceptibility to persistent endometritis (LeBlanc & 
Causey, 2009). However, this hypothesis needs further confirmation with in vivo trials. 
In conclusion, our results suggest that PGE2 may have a protective role against mare 
endometrial fibrosis, mainly mediated by its receptor EP2 but not EP4. Once fibrosis is an 
extremely complex condition, other pathways rather than PG, such as pro-fibrotic cytokines 
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Steroid hormones, prostaglandins and oxytocin are important hormones that dictate different 
physiological events in female reproductive tract, namely in the uterus. Nevertheless, some of 
them may have dual and antagonistic effects depending on the endometrial endocrine 
environment. In addition, these hormones may, in specific situations, be involved in the 
development of pathologies, like the development of endometrial fibrosis in the mare. In the 
endometrium, endocrine environmental changes modify the cross-talk between the different 
cells which may modulate the type of response of this tissue to the same type of stimulus. An 
example of this is the action of OXT. While it has a pro-luteolytic effect between days 10 and 
15 after ovulation, it acts as an anti-luteolytic factor during mid-luteal phase (Rebordão et al., 
2016; Vanderwall et al., 2016). This latter effect is the base of its use as a method to prolong 
luteal function and suppress estrous behavior in the mare.  
In the first part of our work the aim was to evaluate if chronic OXT administration to mares in 
mid-luteal phase would be able to prolong luteal function by modulating PG pathways, steroid 
hormones and OXT receptors in the endometrium. Since we sought to compare mid-luteal 
phase endometrial conditions prior to luteolysis with conditions following failed luteolysis 
induced by OXT administration, endometrial expression studies were performed in day 10 
mid-diestrus in control mares and in day 24 in prolonged CL mares. Besides, as pregnancy 
maintenance requires the inhibition of the luteolytic mechanism during late diestrus, this 
physiological state could perhaps serve as a model for the mechanism by which luteal 
maintenance is achieved in the absence of conception. Our work suggests that administration 
of exogenous OXT on days 7 to 14 after ovulation is an effective method of disrupting 
luteolysis to prolong CL function, as previously reported (Vanderwall et al., 2007; 2012; 
Keith et al., 2013; Vanderwall et al., 2016). Administration of OXT to mares in mid luteal 
phase was able to block luteolysis and extend the luteal phase in 67% (4/6 mares) treated 
mares. Prolonged luteal function associated with chronic OXT treatment seems to be related 
to increased and different spatial expression of OXTR and PGR in the endometrium. The 
detection of increased PGR protein in luminal and glandular epithelium in the OXT-treated 
group differs from the results obtained in earlier studies with prolonged luteal function in 
mares, as in diestrus and early pregnancy, wherein PGR was not detected in luminal 
epithelium (Hartt et al., 2005; Silva et al., 2014). Also, in OXT treated mares, increased 
endometrial OXTR protein expression was found in stromal cells. Since an initial up-
regulation of OXTR in the luminal epithelium is needed to trigger luteolysis (Ruijter-Villani 
et al., 2015), chronic OXT administration in mares might shift cell-specific expression of 
OXTR from luminal epithelium to stroma, leading to luteal maintenance. The observed 
reduction of endometrial ESR2 in OXT-treated mares may be responsible for the maintenance 
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of PGR in luminal and glandular epithelium. Decreased ESR2 may attenuate the 
transcriptional activity of ESR1 in the endometrium, which is responsible for down-regulation 
of PGR in luminal epithelium, as described in mouse uterus (Weihua et al., 2000). 
In the second part of this work, we postulate that some mares might fight bacteria that cause 
endometritis by inducing NETs release, since presence of bacteria or semen in the mare uterus 
induces an inflammatory state characterized by an influx of PMN to uterine lumen (LeBlanc 
& Causey, 2009; Cadario, 2014).  It was shown that human PMN were able to release their 
DNA in response to infectious stimuli and form neutrophil extracellular traps (NETs) that trap 
and kill bacteria (Brinkman et al. 2004). Also, in vitro studies revealed that in the presence of 
spermatozoa, equine PMN were also capable to induce NETs (Alghamdi & Foster, 2005, 
Alghamdi et al., 2009). Thus, we aimed to evaluated the capacity of equine PMN to produce 
NETs not only in vitro by chemical activation, or stimulated with Streptococcus equi 
subspecies zooepidemicus (Szoo), Escherichia coli (Ecoli) or Staphylococcus capitis (Scap) 
strains obtained from mares’ endometritis, but also in vivo in endometrial mucus from mares 
with bacterial endometritis. In this study, we were able to show that stimulated equine PMN 
are able to release NETs in the presence of specific Gram-positive and Gram-negative 
bacteria causing uterine infection in the mare, as for other PMN species and bacteria 
(Brinkman et al. 2004). Also, this study showed that bacteria causing mare endometritis were 
ensnared by NETs showing a direct contact between NETs and bacteria. Besides, the 
expression of histones, myeloperoxidase and neutrophil elastase in in-vivo NETs, suggested 
that they may have antimicrobial activity, as proposed for other bacteria and parasites 
(Brinkmann et al., 2004). 
Recently it has been referred that whenever NETs release is not physiologically controlled, 
NETs persistence can either fight disease but also can trigger tissue injury and cause disease 
themselves (Brinkmann & Zychlinsky, 2012; Corsiero et al., 2016; Nakazawa et al., 2017). 
Thus, in the third part of this work we postulated that persistence of NETs components may 
trigger a harmful effect on the endometrium leading to collagen deposition and fibrosis 
establishment in the mare. Endometrosis is a consequence of diverse insults that result in 
degenerative changes of the uterine glands and surrounding stroma, characterized by 
periglandular arrangement of myofibroblasts and deposition of extracellular matrix (ECM) 
(Kenney & Doig, 1986; Hoffmann et al., 2009a). The exact mechanisms behind endometrial 
fibrosis remains obscure. In the mare, persistent endometritis due to different injuries like 
microorganisms or semen, leading to chronic inflammation has been related with chronic 
degenerative changes of mare endometrium and related with fibrosis formation (Kenney, 
1978; Kenney & Doig, 1986; Ferreira-Dias et al., 1994, 1999; Ricketts & Troeddsson, 2007; 
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LeBlanc & Causey, 2009). Chronic endometrial inflammation/infection produces a uterine 
response characterized by mucus overproduction by epithelial cells, transudation of plasma 
proteins and an influx of immunoglobulins and PMN to uterine lumen (Cadario 2014). PMN 
release a number of chemical mediators, including oxygen-free radicals as they phagocytize 
bacteria and debris (LeBlanc & Causey, 2009). Persistence of these by-products of 
inflammation in uterine lumen for 48h, due to deficient uterine clearance, increases the 
likelihood of cell damage (LeBlanc & Causey, 2009). Also, the extracellular presence of 
PMN serine-proteases (like ELA, CAT and MPO) in other tissues than endometrium has been 
linked to an overwhelming inflammatory response and to the development of fibrosis in 
several human organs (Rudolph et al., 2010; Cantin et al., 2015; Pulli et al., 2015). 
Therefore, the propose was to address the in vitro effect of some NETs proteases (ELA, MPO 
or CAT) on mare’s endometrial capacity to form fibrosis. In this work, increased COL1 
production by endometrial tissues, characteristic of fibrosis was observed with all studied 
NETs proteins, although estrous cycle phase and/or endometrial category affected 
endometrial response to each specific NETs protease. Thus, the follicular phase, appears to be 
the stage at which the mare has increased risk of developing this pathology. Besides, 
endometrium with severe fibrotic lesions, bacterial attachment was significantly higher in the 
estrus phase of the cycle (Ferreira-Dias et al.,1994). Nevertheless, it is at this stage that open 
cervix and uterine contractions will contribute for uterine clearance of bacteria, inflammatory 
products and cellular debris (LeBlanc & Causey, 2009). However, ELA enhanced COL1 
production in all endometrial groups, regardless of estrous cycle phase. Our results are in 
agreement with those obtained by others, in which increased collagen production was 
observed when lung fibroblasts were treated in vitro with NETs (Chrysanthopoulou et al., 
2014). In the mare, after experimentally induced bacterial endometritis, a temporary 
activation of fibrotic stromal cells was seen, although no exacerbation of endometrosis during 
the 2-year period was detected (Hoffmann et al., 2009a). In another study with low 
correlation between inflammation and endometrosis grade, it was proposed that progression 
of the fibrotic process after a critical point becomes independent of inflammation, despite the 
presence of inflammation preceding endometrial fibrosis (Aresu et al., 2012). However, in a 
recent study, mares with closed cervix had larger accumulations of fluid and higher numbers 
of PMNs in uterine fluid and in all mares periglandular fibrosis scores increased during the 
experiment (Reilas et al., 2016). Although our in vitro data suggests that NETs involvement 
in chronic endometritis in the mare may act as putative endometrial fibrogenic mediators, 
further studies are required to confirm if in in vivo conditions the same might occur. 
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In the last two parts of this work we tried to address one of the multiple putative mechanisms 
involved in the extremely complex pathogenesis of mare endometrial fibrosis. In our study, 
increased levels of PGF2α synthesis, after ELA and CAT treatment were only detected in 
follicular phase type I/IIA group endometria and were associated with increased COL1 
protein. Nevertheless, enhanced COL1 and increased levels of FP gene transcription were 
detected in all types of follicular phase tissues after CAT treatment. Also in MLP type IIB/III 
explants higher FP transcripts were noted throughout the experimental period. Both of those 
conditions may trigger fibrogenesis in mare endometrium, since increased PGF2α acting on 
its receptor (FP) is capable to induce fibrogenesis in several systems Oga et al., 2009; Aihara 
et al., 2013; Ding et al., 2012; Kanno et al., 2013; Ding et al., 2014). In the mare, following 
the entrance of bacteria or semen into the uterus, recruitment of PMNs triggers the release of 
PGF2α that induces uterine contractions (Woodward & Troedsson, 2013). In mares 
predisposed to develop persistent endometritis (susceptible mares) have an increased number 
of PMN in the endometrium after breeding when compared with resistant mares (Woodward 
et al., 2013). Also, increased presence of PGF2α in susceptible mares has been related to the 
sustained inflammatory uterine environment in these mares (Cadario et al., 1999).  Likewise, 
in the mare target tissues seem to be exposed to higher concentrations of PGF2α for longer 
periods (Shrestha et al. 2012), and an endometrial PGF2α auto-amplification system seems to 
exist, in which PGF2α can stimulate its own production (Kozai et al., 2016).  This may 
contribute to sustained high levels of PGF2α in the follicular phase. Thus, we postulate that 
sustained high levels of PGF2α due to NETs-proteases persistence may trigger endometrial 
fibrosis formation. 
The hormone PGE2, signaling through EP2 and EP4, is known to be an anti-fibrotic mediator 
(Sokolova et al., 2005), although the subtype of receptor that is involved on this action seems 
to be tissue-dependent (Huang et al., 2010; Ishiwata, et al., 2013; Kach et al., 2014; Wei et 
al., 2014; Wang et al., 2016). Our results suggest that in mare endometrium, EP2 might be 
responsible for putative PGE2 anti-fibrotic effects. Impaired PGE2 (Vancheri et al., 2000; 
Sokolova et al., 2005; Moore et al., 2000) or EP2 receptor in tissues (Huang et al., 2010), 
prevents PGE2 from exerting its anti-fibrotic functions. In our study, impaired PGE2 
synthesis were noted in the endometrium of mares with moderate to severe lesions (type 
IIB/III), regardless of estrous cycle phase. Since increased COL1 formation and low EP2 
transcripts were only seen in FLP endometria challenged with the highest dose of ELA, this 
may be involved in the mechanism of fibrogenesis in this type of endometrium.  Under 
physiological conditions, it is in the mid-luteal phase that there is an increase of EP2 
transcripts in mare endometrium (Atli et al., 2010; Gebhart et al., 2012). Thus, this may be 
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the reason why decreased EP2 gene expression was only detected in follicular phase 
endometrium. So, under physiological conditions, FLP endometria may be more prone to 
develop fibrosis in the presence of a pro-fibrotic injury, due to a diminished capacity to 
synthetize this anti-fibrotic mediator. Also, in MLP endometria with minimum or mild 
pathological alterations (type I/IIA), PGE2 pathway might play a key role triggering 
fibrogenesis, due to a deletion of PGE2 anti-fibrotic action. High COL1 production induced 
by ELA and CAT in these types of tissues was associated with relatively impaired PGE2 
production throughout the experimental period, without any changes in the other PGE2 
pathway studied mediators and linked to low AKR1C3 or FP gene expression. Since PGE2 
seem to prevents TGF-β1 induced differentiation of fibroblasts to myofibroblasts, thereby 
playing a protective role in fibroblast differentiation (Bozyk & Moore; 2011), impaired PGE2 
synthesis may provoke endometrial fibrogenesis through TGF-β1 activation. 
Although our results suggest that PG may be involved in NETs protease-induced COL1 
formation in mare endometrium, as fibrosis is an extremely complex pathologic process, other 
vias besides prostaglandins pathways, such as pro-fibrotic cytokines may be involved.  
Moreover, further studies are needed to elucidate if putative fibrogenic PG may act through 
independent mechanisms.  
Although being one of the main subjects of research in mare reproductive research, the 
complete mechanisms that lead to endometrial fibrosis and its complex etiology remains to be 
fully elucidated. Our in vitro data suggest that NETs components might act as pro-fibrotic 
mediators in mare endometrium, even though an association between the development of 
endometrosis and endometrial chronic inflammation is a controversial topic. Further in vivo 
studies are needed in order to confirm that these proteases are increased in the uterus of mares 
with persistent endometritis. Although increased uterine MPO concentrations in cases of acute 
endometritis in the mare have been reported (Parrilla-Hernandez et al., 2014), there is no 
information in subclinical conditions nor studies on ELA and CAT. Understanding the causes 
and mechanisms that are involved in endometrial fibrosis development in the mare, may 
contribute not only to slow down the progression, but also to counteract this pathological 
process. Although fibrosis has been believed to be irreversible for a long time, many 
researchers also predicted reversibility of fibrosis because fibrosis can regress when the 
causative conditions are removed both in human patients and in rodent models (Seki & 
Brenner, 2015).  
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Conclusions 
The results obtained in this work offer new knowledge not only in the cellular and molecular 
mechanisms involved in OXT-induced luteal maintenance in the mare, but also in possible 
pathways involved in the development of mare endometrial fibrosis. Data analysis regarding 
these two issues allow us to draw the following conclusions: 
 
1. Administration of exogenous OXT on days 7 to 14 after ovulation is an effective 
method of disrupting luteolysis and prolonging luteal function in the mare. The 
different spatial expression of OXTR and PGR in the endometrium may be a 
mechanism by which chronic OXT enables CL persistence. The reduction of 
endometrial ESR2 may be responsible for the maintenance of PGR in luminal and 
glandular epithelium.  
2. Equine PMN are able to release NETs in the presence of bacteria that cause mare 
endometritis, both in vitro and in vivo, and might be a complementary mechanism by 
which mares can combat endometritis. 
3. Increased COL1, characteristic of fibrosis, was observed after in vitro incubation of 
endometrial explants with all NETs proteases, although endometrial response to each 
NETs protease depended on estrous cycle and/or endometrial category. Since elastase 
enhanced COL1 production, regardless of endometrial category or estrous cycle, this 
suggests that NETs persistence might be linked to mare endometrial fibrotic pathology.  
4. Enhanced synthesis of PGF2a and/or increased FP gene transcription were detected in 
follicular phase type I/IIA group endometria and were associated with increased COL1 
protein, both conditions associated to pro-fibrotic effects of PGF2a pathway. 
5. Increased COL1 formation and impaired PGE2 or EP2 transcripts observed in FLP 
type IIB/III endometria or in MLP endometria with minimum or mild pathological 
alterations (type I/IIA) challenged with the highest dose of ELA might have a key role 
triggering fibrogenesis, due to a deletion of PGE2 anti-fibrotic action. 
6. Follicular phase endometria may be more prone to develop fibrosis when triggered by a 
pro-fibrotic stimulus. It was at this stage that a reported pro-fibrotic association 
between both high PGF2a production and low EP2 transcripts under NETs proteases 
action was noted. 
7. NETs components induced changes on PG mediators may instigate PGF2α or PGE2 
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